
<html lang="en"     class="pb-page"  data-request-id="b6fc87a0-3ea3-4917-a76b-0d5d0d4b1f48"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b00672"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors" /></meta><meta name="dc.Creator" content="István  Szabadkai" /></meta><meta name="dc.Creator" content="Robert  Torka" /></meta><meta name="dc.Creator" content="Rita  Garamvölgyi" /></meta><meta name="dc.Creator" content="Ferenc  Baska" /></meta><meta name="dc.Creator" content="Pál  Gyulavári" /></meta><meta name="dc.Creator" content="Sándor  Boros" /></meta><meta name="dc.Creator" content="Eszter  Illyés" /></meta><meta name="dc.Creator" content="Axel  Choidas" /></meta><meta name="dc.Creator" content="Axel  Ullrich" /></meta><meta name="dc.Creator" content="László  Őrfi" /></meta><meta name="dc.Description" content="The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatmen..." /></meta><meta name="Description" content="The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatmen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00672" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00672" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00672" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00672" /></link>
        
    
    

<title>Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00672" /></meta><meta property="og:title" content="Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0024.jpeg" /></meta><meta property="og:description" content="The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatment of the disease. In this study we present a novel compound family that successfully targets the AXL kinase. Through optimization and detailed SAR studies we developed low nanomolar inhibitors, and after further biological characterization we identified a potent AXL kinase inhibitor with favorable pharmacokinetic profile. The antitumor activity was determined in xenograft models, and the lead compounds reduced the tumor size by 40% with no observed toxicity as well as lung metastasis formation by 66% when compared to vehicle control." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00672"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00672">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00672&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00672&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00672&amp;href=/doi/10.1021/acs.jmedchem.8b00672" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6277-6292</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00661" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00704" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">István Szabadkai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">István Szabadkai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vichem Chemie Research Ltd., Budapest 1022, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Istv%C3%A1n++Szabadkai">István Szabadkai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Torka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Torka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Physiological Chemistry, University Halle-Wittenberg, Halle (Saale) 06108, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Torka">Robert Torka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rita Garamvölgyi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rita Garamvölgyi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vichem Chemie Research Ltd., Budapest 1022, Hungary</div><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Semmelweis University, Budapest 1092, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Garamv%C3%B6lgyi">Rita Garamvölgyi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ferenc Baska</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ferenc Baska</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vichem Chemie Research Ltd., Budapest 1022, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ferenc++Baska">Ferenc Baska</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pál Gyulavári</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pál Gyulavári</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest 1094, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=P%C3%A1l++Gyulav%C3%A1ri">Pál Gyulavári</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sándor Boros</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sándor Boros</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vichem Chemie Research Ltd., Budapest 1022, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A1ndor++Boros">Sándor Boros</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eszter Illyés</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eszter Illyés</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vichem Chemie Research Ltd., Budapest 1022, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eszter++Illy%C3%A9s">Eszter Illyés</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Axel Choidas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Axel Choidas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Lead Discovery Center GmbH, Dortmund 44227, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Axel++Choidas">Axel Choidas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Axel Ullrich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Axel Ullrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Biology, Max Planck Institute of Biochemistry, Martinsried 82152, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Axel++Ullrich">Axel Ullrich</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">László Őrfi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">László Őrfi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vichem Chemie Research Ltd., Budapest 1022, Hungary</div><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Semmelweis University, Budapest 1092, Hungary</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +36-30-2316885. Fax: +36-1-4872081. E-mail: <a href="/cdn-cgi/l/email-protection#1c736e7a7532707d6f6670735c6c747d6e717d326f79717179706b79756f316972756a327469"><span class="__cf_email__" data-cfemail="402f3226296e2c21333a2c2f00302821322d216e33252d2d252c372529336d352e29366e2835">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=L%C3%A1szl%C3%B3++%C5%90rfi">László Őrfi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6149-2385" title="Orcid link">http://orcid.org/0000-0001-6149-2385</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00672&amp;href=/doi/10.1021%2Facs.jmedchem.8b00672" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6277–6292</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 April 2018</li><li><span class="item_label"><b>Published</b> online</span>21 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00672" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00672</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6277%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIstv%25C3%25A1n%2BSzabadkai%252C%2BRobert%2BTorka%252C%2BRita%2BGaramv%25C3%25B6lgyi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.8b00672%26title%3DDiscovery%2Bof%2BN-%255B4-%2528Quinolin-4-yloxy%2529phenyl%255Dbenzenesulfonamides%2Bas%2BNovel%2BAXL%2BKinase%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6292%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00672"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1799</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00672" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;István&quot;,&quot;last_name&quot;:&quot;Szabadkai&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Torka&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Garamvölgyi&quot;},{&quot;first_name&quot;:&quot;Ferenc&quot;,&quot;last_name&quot;:&quot;Baska&quot;},{&quot;first_name&quot;:&quot;Pál&quot;,&quot;last_name&quot;:&quot;Gyulavári&quot;},{&quot;first_name&quot;:&quot;Sándor&quot;,&quot;last_name&quot;:&quot;Boros&quot;},{&quot;first_name&quot;:&quot;Eszter&quot;,&quot;last_name&quot;:&quot;Illyés&quot;},{&quot;first_name&quot;:&quot;Axel&quot;,&quot;last_name&quot;:&quot;Choidas&quot;},{&quot;first_name&quot;:&quot;Axel&quot;,&quot;last_name&quot;:&quot;Ullrich&quot;},{&quot;first_name&quot;:&quot;László&quot;,&quot;last_name&quot;:&quot;Őrfi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6277-6292&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00672&quot;},&quot;abstract&quot;:&quot;The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatment of the disease. In this study we present a novel compound family that successfully targets the AXL kinase. Through optimization and detailed SAR studies we developed low nanomolar inhibitors, and after further biological characterization we identified a potent AXL kinase inhibitor with favorable pharmacokinetic profile. The antitumor activity was determined in xenograft models, and the lead compounds reduced the tumor size by 40% with no observed toxicity as well as lung metastasis formation by 66% when compared to vehicle control.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00672&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00672" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00672&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00672" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00672&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00672" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00672&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00672&amp;href=/doi/10.1021/acs.jmedchem.8b00672" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00672" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00672" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00672%26sid%3Dliteratum%253Aachs%26pmid%3D29928803%26genre%3Darticle%26aulast%3DSzabadkai%26date%3D2018%26atitle%3DDiscovery%2Bof%2BN-%255B4-%2528Quinolin-4-yloxy%2529phenyl%255Dbenzenesulfonamides%2Bas%2BNovel%2BAXL%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D6277%26epage%3D6292%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatment of the disease. In this study we present a novel compound family that successfully targets the AXL kinase. Through optimization and detailed SAR studies we developed low nanomolar inhibitors, and after further biological characterization we identified a potent AXL kinase inhibitor with favorable pharmacokinetic profile. The antitumor activity was determined in xenograft models, and the lead compounds reduced the tumor size by 40% with no observed toxicity as well as lung metastasis formation by 66% when compared to vehicle control.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="AbbrevInfo"><span><h4></h4></span><span><p class="first last">The full names of abbreviated kinases mentioned in the manuscript can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information, Table S4 (page S154)</a>.</p></span></div></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Receptor tyrosine kinases (RTKs) are transmembrane proteins, linking the extra- and intracellular environment. As mediators of signal transduction, they play a major role in normal cellular processes, including differentiation, proliferation, adhesion, migration, apoptosis, and metabolism.</div><div class="NLM_p">A subfamily of mammalian RTKs is called TAM family, including AXL, MER, and TYRO-3. AXL was originally identified in chronic myelogenous leukemia (CML)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and chronic myeloproliferative disorder.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Subsequently, its overexpression has been reported in many human cancers, comprising breast, lung, prostate, colon, esophageal, liver, and others, which have been reviewed by Paccez et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">AXL can primarily be stimulated by Gas6 (Growth arrest-specific 6).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As a result of the activation of AXL kinase, various signaling pathways can be activated, such as phosphoinositide 3-kinase (PI3K), including AKT, S6K,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> or NF-κB<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> as downstream targets, mitogen-activated protein kinase (MAPK) pathway,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> or signal transducer and activator of transcription (STAT).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Aberrant regulation of Gas6/AXL signaling contributes to cell proliferation, increased cell survival, migration, and angiogenesis;<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> therefore they play an important role in oncogenic transformation, metastasis, and tumor growth. AXL may be a biomarker of resistance in targeted therapy-resistant cancers.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">According to its central role in neoplastic processes, the AXL signaling pathway represents a notable molecular therapeutic target in the fight against cancer. A number of agents inhibiting the biological activity of AXL has been described in the literature (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), e.g., amuvatinib (MP-470) (<b>1</b>),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> bosutinib (SKI-606) (<b>2</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> foretinib (XL880) (<b>3</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> BMS-777607 (<b>4</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> cabozantinib (XL184) (<b>5</b>),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> or S49076 (<b>6</b>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, most of these small molecule kinase inhibitors were developed against other targets, such as cKIT, SRC/ABL, c-MET, or VEGFR-2. The first selective inhibitor developed purposely to target AXL kinase was compound R428 (<b>7</b>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of reported small-molecule tyrosine kinase inhibitors exhibiting activity against AXL kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have applied Vichem’s Nested Chemical Library technology<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> to discover hit compounds against AXL kinase. As we previously reported, bosutinib (<b>2</b>) was found to inhibit the AXL kinase activity in a dose dependent manner, with an IC<sub>50</sub> of 0.56 μM.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The 4-phenoxyquinoline derivative (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) Ki8751 (<b>8</b>) was originally developed by Kubo et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as a VEGFR-2 tyrosine kinase inhibitor. Since structural similarity can be found between bosutinib (<b>2</b>) and Ki8751 (<b>8</b>), it was practical to determine the AXL kinase inhibitory effect of Ki8751 (<b>8</b>), which was found to be even better (IC<sub>50</sub> = 0.30 μM) than that of bosutinib (<b>2</b>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of an <i>N</i>-phenyl-<i>N</i>′-{4-(4-quinolyloxy)phenyl}urea derivative.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this manuscript, we present a novel <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamide series we have designed to target AXL kinase and describe their synthesis, biological activity, and structure–activity relationships.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemical Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemical synthesis procedures are described in detail in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information</a>. The <i>N</i>-[4-(6,7-dimethoxyquinolin-4-yloxy)phenyl]benzenesulfonamide derivatives (<b>12a</b>–<b>u</b>) were prepared according to the general synthetic route shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-[4-(6,7-Dimethoxyquinolin-4-yloxy)phenyl]benzenesulfonamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-nitrophenols, chlorobenzene, DIPEA, reflux, 2 days; (b) Zn, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, reflux, 3 h; (c) benzenesulfonyl chlorides, pyridine, rt, 2 days.</p></p></figure><div class="NLM_p">The starting material (4-chloro-6,7-dimethoxyquinoline, <b>9</b>) was commercially available. This compound was coupled with various 4-nitrophenols by heating them in chlorobenzene, in the presence of <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA). The isolated 4-(4-nitrophenoxy)quinoline compounds (<b>10a</b>–<b>g</b>) were reduced by zinc powder and ammonium chloride in ethanol/water mixture at reflux temperature. The coupling reaction of the anilines (<b>11a</b>–<b>g</b>) with benzenesulfonyl chlorides in pyridine provided the corresponding sulfonamide derivatives (<b>12a</b>–<b>u</b>).</div><div class="NLM_p">In order to introduce alkoxy side chains containing amino or ester groups into the positions 6 and 7 of the quinoline ring, protection of the hydroxyl group is required. The general synthetic route for the preparation of these compounds is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-[4-(Substituted-quinolin-4-yloxy)phenyl]benzenesulfonamide Derivatives Bearing a Side Chain (R<sup>7</sup>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-nitrophenols, chlorobenzene, reflux, 2 days; (b) 33% HBr solution, rt, 2 h; (c) alkyl halogenides, acetonitrile, Cs<sub>2</sub>CO<sub>3</sub>, KI, rt, 45 min, then reflux 3 h; (d) Zn, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, reflux, 3 h; (e) benzenesulfonyl chlorides, pyridine, 60 °C, 3 days, (f) transformation of <b>20k</b> and <b>21k</b>, HCl, ethyl acetate, rt, 3 h.</p></p></figure><div class="NLM_p last">The starting materials (4-chlorobenzyloxyquinoline derivatives, <b>13a</b>–<b>d</b>) were available from commercial sources. These benzyloxy-4-chloroquinoline derivatives (<b>13a</b>–<b>d</b>) were coupled with 2-fluoro-4-nitrophenol by heating them in chlorobenzene in the presence of <i>N</i>,<i>N</i>-diisopropylethylamine. The benzyloxy protective group was removed from the isolated 4-(4-nitrophenoxy)quinoline compounds (<b>14a</b>–<b>d</b>) by hydrobromic acid in acetic acid. The obtained hydroxyquinolines (<b>15a</b>–<b>d</b>) were alkylated by the proper alkyl halogenides resulting in the appropriate alkoxy derivatives (<b>16a</b>–<b>o</b>). The reduction of the nitro groups of these compounds was carried out by zinc powder and ammonium chloride in ethanol/water mixture at reflux temperature, whereas the coupling of (<b>17a</b>–<b>o</b>) with benzenesulfonyl chlorides in pyridine gave the desired sulfonamides (<b>18a</b>–<b>d</b>, <b>19a</b>–<b>n</b>, <b>20a</b>–<b>k</b>, and <b>21a</b>–<b>k</b>) as final products. In the case of <b>20k</b> and <b>21k</b>, after removing the <i>tert</i>-butoxycarbonyl (BOC) protecting group, we isolated the aminopropoxy derivatives as hydrochloride salt (<b>20l</b> and <b>21l</b>).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds prepared for this study were primarily evaluated by in vitro AXL kinase assay. In order to determine the structure–activity relationships, the following moieties were changed: substituents of the benzenesulfonamide ring (R<sup>1</sup>, R<sup>2</sup>), substituents of the <i>p</i>-aminophenol ring (R<sup>3</sup>, R<sup>4</sup>), and substituents of the quinoline ring (R<sup>5</sup>, R<sup>6</sup>) as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General structure of the prepared <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamide series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First, the effect of the benzenesulfonamide substituents (R<sup>1</sup>, R<sup>2</sup>) was evaluated as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, while the substituents of the quinoline and the <i>p</i>-aminophenol ring remained unchanged, identical to those in Ki8751 (<b>8</b>) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The analogous 2,4-difluoro derivative (<b>12h</b>) (IC<sub>50</sub> = 6.400 μM) showed significantly weaker inhibitory potency against AXL than Ki8751 (<b>8</b>) (IC<sub>50</sub> = 0.300 μM). However, we have discovered a number of compounds having submicromolar IC<sub>50</sub>, from which 2-CF<sub>3</sub> (<b>12c</b>) and 2-OCF<sub>3</sub> (<b>12f</b>) groups showed the best results in this set (0.360 μM and 0.300 μM, respectively).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of <i>N</i>-[4-(6,7-Dimethoxy-quinolin-4-yloxy)-2-fluorophenyl]benzenesulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0017.gif" alt="" id="GRAPHIC-d7e732-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">AXL IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2.600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2.350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.360</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">6.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>3.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">2-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>1.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">6.400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="char" char=".">0.840</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="char" char=".">>1.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">3.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>1.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="char" char=".">1.610</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="char" char=".">1.770</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12o</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">>1.000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are average of at least two independent experiments.</p></div></div></div><div class="NLM_p">Optimization of substituents of the <i>p</i>-aminophenol ring revealed that the R<sup>3</sup> and R<sup>4</sup> substituents (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) can strongly influence the kinase inhibitory activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Introducing a methyl group in either one of these positions (<b>12q</b>, <b>12r</b>) significantly reduced the AXL inhibitory effect. Surprisingly, in the case of methoxy and fluoro moieties we observed a diverse effect. In R<sup>3</sup> position these substituents did not cause considerable changes (<b>12s</b>, 0.289 μM; <b>12c</b>, 0.360 μM); however, in R<sup>4</sup> position the methoxy group reduced the effect (<b>12t</b>, 1.960 μM), while the fluorine substituent unexpectedly increased the AXL inhibitory effect (<b>12u</b>, 0.077 μM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activities of <i>N</i>-[4-(6,7-Dimethoxyquinolin-4-yloxy)-2-subtituted-phenyl]- 2-trifluoromethylbenzenesulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0018.gif" alt="" id="GRAPHIC-d7e1049-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char=".">AXL IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>3.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12s</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.289</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12t</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>O</td><td class="colsep0 rowsep0" align="char" char=".">1.960</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.360</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12u</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.077</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are average of at least two independent experiments.</p></div></div></div><div class="NLM_p">In the next step we explored the effect of R<sup>5</sup> and R<sup>6</sup> substituents and how interchangeable are they (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). To evaluate the effect of bosutinib’s (<b>2</b>) side chain, we introduced the 3-(4-methylpiperazin-1-yl)propoxy moiety into R<sup>5</sup> or R<sup>6</sup> position. We have discovered that compounds featuring this side chain in R<sup>6</sup> position (<b>18b</b>, <b>18d</b>) were significantly more potent than those in R<sup>5</sup> position (<b>18a</b>, <b>18c</b>). We have also found that a methoxy substituent next to the 3-(4-methylpiperazin-1-yl)propoxy moiety (<b>18a</b> and <b>18c</b>; <b>18b</b> and <b>18d</b>) increased the inhibitory potency against AXL kinase. As a result, <b>18d</b> was identified as the most potent compound in this set with an IC<sub>50</sub> of 0.021 μM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Activities of <i>N</i>-(3-Fluoro-4-{6,7-substituted-quinolin-4-yloxy}-phenyl)-2-trifluoromethyl-benzenesulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0019.gif" alt="" id="GRAPHIC-d7e1267-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0020.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are average of at least two independent experiments.</p></div></div><div></div></div><div class="NLM_p">Having selected the optimal substituent combinations on the quinoline (R<sup>5</sup>, R<sup>6</sup>) and <i>p</i>-aminophenol ring (R<sup>3</sup>, R<sup>4</sup>), we aimed to re-evaluate the role of the R<sup>1</sup>, R<sup>2</sup> substituents as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. On the basis of this comparison, in the group the 2-CF<sub>3</sub> moiety bearing (<b>18d</b>) remained the most active with 0.021 μM IC<sub>50</sub>. Furthermore, the following substituents were confirmed to express similar efficacy against AXL kinase: 2-OCF<sub>3</sub> (<b>19e</b>), 2,5-diF (<b>19h</b>), 2,6-diF (<b>19i</b>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activities of <i>N</i>-(3-Fluoro-4-{6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yloxy}phenyl)benzenesulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0021.gif" alt="" id="GRAPHIC-d7e1337-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">AXL IC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.218</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.430</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.354</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.434</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">2-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.051</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19f</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19g</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">0.380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19h</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19i</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19j</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.388</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19k</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.184</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19l</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.201</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19m</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.068</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19n</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">0.202</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are average of at least two independent experiments.</p></div></div></div><div class="NLM_p">Finally, our attention was focused on the R<sup>6</sup> substituent. Two series of derivatives were prepared bearing 2-trifluoromethylbenzenesulfonamide (<b>18d</b>, <b>20a</b>–<b>l</b>) or 2,5-difluorobenzenesulfonamide (<b>19h</b>, <b>21a</b>–<b>l</b>) moiety to validate the effect of the side chain. The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. As a result of our optimization process, we were able to identify numerous submicromolar AXL kinase inhibitors in this compound class.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activities of <i>N</i>-(3-Fluoro-4-{6-methoxyquinolin-4-yloxy}phenyl)-2-trifluoromethylbenzenesulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0022.gif" alt="" id="GRAPHIC-d7e1644-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>7</sup></th><th class="colsep0 rowsep0" align="center" char=".">AXL IC<sub>50</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">3-(4-methylpiperazin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">2-(morpholin-4-yl)ethyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.054</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="left">3-(morpholin-4-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20c</b></td><td class="colsep0 rowsep0" align="left">4-(morpholin-4-yl)butyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20d</b></td><td class="colsep0 rowsep0" align="left">3-(piperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20e</b></td><td class="colsep0 rowsep0" align="left">3-(2-methylpiperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.070</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20f</b></td><td class="colsep0 rowsep0" align="left">3-(3-methylpiperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.031</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20g</b></td><td class="colsep0 rowsep0" align="left">3-(4-methylpiperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.046</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20h</b></td><td class="colsep0 rowsep0" align="left">4-acetoxybutyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.046</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20i</b></td><td class="colsep0 rowsep0" align="left">dimethylcarbamoylmethyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.796</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20j</b></td><td class="colsep0 rowsep0" align="left">3-(dimethylamino)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20k</b></td><td class="colsep0 rowsep0" align="left">3-(<i>tert</i>-butoxycarbonylamino)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.170</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20l</b><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3-aminopropyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.238</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are average of at least two independent experiments.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">HCl salt.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibitory Activities of <i>N</i>-(3-Fluoro-4-{6-methoxyquinolin-4-yloxy}phenyl)-2,5-difluorobenzenesulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0023.gif" alt="" id="GRAPHIC-d7e1842-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>7</sup></th><th class="colsep0 rowsep0" align="center" char=".">AXL IC<sub>50</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19h</b></td><td class="colsep0 rowsep0" align="left">3-(4-methylpiperazin-1-yl)-propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.053</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">2-(morpholin-4-yl)ethyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.052</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">3-(morpholin-4-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="left">4-(morpholin-4-yl)butyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21d</b></td><td class="colsep0 rowsep0" align="left">3-(piperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.072</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21e</b></td><td class="colsep0 rowsep0" align="left">3-(2-methylpiperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="left">3-(3-methylpiperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21g</b></td><td class="colsep0 rowsep0" align="left">3-(4-methylpiperidin-1-yl)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21h</b></td><td class="colsep0 rowsep0" align="left">4-acetoxybutyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.091</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21i</b></td><td class="colsep0 rowsep0" align="left">dimethylcarbamoylmethyl-</td><td class="colsep0 rowsep0" align="char" char=".">>1.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21j</b></td><td class="colsep0 rowsep0" align="left">3-(dimethylamino)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.036</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21k</b></td><td class="colsep0 rowsep0" align="left">3-(<i>tert</i>-butoxycarbonylamino)propyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21l</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3-aminopropyl-</td><td class="colsep0 rowsep0" align="char" char=".">0.636</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are average of at least two independent experiments.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">HCl salt.</p></div></div></div><div class="NLM_p">A detailed protein–inhibitor cocrystal structure of AXL kinase has not been published yet. To identify the important pharmacophore features for the binding, we used the Phase module of Schrödinger Suite 2009 and determined a five point pharmacophore (AAAHR, survival score: 3.037) for the active molecules (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Five point pharmacophore of AXL kinase inhibitors. Compounds <b>18d</b> (orange), <b>19h</b> (gray), and <b>21f</b> (green) are shown on the image.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The marked motifs (A1, A2, A6, H8, R17) are analogous in the best and the moderate active compounds, and according to other kinase inhibitors, these points are necessary for the interactions with the hinge region (A1), DFG motif (A2), and gatekeeper residue (A2, R17). The in vitro AXL kinase assay revealed that the most active compounds differ in two motifs from less active ones. The flexible side chains in R<sup>6</sup> position enhance not only the inhibitory effect (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) but the solubility as well. The position and substitution of the aromatic ring R17 are also crucial because this phenyl ring can be involved in hydrophobic interactions with the gatekeeper residue (Leu620 of the AXL kinase). Although a small gatekeeper residue, like Leu620, could allow larger and more hydrophobic substituents, only small substituents are well tolerated, especially in R<sup>3</sup> and R<sup>4</sup> position (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Due to the size of the molecules the, whole large back cavity can be occupied by the sulfonamide group and the substituted phenyl ring.</div><div class="NLM_p">Having identified the biochemical potency of our compounds against AXL kinase, cellular assays were performed. <b>18d</b>, <b>19e</b>, <b>19h</b>, <b>19i</b>, and <b>21f</b>, all displaying low μM IC<sub>50</sub> values of AXL phosphorylation, were selected for further characterization of kinase selectivity profiles and in migration and invasion related cell based assays.</div><div class="NLM_p">First we determined the kinase selectivity profile of <b>18d</b>, <b>19h</b>, <b>19i</b>, and <b>21f</b> using three different types of assays, namely, IMAP, binding and HTRF assay. The kinase profile of <b>18d</b>, <b>19h</b>, <b>19i</b>, and <b>21f</b> displayed common target profile by inhibition of AXL as well as c-MET, SRC, ABL, cKIT, TIE2, PDGFRbeta, AurA, and VEGFR-2 with efficacy of 83–100% when used at 10 μM concentration (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The comparison of the kinase selectivity profiles identified additional targets with lower affinity especially to compound <b>18d</b> such as DDR1, FLT3, RET, FGFR3, CSK, B-RAF, ERBB2, SYK, INSR, and JAK3. 50% of the tested kinases have not been targeted by any of the compounds with notable affinity.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinase selectivity profile against a panel of 36 human kinases proves AXL as a common target of <i>N</i>-[4-(quinolin-4-yloxy)phenyl]-benzenesulfonamides derivates. The selectivity profiling was performed in triplicate at a compound concentration of 10 μmol/L. The plots indicate the percentages of inhibition for each individual kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We compared the molecular targets of <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides derivates using the kinome-wide DiscoveRx KinomeScan assay. The kinase-binding selectivity of <b>20b</b> and <b>20g</b> was determined on a panel of 442 human wild type and mutated kinases (Kinomscan) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information Table S1</a>.). At 5 μmol/L, apart from the primary target AXL, 12 kinases (8 wild type kinases and 4 mutants) were identified as hits of <b>20b</b> and 23 of <b>20g</b> (17 wild type kinases and 6 mutants), exhibiting equal or lower percentage control values than of AXL (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information Table S2</a>.). Lower numbers indicate stronger binding.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additional common targets are ABL, LOK, cKIT, BRK, SRC, BLK, LCK, RIPK2, PDGFRA and B, CSF1R, c-MET, DDR1, and EGFR. ABL, cKIT; SRC; PDGFRbeta, c-MET and DDR1 were verified by chemical binding assays as displayed in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Increasing the threshold of percentage control to 10 times the percentage control value of AXL, we identified 45 out of 442 tested kinases for <b>20b</b> and 71 out of 442 for <b>20g</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information Table S2</a>.). This corresponds to 10.2% and 16.0% of the kinome being analyzed. Wilson et al, published the selectivity profiles of R428/BGB324 at a concentration of 1 μmol/L using a similar KinomeScan panel. This most selective AXL inhibitor published until now targets 24 kinases and mutants more potently than AXL and hits 128 out of 452 kinases and mutants within a range of 10 times the percentage control value of AXL. This represents 27.8% of the tested kinome.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These data indicate a higher selectivity of <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides <b>20b</b> and <b>20g</b> for AXL compared to R428/BGB324.</div><div class="NLM_p">More in vivo relevant targets were analyzed by KinAffinity technology to determine the target profiles of the small molecule kinase inhibitors <b>19h</b> and <b>19i</b> in lysates from the human breast cancer cell line MDA-MB-231 (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The KinAffinity analysis of MDA-MB-231 lysates demonstrated a broad selectivity of compounds <b>19h</b> and <b>19i</b> for protein kinases. Target spectra for both compounds were fairly similar and revealed high affinities in the low nanomolar range for protein kinases AXL, c-MET, TNK1, MAP4K5, LYN, RIPK2, EGFR, SRC, and several others.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Target Protein Kinases of Compound <b>19h</b> in MDA-MB-231 Cells (Analyzed by KinAffinity Technology)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center">Uniprot</th><th class="colsep0 rowsep0" align="center">protein name</th><th class="colsep0 rowsep0" align="center">gene name</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>d</sub> free [μM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><a href="https://P30530" class="ext-link">P30530</a></td><td class="colsep0 rowsep0" align="left">AXL oncogene</td><td class="colsep0 rowsep0" align="left">AXL</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13470" class="ext-link">Q13470</a></td><td class="colsep0 rowsep0" align="left">Nonreceptor tyrosine-protein kinase TNK1</td><td class="colsep0 rowsep0" align="left">TNK1</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y4K4" class="ext-link">Q9Y4K4</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase kinase 5</td><td class="colsep0 rowsep0" align="left">MAP4K5</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><a href="https://P07948" class="ext-link">P07948</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Lyn</td><td class="colsep0 rowsep0" align="left">LYN</td><td class="colsep0 rowsep0" align="char" char=".">0.029</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><a href="https://P08581" class="ext-link">P08581</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase c-MET</td><td class="colsep0 rowsep0" align="left">c-MET</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left"><a href="https://O43353" class="ext-link">O43353</a></td><td class="colsep0 rowsep0" align="left">Receptor-interacting serine/threonine-protein kinase 2</td><td class="colsep0 rowsep0" align="left">RIPK2</td><td class="colsep0 rowsep0" align="char" char=".">0.043</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left"><a href="https://Q04771" class="ext-link">Q04771</a></td><td class="colsep0 rowsep0" align="left">Activin receptor type I</td><td class="colsep0 rowsep0" align="left">ACVR1</td><td class="colsep0 rowsep0" align="char" char=".">0.052</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><a href="https://O00444" class="ext-link">O00444</a></td><td class="colsep0 rowsep0" align="left">Polo-like kinase 4</td><td class="colsep0 rowsep0" align="left">PLK4</td><td class="colsep0 rowsep0" align="char" char=".">0.053</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left"><a href="https://P06241" class="ext-link">P06241</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Fyn</td><td class="colsep0 rowsep0" align="left">FYN</td><td class="colsep0 rowsep0" align="char" char=".">0.064</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left"><a href="https://Q96GD4" class="ext-link">Q96GD4</a></td><td class="colsep0 rowsep0" align="left">Aurora kinase B</td><td class="colsep0 rowsep0" align="left">AURKB</td><td class="colsep0 rowsep0" align="char" char=".">>0.069</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="left"><a href="https://P42684" class="ext-link">P42684</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase ABL2</td><td class="colsep0 rowsep0" align="left">ABL2</td><td class="colsep0 rowsep0" align="char" char=".">0.071</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left"><a href="https://P00533" class="ext-link">P00533</a></td><td class="colsep0 rowsep0" align="left">Epidermal growth factor receptor</td><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">0.122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left"><a href="https://P53667" class="ext-link">P53667</a></td><td class="colsep0 rowsep0" align="left">LIM domain kinase 1</td><td class="colsep0 rowsep0" align="left">LIMK1</td><td class="colsep0 rowsep0" align="char" char=".">0.130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left"><a href="https://P07947" class="ext-link">P07947</a></td><td class="colsep0 rowsep0" align="left">Proto-oncogene tyrosine-protein kinase Yes</td><td class="colsep0 rowsep0" align="left">YES</td><td class="colsep0 rowsep0" align="char" char=".">0.178</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left"><a href="https://P12931" class="ext-link">P12931</a></td><td class="colsep0 rowsep0" align="left">Proto-oncogene tyrosine-protein kinase Src</td><td class="colsep0 rowsep0" align="left">SRC</td><td class="colsep0 rowsep0" align="char" char=".">0.254</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left"><a href="https://P41240" class="ext-link">P41240</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase CSK</td><td class="colsep0 rowsep0" align="left">CSK</td><td class="colsep0 rowsep0" align="char" char=".">0.270</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left"><a href="https://Q14164" class="ext-link">Q14164</a></td><td class="colsep0 rowsep0" align="left">Inhibitor of nuclear factor kappa-B kinase subunit ε</td><td class="colsep0 rowsep0" align="left">IKKE</td><td class="colsep0 rowsep0" align="char" char=".">0.282</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13131" class="ext-link">Q13131</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase catalytic subunit α1</td><td class="colsep0 rowsep0" align="left">PRKAA1</td><td class="colsep0 rowsep0" align="char" char=".">0.616</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left"><a href="https://P16591" class="ext-link">P16591</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Fer</td><td class="colsep0 rowsep0" align="left">FER</td><td class="colsep0 rowsep0" align="char" char=".">0.679</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="left"><a href="https://O75460" class="ext-link">O75460</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase/endoribonuclease IRE1</td><td class="colsep0 rowsep0" align="left">IRE1</td><td class="colsep0 rowsep0" align="char" char=".">0.723</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left"><a href="https://P54619" class="ext-link">P54619</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit γ1</td><td class="colsep0 rowsep0" align="left">PRKAG1</td><td class="colsep0 rowsep0" align="char" char=".">0.825</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="left"><a href="https://O14965" class="ext-link">O14965</a></td><td class="colsep0 rowsep0" align="left">Aurora kinase A</td><td class="colsep0 rowsep0" align="left">AURKA</td><td class="colsep0 rowsep0" align="char" char=".">0.847</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left"><a href="https://O43741" class="ext-link">O43741</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit β2</td><td class="colsep0 rowsep0" align="left">PRKAB2</td><td class="colsep0 rowsep0" align="char" char=".">0.969</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9UGJ0" class="ext-link">Q9UGJ0</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit γ2</td><td class="colsep0 rowsep0" align="left">PRKAG2</td><td class="colsep0 rowsep0" align="char" char=".">1.078</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9NYL2" class="ext-link">Q9NYL2</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase MLT</td><td class="colsep0 rowsep0" align="left">ZAK</td><td class="colsep0 rowsep0" align="char" char=".">1.180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y478" class="ext-link">Q9Y478</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit β1</td><td class="colsep0 rowsep0" align="left">PRKAB1</td><td class="colsep0 rowsep0" align="char" char=".">1.257</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="left"><a href="https://P37173" class="ext-link">P37173</a></td><td class="colsep0 rowsep0" align="left">Transforming growth factor-β receptor type II</td><td class="colsep0 rowsep0" align="left">TGFBR2</td><td class="colsep0 rowsep0" align="char" char=".">1.860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="left"><a href="https://Q8IVH8" class="ext-link">Q8IVH8</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase kinase 3</td><td class="colsep0 rowsep0" align="left">MAP4K3</td><td class="colsep0 rowsep0" align="char" char=".">2.080</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13043" class="ext-link">Q13043</a></td><td class="colsep0 rowsep0" align="left">Mammalian STE20-like protein kinase 1</td><td class="colsep0 rowsep0" align="left">MST1</td><td class="colsep0 rowsep0" align="char" char=".">2.433</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left"><a href="https://O14976" class="ext-link">O14976</a></td><td class="colsep0 rowsep0" align="left">Cyclin-G-associated kinase</td><td class="colsep0 rowsep0" align="left">GAK</td><td class="colsep0 rowsep0" align="char" char=".">2.448</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="left"><a href="https://Q6PHR2" class="ext-link">Q6PHR2</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase ULK3</td><td class="colsep0 rowsep0" align="left">ULK3</td><td class="colsep0 rowsep0" align="char" char=".">>2.514</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13011" class="ext-link">Q13011</a></td><td class="colsep0 rowsep0" align="left">Δ(3,5)-Δ(2,4)-dienoyl-CoA isomerase</td><td class="colsep0 rowsep0" align="left">ECH1</td><td class="colsep0 rowsep0" align="char" char=".">2.857</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="left"><a href="https://Q99759" class="ext-link">Q99759</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase 3</td><td class="colsep0 rowsep0" align="left">MAP3K3</td><td class="colsep0 rowsep0" align="char" char=".">3.133</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left"><a href="https://Q15418" class="ext-link">Q15418</a></td><td class="colsep0 rowsep0" align="left">90 kDa ribosomal protein S6 kinase 1</td><td class="colsep0 rowsep0" align="left">RPS6KA1</td><td class="colsep0 rowsep0" align="char" char=".">3.152</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left"><a href="https://Q92844" class="ext-link">Q92844</a></td><td class="colsep0 rowsep0" align="left">TRAF family member-associated NF-κB activator</td><td class="colsep0 rowsep0" align="left">TANK</td><td class="colsep0 rowsep0" align="char" char=".">3.418</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left"><a href="https://O95819" class="ext-link">O95819</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase kinase 4</td><td class="colsep0 rowsep0" align="left">MAP4K4</td><td class="colsep0 rowsep0" align="char" char=".">3.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left"><a href="https://O94804" class="ext-link">O94804</a></td><td class="colsep0 rowsep0" align="left">Lymphocyte-oriented kinase</td><td class="colsep0 rowsep0" align="left">LOK</td><td class="colsep0 rowsep0" align="char" char=".">3.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left"><a href="https://P27448" class="ext-link">P27448</a></td><td class="colsep0 rowsep0" align="left">MAP/microtubule affinity-regulating kinase 3</td><td class="colsep0 rowsep0" align="left">MARK3</td><td class="colsep0 rowsep0" align="char" char=".">3.854</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y2U5" class="ext-link">Q9Y2U5</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase 2</td><td class="colsep0 rowsep0" align="left">MAP3K2</td><td class="colsep0 rowsep0" align="char" char=".">4.396</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="left"><a href="https://Q05397" class="ext-link">Q05397</a></td><td class="colsep0 rowsep0" align="left">Focal adhesion kinase 1</td><td class="colsep0 rowsep0" align="left">FAK</td><td class="colsep0 rowsep0" align="char" char=".">4.445</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="left"><a href="https://Q7KZI7" class="ext-link">Q7KZI7</a></td><td class="colsep0 rowsep0" align="left">MAP/microtubule affinity-regulating kinase 2</td><td class="colsep0 rowsep0" align="left">MARK2</td><td class="colsep0 rowsep0" align="char" char=".">4.455</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9H0K1" class="ext-link">Q9H0K1</a></td><td class="colsep0 rowsep0" align="left">Qin-induced kinase</td><td class="colsep0 rowsep0" align="left">QIK</td><td class="colsep0 rowsep0" align="char" char=".">4.518</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="left"><a href="https://Q96PY6" class="ext-link">Q96PY6</a></td><td class="colsep0 rowsep0" align="left">Never in mitosis A-related kinase 1</td><td class="colsep0 rowsep0" align="left">NEK1</td><td class="colsep0 rowsep0" align="char" char=".">5.146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="left"><a href="https://Q96L34" class="ext-link">Q96L34</a></td><td class="colsep0 rowsep0" align="left">MAP/microtubule affinity-regulating kinase 4</td><td class="colsep0 rowsep0" align="left">MARK4</td><td class="colsep0 rowsep0" align="char" char=".">5.975</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="left"><a href="https://Q07002" class="ext-link">Q07002</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase PCTAIRE-3</td><td class="colsep0 rowsep0" align="left">PCTK3</td><td class="colsep0 rowsep0" align="char" char=".">>6.194</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13188" class="ext-link">Q13188</a></td><td class="colsep0 rowsep0" align="left">Mammalian STE20-like protein kinase 2</td><td class="colsep0 rowsep0" align="left">MST2</td><td class="colsep0 rowsep0" align="char" char=".">>6.454</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="left"><a href="https://P36507" class="ext-link">P36507</a></td><td class="colsep0 rowsep0" align="left">Dual specificity mitogen-activated protein kinase kinase 2</td><td class="colsep0 rowsep0" align="left">MAP2K2</td><td class="colsep0 rowsep0" align="char" char=".">6.917</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="left"><a href="https://Q00537" class="ext-link">Q00537</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase PCTAIRE-2</td><td class="colsep0 rowsep0" align="left">PCTK2</td><td class="colsep0 rowsep0" align="char" char=".">>7.651</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Target Protein Kinases of Compound <b>19i</b> in MDA-MB-231 Cells (Analyzed by KinAffinity Technology)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center">Uniprot</th><th class="colsep0 rowsep0" align="center">protein name</th><th class="colsep0 rowsep0" align="center">gene name</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>d</sub> free [μM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><a href="https://P30530" class="ext-link">P30530</a></td><td class="colsep0 rowsep0" align="left">AXL oncogene</td><td class="colsep0 rowsep0" align="left">AXL</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><a href="https://P08581" class="ext-link">P08581</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase c-Met</td><td class="colsep0 rowsep0" align="left">MET</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y4K4" class="ext-link">Q9Y4K4</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase kinase 5</td><td class="colsep0 rowsep0" align="left">MAP4K5</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><a href="https://P07948" class="ext-link">P07948</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Lyn</td><td class="colsep0 rowsep0" align="left">LYN</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13470" class="ext-link">Q13470</a></td><td class="colsep0 rowsep0" align="left">Nonreceptor tyrosine-protein kinase TNK1</td><td class="colsep0 rowsep0" align="left">TNK1</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left"><a href="https://P42684" class="ext-link">P42684</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase ABL2</td><td class="colsep0 rowsep0" align="left">ABL2</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left"><a href="https://P00533" class="ext-link">P00533</a></td><td class="colsep0 rowsep0" align="left">Epidermal growth factor receptor</td><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><a href="https://O43353" class="ext-link">O43353</a></td><td class="colsep0 rowsep0" align="left">Receptor-interacting serine/threonine-protein kinase 2</td><td class="colsep0 rowsep0" align="left">RIPK2</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left"><a href="https://P41240" class="ext-link">P41240</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase CSK</td><td class="colsep0 rowsep0" align="left">CSK</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left"><a href="https://Q96GD4" class="ext-link">Q96GD4</a></td><td class="colsep0 rowsep0" align="left">Aurora kinase B</td><td class="colsep0 rowsep0" align="left">AURKB</td><td class="colsep0 rowsep0" align="char" char=".">0.034</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="left"><a href="https://P06241" class="ext-link">P06241</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Fyn</td><td class="colsep0 rowsep0" align="left">FYN</td><td class="colsep0 rowsep0" align="char" char=".">0.038</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left"><a href="https://P07947" class="ext-link">P07947</a></td><td class="colsep0 rowsep0" align="left">Proto-oncogene tyrosine-protein kinase Yes</td><td class="colsep0 rowsep0" align="left">YES</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left"><a href="https://O00444" class="ext-link">O00444</a></td><td class="colsep0 rowsep0" align="left">Polo-like kinase 4</td><td class="colsep0 rowsep0" align="left">PLK4</td><td class="colsep0 rowsep0" align="char" char=".">0.048</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left"><a href="https://Q04771" class="ext-link">Q04771</a></td><td class="colsep0 rowsep0" align="left">Activin receptor type I</td><td class="colsep0 rowsep0" align="left">ACVR1</td><td class="colsep0 rowsep0" align="char" char=".">>0.070</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left"><a href="https://P53667" class="ext-link">P53667</a></td><td class="colsep0 rowsep0" align="left">LIM domain kinase 1</td><td class="colsep0 rowsep0" align="left">LIMK1</td><td class="colsep0 rowsep0" align="char" char=".">0.093</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left"><a href="https://P12931" class="ext-link">P12931</a></td><td class="colsep0 rowsep0" align="left">Proto-oncogene tyrosine-protein kinase Src</td><td class="colsep0 rowsep0" align="left">SRC</td><td class="colsep0 rowsep0" align="char" char=".">0.096</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left"><a href="https://Q14164" class="ext-link">Q14164</a></td><td class="colsep0 rowsep0" align="left">Inhibitor of nuclear factor κB kinase subunit ε</td><td class="colsep0 rowsep0" align="left">IKKE</td><td class="colsep0 rowsep0" align="char" char=".">0.122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left"><a href="https://O14965" class="ext-link">O14965</a></td><td class="colsep0 rowsep0" align="left">Aurora kinase A</td><td class="colsep0 rowsep0" align="left">AURKA</td><td class="colsep0 rowsep0" align="char" char=".">0.146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left"><a href="https://P36897" class="ext-link">P36897</a></td><td class="colsep0 rowsep0" align="left">Transforming growth factor-β receptor type I</td><td class="colsep0 rowsep0" align="left">TGFBR1</td><td class="colsep0 rowsep0" align="char" char=".">0.205</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="left"><a href="https://O75460" class="ext-link">O75460</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase/endoribonuclease IRE1</td><td class="colsep0 rowsep0" align="left">IRE1</td><td class="colsep0 rowsep0" align="char" char=".">0.243</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left"><a href="https://P16591" class="ext-link">P16591</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Fer</td><td class="colsep0 rowsep0" align="left">FER</td><td class="colsep0 rowsep0" align="char" char=".">0.304</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13163" class="ext-link">Q13163</a></td><td class="colsep0 rowsep0" align="left">Dual specificity mitogen-activated protein kinase kinase 5</td><td class="colsep0 rowsep0" align="left">MAP2K5</td><td class="colsep0 rowsep0" align="char" char=".">0.539</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13131" class="ext-link">Q13131</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase catalytic subunit α1</td><td class="colsep0 rowsep0" align="left">PRKAA1</td><td class="colsep0 rowsep0" align="char" char=".">0.786</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left"><a href="https://Q8IVH8" class="ext-link">Q8IVH8</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase kinase 3</td><td class="colsep0 rowsep0" align="left">MAP4K3</td><td class="colsep0 rowsep0" align="char" char=".">1.367</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="left"><a href="https://Q92844" class="ext-link">Q92844</a></td><td class="colsep0 rowsep0" align="left">TRAF-interacting protein</td><td class="colsep0 rowsep0" align="left">TANK</td><td class="colsep0 rowsep0" align="char" char=".">1.567</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="left"><a href="https://P54619" class="ext-link">P54619</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit γ1</td><td class="colsep0 rowsep0" align="left">PRKAG1</td><td class="colsep0 rowsep0" align="char" char=".">1.871</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="left"><a href="https://O43741" class="ext-link">O43741</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit β2</td><td class="colsep0 rowsep0" align="left">PRKAB2</td><td class="colsep0 rowsep0" align="char" char=".">1.907</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13043" class="ext-link">Q13043</a></td><td class="colsep0 rowsep0" align="left">Mammalian STE20-like protein kinase 1</td><td class="colsep0 rowsep0" align="left">MST1</td><td class="colsep0 rowsep0" align="char" char=".">2.080</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="left"><a href="https://TBKBP1" class="ext-link">TBKBP1</a></td><td class="colsep0 rowsep0" align="left">TANK-binding kinase 1-binding protein 1</td><td class="colsep0 rowsep0" align="left">TBKBP1</td><td class="colsep0 rowsep0" align="char" char=".">2.090</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left"><a href="https://Q05397" class="ext-link">Q05397</a></td><td class="colsep0 rowsep0" align="left">Focal adhesion kinase 1</td><td class="colsep0 rowsep0" align="left">FAK</td><td class="colsep0 rowsep0" align="char" char=".">2.212</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y478" class="ext-link">Q9Y478</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit β1</td><td class="colsep0 rowsep0" align="left">PRKAB1</td><td class="colsep0 rowsep0" align="char" char=".">2.279</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9UGJ0" class="ext-link">Q9UGJ0</a></td><td class="colsep0 rowsep0" align="left">5-AMP-activated protein kinase subunit γ2</td><td class="colsep0 rowsep0" align="left">PRKAG2</td><td class="colsep0 rowsep0" align="char" char=".">2.296</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="left"><a href="https://Q6PHR2" class="ext-link">Q6PHR2</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase ULK3</td><td class="colsep0 rowsep0" align="left">ULK3</td><td class="colsep0 rowsep0" align="char" char=".">>2.513</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left"><a href="https://P53671" class="ext-link">P53671</a></td><td class="colsep0 rowsep0" align="left">LIM domain kinase 2</td><td class="colsep0 rowsep0" align="left">LIMK2</td><td class="colsep0 rowsep0" align="char" char=".">2.784</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9H6S1" class="ext-link">Q9H6S1</a></td><td class="colsep0 rowsep0" align="left">5-Azacytidine-induced protein 2</td><td class="colsep0 rowsep0" align="left">AZI2</td><td class="colsep0 rowsep0" align="char" char=".">2.982</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left"><a href="https://O94804" class="ext-link">O94804</a></td><td class="colsep0 rowsep0" align="left">Lymphocyte-oriented kinase</td><td class="colsep0 rowsep0" align="left">LOK</td><td class="colsep0 rowsep0" align="char" char=".">3.039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9NYL2" class="ext-link">Q9NYL2</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase MLT</td><td class="colsep0 rowsep0" align="left">ZAK</td><td class="colsep0 rowsep0" align="char" char=".">3.210</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9UHD2" class="ext-link">Q9UHD2</a></td><td class="colsep0 rowsep0" align="left">TANK-binding kinase 1</td><td class="colsep0 rowsep0" align="left">TBK1</td><td class="colsep0 rowsep0" align="char" char=".">3.273</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9H0K1" class="ext-link">Q9H0K1</a></td><td class="colsep0 rowsep0" align="left">Qin-induced kinase SNF1-like kinase 2</td><td class="colsep0 rowsep0" align="left">QIK</td><td class="colsep0 rowsep0" align="char" char=".">3.545</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="left"><a href="https://P42680" class="ext-link">P42680</a></td><td class="colsep0 rowsep0" align="left">Tyrosine-protein kinase Tec</td><td class="colsep0 rowsep0" align="left">TEC</td><td class="colsep0 rowsep0" align="char" char=".">>3.674</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="left"><a href="https://O14976" class="ext-link">O14976</a></td><td class="colsep0 rowsep0" align="left">Cyclin-G-associated kinase</td><td class="colsep0 rowsep0" align="left">GAK</td><td class="colsep0 rowsep0" align="char" char=".">4.166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="left"><a href="https://Q96PY6" class="ext-link">Q96PY6</a></td><td class="colsep0 rowsep0" align="left">Never in mitosis A-related kinase 1</td><td class="colsep0 rowsep0" align="left">NEK1</td><td class="colsep0 rowsep0" align="char" char=".">5.043</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="left"><a href="https://Q13188" class="ext-link">Q13188</a></td><td class="colsep0 rowsep0" align="left">Mammalian STE20-like protein kinase 2</td><td class="colsep0 rowsep0" align="left">MST2</td><td class="colsep0 rowsep0" align="char" char=".">5.223</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="left"><a href="https://Q15418" class="ext-link">Q15418</a></td><td class="colsep0 rowsep0" align="left">90 kDa ribosomal protein S6 kinase 1</td><td class="colsep0 rowsep0" align="left">RPS6KA1</td><td class="colsep0 rowsep0" align="char" char=".">5.474</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y2U5" class="ext-link">Q9Y2U5</a></td><td class="colsep0 rowsep0" align="left">Mitogen-activated protein kinase kinase kinase 2</td><td class="colsep0 rowsep0" align="left">MAP3K2</td><td class="colsep0 rowsep0" align="char" char=".">5.518</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="left"><a href="https://P27448" class="ext-link">P27448</a></td><td class="colsep0 rowsep0" align="left">MAP/microtubule affinity-regulating kinase 3</td><td class="colsep0 rowsep0" align="left">MARK3</td><td class="colsep0 rowsep0" align="char" char=".">5.622</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="left"><a href="https://Q14289" class="ext-link">Q14289</a></td><td class="colsep0 rowsep0" align="left">Focal adhesion kinase 2</td><td class="colsep0 rowsep0" align="left">PYK2</td><td class="colsep0 rowsep0" align="char" char=".">6.928</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="left"><a href="https://Q7KZI7" class="ext-link">Q7KZI7</a></td><td class="colsep0 rowsep0" align="left">MAP/microtubule affinity-regulating kinase 2</td><td class="colsep0 rowsep0" align="left">MARK2</td><td class="colsep0 rowsep0" align="char" char=".">7.086</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="left"><a href="https://P37173" class="ext-link">P37173</a></td><td class="colsep0 rowsep0" align="left">Transforming growth factor-beta receptor type II</td><td class="colsep0 rowsep0" align="left">TGFBR2</td><td class="colsep0 rowsep0" align="char" char=".">7.385</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="left"><a href="https://Q9Y2K2" class="ext-link">Q9Y2K2</a></td><td class="colsep0 rowsep0" align="left">Serine/threonine-protein kinase QSK</td><td class="colsep0 rowsep0" align="left">QSK</td><td class="colsep0 rowsep0" align="char" char=".">7.630</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="left"><a href="https://P36507" class="ext-link">P36507</a></td><td class="colsep0 rowsep0" align="left">Dual specificity mitogen-activated protein kinase kinase 2</td><td class="colsep0 rowsep0" align="left">MAP2K2</td><td class="colsep0 rowsep0" align="char" char=".">8.852</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="left"><a href="https://P30084" class="ext-link">P30084</a></td><td class="colsep0 rowsep0" align="left">Enoyl-CoA hydratase 1</td><td class="colsep0 rowsep0" align="left">ECHS1</td><td class="colsep0 rowsep0" align="char" char=".">9.237</td></tr></tbody></table></div></div><div class="NLM_p">The receptor tyrosine kinase AXL exhibited the highest affinity with a <i>K</i><sub>d</sub> value of 0.015 μM for compound <b>19h</b>. Additional target kinases with <i>K</i><sub>d</sub> values of <0.150 μM (10-fold the <i>K</i><sub>d</sub> of AXL) were TNK1, MAP4K5, LYN, c-MET, RIPK2, ACVR1, PLK4, FYN, AURKB, ABL2, EGFR, and LIMK1. In summary, 13 protein kinases were identified with <i>K</i><sub>d</sub> values of <0.150 μM for compound <b>19h</b>. In total, 168 kinase targets were enriched from MDA-MB-231 cells, 48 of which were identified as target proteins of compound <b>19h</b> within a <i>K</i><sub>d</sub> range between 0.015 and 7.650 μM. This corresponds to 7.7% and 25% of the kinome being detected in MDA-MB231 cells. The remaining 126 kinases bound to the KinAffinity matrix but were not competed by compound <b>19h</b>. Consequently, these kinases showed no binding characteristics expected for target proteins of compound <b>19h</b>. <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> shows the target protein kinases of compound <b>19h</b> in MDA-MB-231 cells. Targets were ranked according to their affinities and targets with low <i>K</i><sub>d</sub> values ranging from 0.015 to 7.650 μM.</div><div class="NLM_p">The receptor tyrosine kinase AXL and the receptor tyrosine-protein kinase c-MET exhibited the highest affinities each with a <i>K</i><sub>d</sub> value of 0.006 μM for compound <b>19i</b>. Additional high affinity target kinases with <i>K</i><sub>d</sub> values of <0.060 μM (10-fold the <i>K</i><sub>d</sub> of AXL) were MAP4K5, LYN, TNK1, ABL2, EGFR, RIPK2, CSK, FYN, YES, and PLK4. In summary, 13 protein kinases were identified with <i>K</i><sub>d</sub> values of <0.060 μM for compound <b>19i</b>. In total, 168 kinase targets were enriched from MDA-MB-231 cells, 52 of which were identified as target proteins of compound <b>19i</b> within a <i>K</i><sub>d</sub> range between 0.006 and 9.230 μM. This corresponds to 7.7% and 25.6% of the kinome being detected in MDA-MB231 cells. The remaining 125 kinases bound to the KinAffinity matrix but were not competed by compound <b>19i</b>. Consequently, these kinases showed no binding characteristics expected for target proteins of compound <b>19i</b>. <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> shows the target protein kinases of compound <b>19i</b> in MDA-MB-231 cells. Targets are ranked according to their affinities with <i>K</i><sub>d</sub> values ranging from 0.006 to 9.230 μM.</div><div class="NLM_p">Complete lists of all kinases that bound to the KinAffinity matrix and of all identified target kinases of compound <b>19h</b> and <b>19i</b> are provided in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information Table S3</a>. This gave us the opportunity to discriminate between <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides derivates with higher and lower target selectivity profiles to AXL.</div><div class="NLM_p">To elucidate the affinities of examples <b>18d</b>, <b>19e</b>, <b>19h</b>, <b>19i</b>, <b>20b</b>, <b>20g</b>, and <b>21f</b> to four migration related kinases in more detail, we determined IC<sub>50</sub> values for AXL, SRC, c-MET, and EGFR kinases (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). All seven examples exhibit low IC<sub>50</sub> values for AXL confirming the high affinity of these <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides as AXL inhibitors. The affinity to SRC, c-MET, and EGFR was more variable for the tested examples (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). The IC<sub>50</sub> values especially for c-MET and EGFR were increasing from 0.127 μM for c-MET and 0.178 μM for EGFR, using example <b>19i</b>, to 1.535 μM for c-MET and 3.081 μM for EGFR in the case of example <b>19e</b>. The IC<sub>50</sub> values were increasing in general from <b>19i</b> < <b>19h</b> < <b>18d</b> < <b>20b</b> < <b>20g</b> < <b>21f</b> < <b>19e</b>, identifying <b>19e</b> as the most selective compound for AXL. Finally we were able to categorize compounds <b>19i</b> and <b>19h</b> into a lower selective group, <b>18d</b>, <b>20b</b>, <b>20g</b> as an intermediate group, and <b>21f</b> and <b>19e</b> as compounds with higher selectivity for AXL.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. IC<sub>50</sub> Values of <i>N</i>-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamide Derivates on AXL, SRC, c-MET, and Wild Type EGFR<a class="ref internalNav" href="#tbl9-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">AXL</th><th class="colsep0 rowsep0" align="center" char=".">SRC</th><th class="colsep0 rowsep0" align="center" char=".">c-MET</th><th class="colsep0 rowsep0" align="center" char=".">EGFR wt</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19i</b></td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="char" char=".">0.127</td><td class="colsep0 rowsep0" align="char" char=".">0.178</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="char" char=".">0.088</td><td class="colsep0 rowsep0" align="char" char=".">0.358</td><td class="colsep0 rowsep0" align="char" char=".">0.149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.544</td><td class="colsep0 rowsep0" align="char" char=".">0.488</td><td class="colsep0 rowsep0" align="char" char=".">0.281</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.995</td><td class="colsep0 rowsep0" align="char" char=".">0.338</td><td class="colsep0 rowsep0" align="char" char=".">0.650</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20g</b></td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="char" char=".">1.723</td><td class="colsep0 rowsep0" align="char" char=".">0.609</td><td class="colsep0 rowsep0" align="char" char=".">0.592</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.028</td><td class="colsep0 rowsep0" align="char" char=".">0.113</td><td class="colsep0 rowsep0" align="char" char=".">1.307</td><td class="colsep0 rowsep0" align="char" char=".">1.128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="char" char=".">0.051</td><td class="colsep0 rowsep0" align="char" char=".">1.951</td><td class="colsep0 rowsep0" align="char" char=".">1.535</td><td class="colsep0 rowsep0" align="char" char=".">3.081</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl9-fn1"><div class="footnote" id="tbl9-fn1"><sup><sup>a</sup></sup><p class="last">The IC<sub>50</sub> determinations were performed in triplicate.</p></div></div></div><div class="NLM_p">Overexpression of the RTK AXL and its implication in the migration and invasion of mammary carcinoma have already been demonstrated in various publications.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Therefore, we studied the impact of <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides derivates on AXL mediated migration and invasion of an AXL-overexpressing human breast cancer cell line, namely, MDA-MB231.</div><div class="NLM_p">First, we determined the inhibitory effect of <b>18d</b>, <b>19e</b>, <b>19h</b>, <b>19i</b>, and <b>21f</b> on cell migration using Boyden chamber assays. The IC<sub>50</sub> value was 1.5 μM for <b>19i</b>, 2.5 μM for <b>19h</b>, 3.3 for <b>21f</b>, 4.6 μM for <b>18d</b>, and 4.3 μM for <b>19e</b> in MDA-MB231 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Migration inhibition (%) of the compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative images of MDA-MB231 transmigrating the porous membrane. MDA-MB231 cells were incubated with indicated compound concentrations relative to DMSO control for 3.5 h. Scale bars indicate 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Comparing the IC<sub>50</sub> values, we discovered that migration inhibition was correlating with the selectivity profiles of the compounds. Thereby it was evident that less selective compounds, namely, <b>19h</b> and <b>19i</b>, were superior in blocking migration of MDA-MB-231 cells in contrast to more AXL selective derivates, in terms of migration related kinases, like SRC, c-MET, and EGFR as displayed in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>. A similar conclusion were drawn by Pénzes et al. (2014) that inhibition of MDA-MB231 cell migration by AXL inhibitors is dependent on additional targets like a SRC family kinase LYN and the migration related CRK-associated substrate p130Cas.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">In summary, the inhibition values of migration were significantly (more than 50-fold) higher than those determined for inhibition of AXL phosphorylation, suggesting that migration of MDA-MB231 does not solely depend on AXL phosphorylation but might be regulated by multiple additional kinases such as SRC, c-MET and EGFR.</div><div class="NLM_p">Second, we determined the inhibitory effect of <b>18d</b>, <b>19e</b>, <b>19h</b>, <b>19i</b>, and <b>21f</b> on invasion of MDA-MB231 cells (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). MDA-MB231 cells have the ability for invasion of semisolid Matrigel. We used this capacity of MDA-MB231 cells and seeded a single cell suspension on top of a solid Matrigel. Then we allowed the single cells to migrate toward each other within 5 h, resulting in the formation of large cell aggregates (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Compounds blocking invasion are able to arrest MDA-MB231 cells in a single cell status prohibiting mesenchymal cell invasion and subsequent aggregate formation. The percentage of the large multicellular aggregates was subsequently quantified.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Invasion inhibition (%) of the molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative images of MDA-MB231 aggregates. MDA-MB231 cells were incubated with indicated compound concentrations relative to DMSO control for 5 h. Scale bars indicate 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The IC<sub>50</sub> value for aggregate formation was 156 nM for <b>19i</b>, 158 nM for <b>19h</b>, 185 nM for <b>21f</b>, 158 nM for <b>18d</b>, and 103 nM for <b>19e</b> in MDA-MB231 cells. The comparison of IC<sub>50</sub> values of invasion and aggregate formation correlated with the IC<sub>50</sub> values of AXL phosphorylation inhibition. Thereby it was evident that all compounds exhibit very similar IC<sub>50</sub> blocking invasion of MDA-MB-231 cells in the nM range.</div><div class="NLM_p">In summary, the inhibition values of invasion were 2- to 6-fold higher than those determined for inhibition of AXL phosphorylation, suggesting that invasion inhibition of MDA-MB231 is closely correlated to AXL phosphorylation inhibition in contrast to migration. This is in line with the results that invasion is more affected than migration by AXL specific siRNA in colorectal cancer cell lines,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> AXL specific blocking antibody 20G7-D9 in triple-negative breast cancer cell line HBL-100,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and selective RNA-based aptamer, GL21.T, that binds the extracellular domain of AXL at high affinity AXL specific aptamer in GBM cell line U87MG.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">Migration inhibition correlates positively with lower selectivity of <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides toward AXL kinase and highlights the importance of additional migration related kinases, as EGFR, c-MET, SRC family kinases, LIMK1, or ABL. These migration related kinases were validated as target proteins with <1 μM <i>K</i><sub>d</sub> values in MDA-MB231 cells using KinAffinity. Nevertheless, we cannot exclude other factors being important for metastasis inhibition as shown for NK-cell activation in vivo.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Two compounds <b>19h</b> and <b>21f</b> exhibiting good selectivity profiles and low nanomolar AXL inhibition values were selected for further ADME and pharmacokinetic studies. The obtained parameters for compound <b>19h</b> and <b>21f</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. ADME and Pharmacokinetic Parameters Obtained for Compounds <b>19h</b> and <b>21f</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>19h</b></th><th class="colsep0 rowsep0" align="center"><b>21f</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SolRank pH 7.4 rel concn [μM]</td><td class="colsep0 rowsep0" align="left">68.8</td><td class="colsep0 rowsep0" align="left">18.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAMPA pH 7.4 % flux [%]</td><td class="colsep0 rowsep0" align="left">24.3</td><td class="colsep0 rowsep0" align="left">46.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 <i>P</i><sub>app</sub>(A→B) [10<sup>–6</sup> cm/s]</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 <i>P</i><sub>app</sub>(B→A) [10<sup>–6</sup> cm/s]</td><td class="colsep0 rowsep0" align="left">17.0</td><td class="colsep0 rowsep0" align="left">14.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 ratio (B→A)/(A→B)</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Microsomal stability, phase I human Cl<sub>int</sub> [μL min<sup>–1</sup> mg<sup>–1</sup>]</td><td class="colsep0 rowsep0" align="left">60.5</td><td class="colsep0 rowsep0" align="left">18.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Microsomal stability, phase I murine Cl<sub>int</sub> [μL min<sup>–1</sup> mg<sup>–1</sup>]</td><td class="colsep0 rowsep0" align="left">143.3</td><td class="colsep0 rowsep0" align="left">19.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Plasma stability, human % remain</td><td class="colsep0 rowsep0" align="left">96.3</td><td class="colsep0 rowsep0" align="left">99.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Plasma stability, murine % remain</td><td class="colsep0 rowsep0" align="left">108.0</td><td class="colsep0 rowsep0" align="left">98.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Plasma protein binding, human % bound</td><td class="colsep0 rowsep0" align="left">99.1</td><td class="colsep0 rowsep0" align="left">98.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Plasma protein binding, murine % bound</td><td class="colsep0 rowsep0" align="left">97.2</td><td class="colsep0 rowsep0" align="left">95.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK mouse iv AUC<sub>(0–INF)</sub> [ng·h/mL]</td><td class="colsep0 rowsep0" align="left">2646.0</td><td class="colsep0 rowsep0" align="left">1395.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK mouse iv AUC<sub>(0–Tz)</sub> [ng·h/mL]</td><td class="colsep0 rowsep0" align="left">1433.0</td><td class="colsep0 rowsep0" align="left">669.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK mouse iv CL [L h<sup>–1</sup> kg<sup>–1</sup>]</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK mouse iv <i>C</i><sub>0</sub> [ng/mL]</td><td class="colsep0 rowsep0" align="left">310.0</td><td class="colsep0 rowsep0" align="left">216.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK mouse iv <i>t</i><sub>1/2<i>z</i></sub> [h]</td><td class="colsep0 rowsep0" align="left">18.7</td><td class="colsep0 rowsep0" align="left">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK mouse iv <i>V</i><sub><i>z</i></sub> [L/kg]</td><td class="colsep0 rowsep0" align="left">10.2</td><td class="colsep0 rowsep0" align="left">8.8</td></tr></tbody></table></div></div><div class="NLM_p">Compounds <b>21f</b> and <b>19h</b> displayed a good solubility at pH 7.4 (18.0 or 68.8 μM, respectively) and exhibited a good permeability in PAMPA and Caco-2 assays. The intrinsic clearance had been assessed by microsomal stability assays displaying sufficient stability of 18.3 μL min<sup>–1</sup> mg<sup>–1</sup> in human microsomes and 19.1 μL min<sup>–1</sup> mg<sup>–1</sup> in mouse microsomes for compound <b>21f</b> and 60.5 μL min<sup>–1</sup> mg<sup>–1</sup> in human microsomes and 143.3 μL min<sup>–1</sup> mg<sup>–1</sup> in mouse microsomes for compound <b>19h</b>. Both compounds feature very high human and murine plasma stability and are characterized by low plasma protein binding especially to murine plasma proteins with 95.9% and 97.2% (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>).</div><div class="NLM_p">After intravenous (iv) administration (3 mg/kg), compound <b>21f</b> demonstrated a good volume of distribution (<i>V</i><sub><i>z</i></sub>) of 8.8 L/kg in mouse and low systemic clearance (Cl) of 0.7 L h<sup>–1</sup> kg<sup>–1</sup> and a favorable half-life (<i>t</i><sub>1/2</sub>) of 8.5 h. Compound <b>19h</b> was characterized by slightly better volume of distribution (<i>V</i><sub><i>z</i></sub>) of 10.2 L/kg in mouse and lower systemic clearance (Cl) of 0.4 L h<sup>–1</sup> kg<sup>–1</sup> and a good half-life (<i>t</i><sub>1/2</sub>) of 18.7 h. Both compounds were well tolerated after oral administration (300 mg/kg), but unfortunately the measured oral bioavailability was very poor in mice.</div><div class="NLM_p">On the basis of its encouraging pharmacokinetic profile, compound <b>21f</b> was evaluated in in vivo efficacy studies (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Tumor volume reduction of compound <b>21f</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An AXL expressing MXT mammary tumor xenograft model was examined in which tumor cells were implanted subcutaneously and staged to approximately 125 mm<sup>3</sup> prior to commencement of daily intraperitoneal (ip) dosing of the compound for 21 consecutive days. Compound <b>21f</b> was active at all dose levels tested as defined by >50% tumor growth inhibition (TGI) over one tumor volume doubling time (TVDT). The minimum efficacious dose of 5 mg/kg corresponded with prolongation of survival time to 118% (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>).</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. In Vivo Efficiency of Compound <b>21f</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">adm</th><th class="colsep0 rowsep0" align="center" char=".">animal</th><th class="colsep0 rowsep0" align="center">survival (days)</th><th class="colsep0 rowsep0" align="center">average ± SD</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i>/<i>C</i><sub><i>x</i></sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">21 × qd</td><td class="colsep0 rowsep0" align="left">ip</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left">30, 30, 31, 31, 32, 32, 33</td><td class="colsep0 rowsep0" align="left">31.28 ± 1.11</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">21 × qd</td><td class="colsep0 rowsep0" align="left">ip</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left">35, 35, 36, 37, 37, 39, 39</td><td class="colsep0 rowsep0" align="left">36,.86 ± 1.68</td><td class="colsep0 rowsep0" align="char" char=".">118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">21 × qd</td><td class="colsep0 rowsep0" align="left">ip</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left">36, 37, 39, 39, 42, 43, 43</td><td class="colsep0 rowsep0" align="left">39.86 ± 2.85</td><td class="colsep0 rowsep0" align="char" char=".">127</td></tr></tbody></table></div></div><div class="NLM_p">The antitumor activity of example <b>21f</b> was dose responsive, and the compound reduced the tumor size by 40% compared to vehicle treatment after 3 weeks at a dose of 15 mg/kg and simultaneously prolonged the average survival time of the animals by 27% (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). No overt toxicity was observed at any of these dose levels as defined by weight loss or morbidity.</div><div class="NLM_p">Subsequently we performed a study to determine antimetastatic efficacy of <b>19h</b> against the MDA-MB231 human breast tumor in female SCID/beige mice; as reference treatment, paclitaxel was included for comparison. The mice were inoculated with MDA-MB-231 human breast tumor cells, orthotopically into the third mammary fat pad. Mice received treatment with vehicle control, <b>19h</b> (30 mg/kg), or paclitaxel (10 mg/kg). Vehicle control and <b>19h</b> were administered twice daily via intraperitoneal injection. Paclitaxel was administered three times weekly via intravenous injection.</div><div class="NLM_p">Body weight and tumor size measurements were made three times weekly for the duration of the study. Overall, there was significant mean body weight gain over the course of the study in the groups treated with vehicle control, <b>19h</b>, and paclitaxel (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Average body weight of female SCID/beige mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast to <b>19h</b> tumor growth was dramatically inhibited by paclitaxel (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).</div><figure id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Growth of MDA-MB-231 tumor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lung surface metastases and lymph node metastasis were assessed after formalin fixation, embedding, sectioning, and H&E for assessment of tumor cell infiltration. Although treatment with <b>19h</b> was not efficacious in inhibiting growth of the primary tumors, lung metastases were reduced by 65.7% and lymph node infiltrates by 14.3% compared with the vehicle control. The reference control treatment, paclitaxel, resulted in 54.3% inhibition of total lung metastases compared with vehicle control but did not prevent tumor cell infiltration into the regional lymph nodes compared with vehicle control as displayed in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> and <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>.</div><figure id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Mean total number of lung surface metastases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Mean score for tumor cell infiltration in lymph nodes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Novel substituted <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides were identified as potent inhibitors of AXL kinase. Optimization of the series SARs led to the identification of example <b>21f</b> as a selective and applicable AXL kinase inhibitor. A partial tumor stasis of 40% tumor growth was achieved in the MXT human mammary carcinoma xenograft model following ip administration with no observed toxicity.</div><div class="NLM_p last">On the basis of its favorable in vivo efficacy, pharmacokinetic profile, and safety profile, <b>19h</b> was additionally used to determine antimetastatic activity in an orthotopic and metastatic breast cancer model using human MDA-MB231 cell. Thereby we could prove the selective inhibition of lung surface metastasis by <b>19h</b> by 65.7% compared to vehicle control.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Information</h3><div class="NLM_p last">The commercially available reagents and solvents were used without further purification. The reactions were monitored by TLC, with Kieselgel 60 F<sub>254</sub> (Merck) plates, and visualized by UV light. Analytical data of compounds can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information</a>. Analytical HPLC–MS was performed on a Waters HPLC–MS system using reverse phase. Method A: Waters XBridge C18 (5 cm × 4.6 mm, 5 μm), gradient 0–95% B (0.00 min 5% B, 0.50 min 5% B, 5.50 min 95% B, 6.00 min 95% B, 6.50 min 5% B, 7.00 min 5% B). Solvent A: water/0.05% HCO<sub>2</sub>H. Solvent B: AcCN/0.05% HCO<sub>2</sub>H over 7.00 min, flow = 2.0 mL/min. Separation module was Waters Alliance 2795. Method B: Waters X Waters XBridge C18 (5 cm × 4.6 mm, 3.5 μm), gradient 0–95% B (0.00 min 5% B, 0.50 min 5% B, 5.5 min 95% B, 6.00 min 95% B, 6.50 min 5% B, 7.00 min 5% B). Solvent A: 5 mM NH<sub>4</sub>HCO<sub>3</sub>. Solvent B: AcCN over 7.00 min, flow = 2.0 mL/min. The separation module was Waters Alliance 2795. UV spectra were recorded using a Waters 996 DAD UV detector. Mass spectra were obtained using Waters SQD MS detector (ionization, ES<sup>+</sup>/ES<sup>–</sup>; source block temp, 120 °C; desolvation temp, 350 °C; desolvation gas, 400 L/h; cone gas, 100 L/h; capillary, 3000 V; cone, 25 V; extractor, 3 V; Rf lens, 0.2 V; scan, 120–1000 <i>m</i>/<i>z</i> in 1 s; interscan delay, 0.1 s). The NMR spectra were recorded on a Bruker Avance 300 MHz AV spectrometer operating at 7.05 T magnetic field, equipped with a 5 mm dual invese <i>z</i>-grad probehead, in deuterated dimethylsulfoxide (DMSO-<i>d</i><sub>6</sub>) solution, at 30 °C. The instrument was controlled, and the data were processed using TopSpin 1.3 software package. Chemical shifts (δ) are in parts per million (ppm) referenced to tetramethylsilane. HRMS was performed on an Agilent 6230C TOF LC/MS system with Agilent Jet Stream source, ESI positive mode. Buffer: ammonium formate in water/acetonitrile. Drying gas: 325 °C. V cap: 3000 V. Fragmentor: 100 V. Melting points were determined on a Büchi melting point B-540 instrument. All final compounds were purified to have ≥95% purity, controlled by analytical HPLC/UV/MS method (as described above), and confirmed by NMR.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of Compounds</h3><div class="NLM_p last">The detailed synthesis procedures of the compounds, the purity, and the chemical structure characterization are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Molecular Modeling</h3><div class="NLM_p last">The molecular modeling and pharmacophore model generation were carried out by Schrödinger Suite 2009 update 2 with the Confgen, LigPrep, Maestro, and Phase programs. The 3D structures of the molecules were generated by the LigPrep v2.3 at pH = 7.4 using the OPLS_2005 force field. All conformers were produced by Confgen with default settings. To specify the common pharmacophore features of the inhibitors, we applied Phase v3.1 which utilized a set of six pharmacophore points for model generation. These features were H-bond acceptor (A), H-bond donor (D), hydrophobic group (H), negatively (N) and positively ionizable (P) and aromatic ring (R). After the site creations pharmacophore hypotheses were generated, scored, and ranked by the software.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Biological Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Cellular Assays</h4><div class="NLM_p last">MDA-MB231 cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 1% sodium pyruvate (GE Heathcare, Wien, Austria), supplemented with 1% glutamine (GE Heathcare, Wien, Austria). Media were purchased from GIBCO and supplemented with 10% fetal calf serum (GIBCO, Invitrogen, Bleiswijk, The Netherlands). Cells were maintained at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub>.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3D Spheroid Culture</h4><div class="NLM_p last">BD Matrigel matrix basement membrane (BD Bioscience, USA, no. 354234) was diluted at a concentration of 3 mg/mL in cell line corresponding to serum free medium. 80 μL of precooled Matrigel was pipetted into the wells of precooled 96-well plates. The Matrigel polymerized at least 16 h at 37 °C. 7000 cells/well in 120 μL of medium were seeded on top of the solid Matrigel and formed aggregates in 5 h. Inhibitor treatments were initiated at the moment of cell seeding into Matrigel.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Cell Migration Assay</h4><div class="NLM_p last">The motility of the cells was determined by modified Boyden chamber assay. Cells were plated in medium with 0.1% FCS and transmigrated a 8 μm pores membrane (BD Transduction Laboratories, Heidelberg, Germany) toward medium with 1% FCS serving as a chemoattractant for 3.5 h. The cells which had traversed the membrane were counted on images taken with Axiovert 300 microscope (Zeiss, Jena, Germany). At least 5 random fields were counted per well.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Phospho-AXL ELISA</h4><div class="NLM_p last">AXL phosphorylation was determined using phosphotyrosine AXL enzyme-linked immunosorbant assay (p-Tyr-AXL ELISA). 75 000 NIH/3T3-AXL cells were seeded onto 6-well plates, starved for 24 h, and then treated with serially diluted inhibitor concentrations for 1 h. Cells were lysed on ice in 400 μL of lysis buffer for 15 min. 96-well Nunc MicroWell plates (Fisher Scientific GmbH, Germany) were coated overnight with 2 μg/mL of homemade anti-AXL capture antibody (homemade clone 259/2, IgG1 isotype) in PBS (100 μL/well). Subsequently 96-well plates were blocked with PBS/0.05% Tween 20 (Sigma-Aldrich, Germany) + 10% FBS for 4 h at 37 °C. Plates were washed 5 times with PBS/0.05% Tween 20, and 95 μL of lysate was transferred per well for incubation overnight at 4 °C. Plates were washed 5 times with PBS/0.05% Tween 20. For detection of phosphorylated tyrosine we used the biotinylated homemade anti-p-Tyr clone 4G10 antibody (0.5 μg/mL) in PBS/0.05% Tween 20 + 10% FBS (100 μL/well) and incubated the 96-well plate for 2 h at room temperature. The 4G10 antibody was biotinylated with sulfo-NHS-biotin according to the suppliers protocol (Pierce, USA) and purified by Micro Bio-Spin 6 chromatography columns (BIO RAD Laboratories, Inc., USA) using PBS as diluent. Plates were washed 5 times with PBS/0.05% Tween 20. Alkaline phosphatase-conjugated streptavidin SA110 (Millipore, USA) (1:4000) was used in PBS/0.05% Tween 20 + 10% FBS (100 μL/well) and incubated for 30 min at room temperature. Plates were washed 5 times with PBS/0.05% Tween 20. For fluorometric detection of alkaline phosphatase AttoPhos substrate set (Roche Diagnostics GmbH, Germany) was used (100 μL/well). The fluorometric signal was quantified after 90 min at a wavelength of 430/560 nm using a TECAN Ultra Evolution plate reader (Tecan Deutschland GmbH, Germany).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Kinase Selectivity Profiling</h4><div class="NLM_p last">The kinase selectivity profiling was performed by Proteros Biostructures GmbH (Germany) according to the companỳs standard operation procedure. The calculations of percent inhibition have been performed using three different types of assays, namely, IMAP, binding, and HTRF assay. The experiments have been performed in triplicate.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> IMAP Assay</h4><div class="NLM_p last">The IMAP assay (Molecular Devices) detects kinase activity in solution. A fluorescently labeled substrate peptide is phosphorylated in the kinase reaction. After the reaction, a binding solution containing large trivalent metal-based nanoparticles is added and the phosphorylated substrate binds to these beads. This reduces the rotational speed of the substrate which can be detected using fluorescence polarization. The following kinases were used: ABL, AKT1, AURA, AXL, CDK2, CDK4, CHK1, cKIT, c-MET, CSK, FGFR3, FLT3, IKKβ, INSR, IRAK4, JAK3, JNK1, ERK1, PAK1, PAK4, PDGFRβ, PIM1, PKCa, PLK3, Ret, RockII, SRC, SYC, TIE2, TRKA, VEGFR-2, and ZIPK.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Binding Assay</h4><div class="NLM_p last">The binding assay is based on reporter probes that are designed to bind to the site of interest of the target protein. The binding of the reporter probe to the protein results in the emission of an optical signal. Compounds that bind to the same site as the reporter probe displace the probe, causing signal diminution. Probe displacement is calculated in percent. Signal reflecting 100% probe displacement is determined in the absence of enzyme, while 0% probe displacement is measured in the absence of compound. The reporter probe is used at a concentration reflecting its own <i>K</i><sub>d</sub> (probe) value. The following kinases were used: BRAF, DDR1, and mTOR.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> HTRF Assay</h4><div class="NLM_p last">This assay detects kinase activity with time-resolved fluorescence transfer (TR-FRET). A biotinylated, kinase-specific peptide is phosphorylated in the kinase reaction. After the reaction, two detection reagents are added, first an antibody recognizing the phosphorylated amino acid residue which is labeled with europium cryptate as a FRET-donor, and second streptavidin which binds to the peptide via its biotin group and carries XL665 as a FRET-acceptor. If the substrate becomes phosphorylated, the close proximity between the FRET-donor and -acceptor allows for the measurement of the TR-FRET signal. The HER2 kinase was analyzed by HTRF-assay.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> KinAffinity</h4><div class="NLM_p last">To determine the quantitative kinase–target profile of these compounds, proprietary chemical proteomics methodologies and quantitative mass spectrometry were combined. The method was used as described by Sharma et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and Delehouzé et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In brief, a total lysate of SILAC-labeled MDA-MB-231 cells was prepared. Subsequently, a matrix comprising immobilized broad-spectrum kinase inhibitors was used to enrich the expressed kinome of the cell sample. Competition assays with the free compounds and quantitative mass spectrometric analyses revealed the compounds’ affinity profiles, ranking all kinase targets according to their <i>K</i><sub>d</sub> values for the free compounds. In summary, KinAffinity comprises five steps: (a) cell culture; (b) equilibrium binding of the target proteins to the KinAffinity matrix and the free test compound; (c) differential chemical isotope labeling of proteins retained by the KinAffinity matrix; (d) target identification and quantification by mass spectrometry; and (e) data processing, curve fitting, and target-affinity determination. Quantitative mass spectrometry requires the generation of differentially labeled protein samples. In the case of the MDA-MB-231 cells, this was achieved by stable isotope dimethyl labeling. The experimental setup of the chemical proteomics part was divided into two steps, both performed under equilibrium conditions. First, a lysate of MDA-MB-231 cells was applied to the KinAffinity matrix comprising different concentrations of various immobilized broadband kinase inhibitors, adjusted by dilution with control resin. These quantitative binding experiments allow one to determine the concentration of the immobilized compounds required to obtain 50% binding (BC<sub>50</sub>) of each target protein to the matrix. Second, a lysate of the MDA-MB-231 cells was applied to the KinAffinity matrix with the highest loading density of kinase inhibitors in the presence of increasing concentrations of the free compound <b>19h</b> or <b>19i</b>, respectively. These quantitative competition experiments determine the free compound concentration at which as many target proteins bind to the free compound as to the KinAffinity matrix (CC<sub>50</sub>). The final <i>K</i><sub>d</sub> values for the free compound are calculated for each target protein using the Cheng–Prusoff equation. Two quantitative competition experiments were performed in parallel to monitor whether equilibrium conditions were established. In the first experiment, the cell lysate was incubated with the free compound and the KinAffinity matrix was added subsequently. In the second experiment, the free compound and the KinAffinity matrix were added simultaneously. Under equilibrium conditions the competition curves from both experiments should be congruent for each target protein. Complete lists of all identified target kinases of <b>19h</b> and <b>19i</b> and of all kinases that bound to the KinAffinity matrix are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information, Table S3</a>.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Kinase Interaction Panel (DiscovRx KinomeScan 442 Kinases)</h4><div class="NLM_p last">Assays were performed essentially as described previously by Fabian et al.,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Karaman et al.,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and Wilson et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec4_4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> ADME Assays. Chemicals and Instruments</h4><div class="NLM_p last">All solvents, reagents, and l-α-phosphatidylcholine were purchased from Sigma-Aldrich Srl (Milan, Italy). Dodecane was purchased from Fluka (Milan, Italy). Pooled male donors 20 mg/mL HLM were from BD Gentest-Biosciences (San Jose, California). Milli-Q quality water (Millipore, Milford, MA, USA) was used. Hydrophobic filter plates (MultiScreen-IP, clear plates, 0.45 μm diameter pore size), 96-well microplates, and 96-well UV-transparent microplates were obtained from Millipore (Bedford, MA, USA). LC analyses for the PAMPA studies were performed with a PerkinElmer HPLC (series 200) equipped with an injector valve, a 20 μL sample loop (Mod. Rheodyne), and a UV detector (PerkinElmer 785A, UV/vis detector). UV detection was monitored at 254 nm. LC analyses for the solubility and metabolic stability studies were performed with an Agilent 1100 LC/MSD VL system (G1946C) (Agilent Technologies, Palo Alto, CA) constituted by a vacuum solvent degassing unit, a binary high-pressure gradient pump, an 1100 series UV detector, and an 1100 MSD model VL benchtop mass spectrometer. The Agilent 1100 series mass spectra detection (MSD) single-quadrupole instrument was equipped with the orthogonal spray API-ES (Agilent Technologies, Palo Alto, CA). Nitrogen was used as nebulizing and drying gas. The pressure of the nebulizing gas, the flow of the drying gas, the capillary voltage, the fragmentor voltage, and the vaporization temperature were set at 40 psi, 9 L/min, 3000 V, 70 V, and 350 °C, respectively. UV detection was monitored at 254 nm. The LC–ESI-MS determination was performed by operating the MSD in the positive ion mode. Spectra were acquired over the scan range <i>m</i>/<i>z</i> 100–1500 using a step size of 0.1 us.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Solubility Assay</h4><div class="NLM_p last">Stock solutions of each compound in 10<sup>–3</sup> M DMSO were prepared and sequentially diluted to reach the 10<sup>–6</sup> M concentration. Four different aliquots (1.0, 1.5, 3.0, and 6.0 μL) of each 10<sup>–6</sup> M stock solution of all compounds were dispensed into well plates with the necessary amount of water to reach the final volume of 300 μL. Wells were shaken in a shaker bath at room temperature for 24 h. These suspensions were filtered through a 0.45 μm nylon filter (Acrodisc), proceeding with the chromatographic assays, performed in triplicate for each compound. Quantitative analysis was performed by means of the LC–UV method above-reported. LC analyses were conducted via HPLC (Agilent 1100 LC/MSD VL system) using a Varian Polaris 5 C18-A column (150 mm × 4.6 mm, 5 μm particle size) maintained at room temperature at a flow rate of 0.8 mL/min with a mobile phase composed of 70% ACN/H<sub>2</sub>O 30%.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Parallel Artificial Membrane Permeability Assay (PAMPA)</h4><div class="NLM_p last">Donor solution (0.5 mM) was prepared by diluting 1 mM dimethyl sulfoxide (DMSO) compound stock solution using phosphate buffer (pH 7.4, 0.025 M). Filters were coated with 5 μL of a 1% (w/v) dodecane solution of phosphatidylcholine. Donor solution (150 μL) was added to each well of the filter plate. To each well of the acceptor plate was added 300 μL of solution (50% DMSO in phosphate buffer). All compounds were tested in three different plates on different days. The sandwich was incubated for 5 h at room temperature under gentle shaking. After the incubation time, the sandwich plates were separated, and samples were taken from both receiver and donor sides and analyzed using LC with UV detection. LC analyses were conducted via HPLC (PerkinElmer series 200) using a Polaris C18 column (150 mm × 4.6 mm, 5 μm particle size) at a flow rate of 0.8 mL/min with a mobile phase composed of 80% ACN/20% H<sub>2</sub>O–formic acid 0.1%. Permeability (<i>P</i><sub>app</sub>) for PAMPA was calculated to obtain permeability values in cm/s, where VA is the volume in the acceptor well, VD is the volume in the donor well (cm<sup>3</sup>), <i>A</i> is the “effective area” of the membrane (cm<sup>2</sup>), <i>t</i> is the incubation time (s), and <i>r</i> is the ratio between drug concentration in the acceptor and equilibrium concentration of the drug in the total volume (VD + VA). Drug concentration is estimated by using the peak area integration.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Caco-2 Permeability Assay</h4><div class="NLM_p last">Caco-2 cells, grown in tissue culture flasks, were trypsinized, resuspended, and grown and differentiated in 96-well plates for 3 weeks; monolayer formation was determined by measuring transport of Lucifer yellow, an impermeable dye. All assays were performed at a concentration of 10 μM for 2 h. For apical to basolateral (A → B) permeability, compounds were added on the apical side (A), with permeation determined at the receiving (basolateral, B) side, where the receiving buffer was removed for analysis by LC/MS/MS using an Agilent 6410 mass spectrometer (ESI, MRM mode) coupled with an Agilent 1200 HPLC. Buffers used were 100 μM Lucifer yellow in transport buffer (1.98 g/L glucose in 10 mM HEPES, 1× Hank’s balanced salt solution, pH 6.5) (apical side) and transport buffer, pH 7.4 (basolateral side). Apparent permeability (<i>P</i><sub>app</sub>) is expressed using the following equation: <i>P</i><sub>app</sub> = (d<i>Q</i>/d<i>t</i>)/(<i>C</i><sub>0</sub><i>A</i>), where the numerator is the rate of permeation, <i>C</i><sub>0</sub> is initial concentration, and <i>A</i> is the monolayer area. For bidirectional permeability, the efflux ratio was defined as <i>P</i><sub>app</sub>(B→A)/<i>P</i><sub>app</sub>(A→B); high efflux ratio values (>3) indicate that a compound may be a substrate for P-gp or other active transport systems.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Microsomal Stability Assay</h4><div class="NLM_p last">Each compound in DMSO solution was incubated at 37 °C for 60 min in 125 mM phosphate buffer (pH 7.4), 5 μL of human liver microsomal protein (0.2 mg/mL), in the presence of a NADPH-generating system at a final volume of 0.5 mL (compounds’ final concentration, 100 μM); DMSO did not exceed 2% (final solution). The reaction was stopped by cooling in ice and adding 1.0 mL of acetonitrile. The reaction mixtures were then centrifuged, and the parent drug and metabolites were subsequently determined by LC–MS. Quantitative and qualitative analysis was performed by means of the LC–UV method above-reported. LC analyses were conducted via HPLC (Agilent 1100 LC/MSD VL system) using a Varian Polaris 5 C18-A column (150 mm × 4.6 mm, 5 μm particle size) maintained at room temperature. Chromatographic analysis was carried out using gradient elution with eluent A being ACN and eluent B consisting of an aqueous solution of formic acid (0.1%). The analysis started with 10% of eluent A, which was rapidly increased up to 70% in 10 min, then slowly increased up to 98% in 15 min, and finally returned to 10% of eluent A in 1.0 min. The flow rate was 0.8 mL/min, and injection volume was 5 μL.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Procedures for the Microsomal Stability Assay</h4><div class="NLM_p last">All assays were conducted in duplicate. The incubation mixtures were prepared in E-tube and were contained with 5 μM synthesized analogue, 1 mg/mL liver microsomes (from mouse and human), and NADPH regeneration solution (1.3 mM NADP<sup>+</sup>, 3.3 mM glucose 6-phosphate, 3.3 mM MgCl<sub>2</sub>, and 0.4 U/mL glucose 6-phosphate dehydrogenase) in 100 mM potassium phosphate buffer solution. Reactions were initiated by the addition of NADPH and kept in a shaking water bath at 37 °C. At each sampling time, aliquots were removed and added to termination solvent (acetonitrile). The samples were centrifuged for 4–5 min at 13 000 rpm, and the supernatant was subjected to HPLC analysis (HPLC/Agilent 1200 series). In the determination of the in vitro <i>t</i><sub>1/2</sub> (half-life, HL), the analyte peak areas were converted to percentage of drug remaining, using the <i>T</i> = 0 peak area values as 100%. The slope of the linear regression from log percentage remaining versus incubation time relationships (−<i>k</i>) was used in the conversion to the in vitro <i>t</i><sub>1/2</sub> values by the in vitro <i>t</i><sub>1/2</sub> = −0.693/<i>k</i>. The percent remaining of test compound is calculated compared to the initial quantity at 0 time.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Pharmacokinetic Studies</h4><div class="NLM_p last">Male mice (imprinting control region mice, body-weight range of 27 ± 5 g, iv, <i>n</i> = 3, po, <i>n</i> = 3) were administered intravenously via the tail vein at 2 and 1 mg/kg, respectively, or orally at 10 and 5 mg/kg, respectively, by gavage in a solution of 30% PEG400 and 5% ethanol in distilled water. At predetermined times 24 h or more after dosing, 0.3 mL of blood was collected from the jugular vein using a tube containing anticoagulant (1000 IU/mL, heparin, 3 μL). The plasma was separated by centrifugation (12 000 rpm, 2 min, Eppendorf). The concentrations of the compound were measured in the plasma using LC/MS/MS after protein precipitation with acetonitrile. The relevant estimated pharmacokinetic parameters for plasma were derived using WinNonlin, version 5.2 (Pharsight).</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Mouse Studies</h4><div class="NLM_p">MDA-MB231 human breast tumors were orthotopically inoculated into female SCID/beige mice (Harlan Laboratories, Inc., USA). MBA-MB231 human breast tumor cells were cultured in MEM cell culture medium, supplemented with 10% FBS, 1% Glutamax, 1% sodium pyruvate, NEAA, and 1% penicillin–streptomycin. The cells were suspended in HBSS/Matrigel (1:1, v/v) to a final concentration of 4 × 10<sup>7</sup> cells/mL. The mice were anesthetized with ketamine (14 mg/mL)/xylazine (0.9 mg/mL) prior to inoculation. The needle was introduced directly into the third mammary fat pad where 50 μL of cells (2 × 10<sup>6</sup> cells) were discharged. Vehicle control (PEG400/H<sub>2</sub>0 (70:30 v/v), <b>19h</b> (30 mg/kg) were administered twice daily (12 h apart) via intraperitoneal injection (ip). Paclitaxel (10 mg/kg) was administered three times weekly via intravenous injection (iv). 10 animals per group were used. Body weights were recorded for all animals three times per week. Tumor dimensions (length and diameter) were measured for all animals beginning when first palpable (day 12 of the study) and then three times per week. The tumor, lungs, and regional lymph nodes (as many as could be found in each mouse) were excised from all mice. Lung surface and lung micrometastases were assessed. Lungs and lymph nodes were preserved in 10% neutral buffered formalin. Lymph nodes were embedded, and sections were stained with hematoxylin & eosin (H&E) for assessment of tumor cell infiltration. Mean score ± SEM values of all lymph nodes in each group were calculated.</div><div class="NLM_p last">During the study, the care and use of animals was conducted in accordance with the principles outlined in the Guide for the Care and Use of Laboratory Animals, 8th ed., 2010 (National Research Council). All procedures used in the performance of this study were carried out in accordance with vivoPharm’s standard operating procedures.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00672" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00672" class="ext-link">10.1021/acs.jmedchem.8b00672</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed synthesis procedures and characterization data for all compounds, 1D and correlation NMR spectra for the selected compounds (<b>18d</b>, <b>19e</b>, <b>19h</b>, <b>19i</b>, <b>20b</b>, <b>20g</b>, <b>21f</b>), DiscoveRx Kinomescan kinase selectivity panel (442 kinases) at 5 μM concentration for <b>20b</b> and <b>20g</b> (Tables S1 and S2), and complete lists of all kinases that bound to the KinAffinity matrix and of all identified target kinases (Table S3) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound characterization checklist (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_002.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">Molecular formula strings and AXL IC<sub>50</sub>values (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf">jm8b00672_si_001.pdf (3.93 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_002.xls">jm8b00672_si_002.xls (121.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_003.csv">jm8b00672_si_003.csv (5.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00672" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">László Őrfi</span> - <span class="hlFld-Affiliation affiliation">Vichem
Chemie Research Ltd., Budapest 1022, Hungary</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Semmelweis
University, Budapest 1092, Hungary</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6149-2385" title="Orcid link">http://orcid.org/0000-0001-6149-2385</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5c332e3a3572303d2f2630331c2c343d2e313d722f39313139302b39352f712932352a723429"><span class="__cf_email__" data-cfemail="b2ddc0d4db9cded3c1c8deddf2c2dad3c0dfd39cc1d7dfdfd7dec5d7dbc19fc7dcdbc49cdac7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">István Szabadkai</span> - <span class="hlFld-Affiliation affiliation">Vichem
Chemie Research Ltd., Budapest 1022, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Torka</span> - <span class="hlFld-Affiliation affiliation">Institute
of Physiological Chemistry, University Halle-Wittenberg, Halle (Saale) 06108, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Garamvölgyi</span> - <span class="hlFld-Affiliation affiliation">Vichem
Chemie Research Ltd., Budapest 1022, Hungary</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Semmelweis
University, Budapest 1092, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferenc Baska</span> - <span class="hlFld-Affiliation affiliation">Vichem
Chemie Research Ltd., Budapest 1022, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pál Gyulavári</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest 1094, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sándor Boros</span> - <span class="hlFld-Affiliation affiliation">Vichem
Chemie Research Ltd., Budapest 1022, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eszter Illyés</span> - <span class="hlFld-Affiliation affiliation">Vichem
Chemie Research Ltd., Budapest 1022, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Axel Choidas</span> - <span class="hlFld-Affiliation affiliation">Lead
Discovery Center GmbH, Dortmund 44227, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Axel Ullrich</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Biology, Max Planck Institute
of Biochemistry, Martinsried 82152, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>I.S. and R.T. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The research leading to these results was supported by the Max-Planck Society. The authors thank Servier Research Institute of Medicinal Chemistry (Budapest) for the HRMS measurements and Dr. András Dancsó (EGIS Pharmaceuticals PLC) for his help in the molecular modeling and pharmacophore model generation.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DFG</td><td class="NLM_def"><p class="first last">Asp(D)-Phe(F)-Gly(G) residues of the activation loop</p></td></tr><tr><td class="NLM_term">IMAP</td><td class="NLM_def"><p class="first last">immobilized metal assay for phosphochemicals</p></td></tr><tr><td class="NLM_term">MXT</td><td class="NLM_def"><p class="first last">mammary tumor xenograft model</p></td></tr></table><span class="title" id="d410528955e3657">Additional Note</span><div class="NLM_fn" id="AbbrevInfo"><p class="first last">The full names of abbreviated kinases mentioned in the manuscript can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf" class="ext-link">Supporting Information, Table S4 (page S154)</a>.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Bryan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogswell, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokop, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le
Beau, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E. T.</span></span> <span> </span><span class="NLM_article-title">AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5016</span>– <span class="NLM_lpage">5031</span>, <span class="refDoi"> DOI: 10.1128/MCB.11.10.5016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1128%2FMCB.11.10.5016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1656220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADyaK38XlvVGrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=5016-5031&author=J.+P.+O%E2%80%99Bryanauthor=R.+A.+Fryeauthor=P.+C.+Cogswellauthor=A.+Neubauerauthor=B.+Kitchauthor=C.+Prokopauthor=R.+Espinosaauthor=M.+M.+Le%0ABeauauthor=H.+S.+Earpauthor=E.+T.+Liu&title=AXL%2C+a+transforming+gene+isolated+from+primary+human+myeloid+leukemia+cells%2C+encodes+a+novel+receptor+tyrosine+kinase&doi=10.1128%2FMCB.11.10.5016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">axl, A transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase</span></div><div class="casAuthors">O'Bryan, John P.; Frye, Roy A.; Cogswell, Patricia C.; Neubauer, Andreas; Kitch, Barry; Prokop, Carol; Espinosa, Rafael, III; Le Beau, Michelle M.; Earp, H. Shelton; Liu, Edison T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5016-31</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A sensitive transfection-tumorigenicity assay was used to isolate a novel transforming gene from the DNA of 2 patients with chronic myelogenous leukemia.  Sequence anal. indicates that the product of this gene, axl, is a receptor tyrosine kinase.  Overexpression of axl cDNA in NIH 3T3 cells induces neoplastic transformation with the concomitant appearance of a 140-kDa axl tyrosine-phosphorylated protein.  Expression of axl cDNA in the baculovirus system results in the expression of the appropriate recombinant protein that is tyrosine kinase.  The juxtaposition of fibronectin type III and immunoglobulinlike repeats in the extracellular domain, as well as distinct amino acid sequences in the kinase domain, indicate that the axl protein represents a novel subclass of receptor tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCIaouGK3RfrVg90H21EOLACvtfcHk0liTqyOzPjd4gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVGrsLs%253D&md5=f244ff83822fdb98c22a35f918723d3a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FMCB.11.10.5016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.11.10.5016%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Bryan%26aufirst%3DJ.%2BP.%26aulast%3DFrye%26aufirst%3DR.%2BA.%26aulast%3DCogswell%26aufirst%3DP.%2BC.%26aulast%3DNeubauer%26aufirst%3DA.%26aulast%3DKitch%26aufirst%3DB.%26aulast%3DProkop%26aufirst%3DC.%26aulast%3DEspinosa%26aufirst%3DR.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26atitle%3DAXL%252C%2520a%2520transforming%2520gene%2520isolated%2520from%2520primary%2520human%2520myeloid%2520leukemia%2520cells%252C%2520encodes%2520a%2520novel%2520receptor%2520tyrosine%2520kinase%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1991%26volume%3D11%26spage%3D5016%26epage%3D5031%26doi%3D10.1128%2FMCB.11.10.5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steenvoorden, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strehl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambros, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartram, C. R.</span></span> <span> </span><span class="NLM_article-title">A novel putative tyrosine kinase receptor with oncogenic potential</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2113</span>– <span class="NLM_lpage">2120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=2113-2120&author=J.+W.+Janssenauthor=A.+S.+Schulzauthor=A.+C.+Steenvoordenauthor=M.+Schmidbergerauthor=S.+Strehlauthor=P.+F.+Ambrosauthor=C.+R.+Bartram&title=A+novel+putative+tyrosine+kinase+receptor+with+oncogenic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DJ.%2BW.%26aulast%3DSchulz%26aufirst%3DA.%2BS.%26aulast%3DSteenvoorden%26aufirst%3DA.%2BC.%26aulast%3DSchmidberger%26aufirst%3DM.%26aulast%3DStrehl%26aufirst%3DS.%26aulast%3DAmbros%26aufirst%3DP.%2BF.%26aulast%3DBartram%26aufirst%3DC.%2BR.%26atitle%3DA%2520novel%2520putative%2520tyrosine%2520kinase%2520receptor%2520with%2520oncogenic%2520potential%26jtitle%3DOncogene%26date%3D1991%26volume%3D6%26spage%3D2113%26epage%3D2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paccez, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelsang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerbini, L. F.</span></span> <span> </span><span class="NLM_article-title">The receptor tyrosine kinase AXL in cancer: Biological functions and therapeutic implications</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1002/ijc.28246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1002%2Fijc.28246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=23649974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFOls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=1024-1033&issue=5&author=J.+D.+Paccezauthor=M.+Vogelsangauthor=M.+I.+Parkerauthor=L.+F.+Zerbini&title=The+receptor+tyrosine+kinase+AXL+in+cancer%3A+Biological+functions+and+therapeutic+implications&doi=10.1002%2Fijc.28246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implications</span></div><div class="casAuthors">Paccez, Juliano D.; Vogelsang, Matjaz; Parker, M. Iqbal; Zerbini, Luiz F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1024-1033</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The receptor tyrosine kinase Axl has been implicated in the malignancy of different types of cancer.  Emerging evidence of Axl upregulation in numerous cancers, as well as reports demonstrating that its inhibition blocks tumor formation in animal models, highlight the importance of Axl as a new potential therapeutic target.  Furthermore, recent data demonstrate that Axl plays a pivotal role in resistance to chemotherapeutic regimens.  In this review we discuss the functions of Axl and its regulation and role in cancer development, resistance to therapy, and its importance as a potential drug target, focusing on acute myeloid leukemia, breast, prostate and non-small cell lung cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj6kP36FkPT7Vg90H21EOLACvtfcHk0liTqyOzPjd4gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFOls7w%253D&md5=3a4604c7451c3b64911230c4ca2841b3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.28246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28246%26sid%3Dliteratum%253Aachs%26aulast%3DPaccez%26aufirst%3DJ.%2BD.%26aulast%3DVogelsang%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DM.%2BI.%26aulast%3DZerbini%26aufirst%3DL.%2BF.%26atitle%3DThe%2520receptor%2520tyrosine%2520kinase%2520AXL%2520in%2520cancer%253A%2520Biological%2520functions%2520and%2520therapeutic%2520implications%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2014%26volume%3D134%26issue%3D5%26spage%3D1024%26epage%3D1033%26doi%3D10.1002%2Fijc.28246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stitt, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goret, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radzlejewski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masiakowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobkes, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiStefano, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basilico, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfarb, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yancopoulos, G. D.</span></span> <span> </span><span class="NLM_article-title">The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro3/AXL family of receptor tyrosine kinases</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90520-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1016%2F0092-8674%2895%2990520-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=661-670&author=T.+N.+Stittauthor=G.+Connauthor=M.+Goretauthor=C.+Laiauthor=J.+Brunoauthor=C.+Radzlejewskiauthor=K.+Mattssonauthor=J.+Fisherauthor=D.+R.+Giesauthor=P.+F.+Jonesauthor=P.+Masiakowskiauthor=T.+E.+Ryanauthor=N.+J.+Tobkesauthor=D.+H.+Chenauthor=P.+S.+DiStefanoauthor=G.+L.+Longauthor=C.+Basilicoauthor=M.+P.+Goldfarbauthor=G.+Lemkeauthor=D.+J.+Glassauthor=G.+D.+Yancopoulos&title=The+anticoagulation+factor+protein+S+and+its+relative%2C+Gas6%2C+are+ligands+for+the+Tyro3%2FAXL+family+of+receptor+tyrosine+kinases&doi=10.1016%2F0092-8674%2895%2990520-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990520-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990520-0%26sid%3Dliteratum%253Aachs%26aulast%3DStitt%26aufirst%3DT.%2BN.%26aulast%3DConn%26aufirst%3DG.%26aulast%3DGoret%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DC.%26aulast%3DBruno%26aufirst%3DJ.%26aulast%3DRadzlejewski%26aufirst%3DC.%26aulast%3DMattsson%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DJ.%26aulast%3DGies%26aufirst%3DD.%2BR.%26aulast%3DJones%26aufirst%3DP.%2BF.%26aulast%3DMasiakowski%26aufirst%3DP.%26aulast%3DRyan%26aufirst%3DT.%2BE.%26aulast%3DTobkes%26aufirst%3DN.%2BJ.%26aulast%3DChen%26aufirst%3DD.%2BH.%26aulast%3DDiStefano%26aufirst%3DP.%2BS.%26aulast%3DLong%26aufirst%3DG.%2BL.%26aulast%3DBasilico%26aufirst%3DC.%26aulast%3DGoldfarb%26aufirst%3DM.%2BP.%26aulast%3DLemke%26aufirst%3DG.%26aulast%3DGlass%26aufirst%3DD.%2BJ.%26aulast%3DYancopoulos%26aufirst%3DG.%2BD.%26atitle%3DThe%2520anticoagulation%2520factor%2520protein%2520S%2520and%2520its%2520relative%252C%2520Gas6%252C%2520are%2520ligands%2520for%2520the%2520Tyro3%252FAXL%2520family%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCell%26date%3D1995%26volume%3D80%26spage%3D661%26epage%3D670%26doi%3D10.1016%2F0092-8674%2895%2990520-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goruppi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruaro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnum, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span> <span> </span><span class="NLM_article-title">Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-AXL mitogenic and survival activities in NIH3T3 fibroblasts</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4442</span>– <span class="NLM_lpage">4453</span>, <span class="refDoi"> DOI: 10.1128/MCB.17.8.4442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1128%2FMCB.17.8.4442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=9234702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVersbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=4442-4453&author=S.+Goruppiauthor=E.+Ruaroauthor=B.+Varnumauthor=C.+Schneider&title=Requirement+of+phosphatidylinositol+3-kinase-dependent+pathway+and+Src+for+Gas6-AXL+mitogenic+and+survival+activities+in+NIH3T3+fibroblasts&doi=10.1128%2FMCB.17.8.4442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts</span></div><div class="casAuthors">Goruppi, Sandro; Ruaro, Elisabetta; Varnum, Brian; Schneider, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4442-4453</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Gas6 is a secreted protein previously identified as the ligand of the Axl receptor tyrosine kinase.  We have shown that Gas6 is able to induce cell cycle reentry of serum-starved NIH 3T3 cells and to efficiently prevent apoptosis after complete growth factor removal, a survival effect uncoupled from Gas6-induced mitogenesis.  Here we report that the mitogenic effect of Gas6 requires phosphatidylinositol 3-kinase (PI3K) activity since it is abrogated both by the specific inhibitor wortmannin and by overexpression of the dominant neg. PI3K p85 subunit.  Consistently, Gas6 activates the PI3K downstream targets S6K and Akt, whose activation is abrogated by addn. to wortmannin.  Moreover, rapamycin treatment blocks Gas6-induced entry into the S phase of serum-starved NIH 3T3 cells.  We also demonstrate the requirement of Src tyrosine kinase for Gas6 signalling since stable or transient expression of a catalytically inactive form of Src significantly inhibited Gas6-stimulated entry into the S phase.  Accordingly, Gas6 addn. to serum-starved NIH 3T3 cells causes activation of the intrinsic Src kinase activity.  When specifically analyzed in a survival assay, these elements were found to be required for the survival effect of Gas6.  Taken together, the evidence presented here identifies elements involved in the Gas6 transduction pathway that are responsible for its antiapoptotic effect and suggests that Src is involved in the events regulating cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCEApQM2nLQ7Vg90H21EOLACvtfcHk0liPwLic_v_OVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVersbY%253D&md5=b12b92b14568e2e41f04818caf82a1dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FMCB.17.8.4442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.17.8.4442%26sid%3Dliteratum%253Aachs%26aulast%3DGoruppi%26aufirst%3DS.%26aulast%3DRuaro%26aufirst%3DE.%26aulast%3DVarnum%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DRequirement%2520of%2520phosphatidylinositol%25203-kinase-dependent%2520pathway%2520and%2520Src%2520for%2520Gas6-AXL%2520mitogenic%2520and%2520survival%2520activities%2520in%2520NIH3T3%2520fibroblasts%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1997%26volume%3D17%26spage%3D4442%26epage%3D4453%26doi%3D10.1128%2FMCB.17.8.4442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verardo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnum, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span> <span> </span><span class="NLM_article-title">Gas6 anti-apoptotic signaling requires NF-kappa B activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">31738</span>– <span class="NLM_lpage">31744</span>, <span class="refDoi"> DOI: 10.1074/jbc.M104457200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1074%2Fjbc.M104457200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=31738-31744&author=F.+Demarchiauthor=R.+Verardoauthor=B.+Varnumauthor=C.+Brancoliniauthor=C.+Schneider&title=Gas6+anti-apoptotic+signaling+requires+NF-kappa+B+activation&doi=10.1074%2Fjbc.M104457200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M104457200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M104457200%26sid%3Dliteratum%253Aachs%26aulast%3DDemarchi%26aufirst%3DF.%26aulast%3DVerardo%26aufirst%3DR.%26aulast%3DVarnum%26aufirst%3DB.%26aulast%3DBrancolini%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DGas6%2520anti-apoptotic%2520signaling%2520requires%2520NF-kappa%2520B%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D31738%26epage%3D31744%26doi%3D10.1074%2Fjbc.M104457200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goruppi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruaro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span> <span> </span><span class="NLM_article-title">Gas6, the ligand of AXL tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1996&pages=471-480&author=S.+Goruppiauthor=E.+Ruaroauthor=C.+Schneider&title=Gas6%2C+the+ligand+of+AXL+tyrosine+kinase+receptor%2C+has+mitogenic+and+survival+activities+for+serum+starved+NIH3T3+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoruppi%26aufirst%3DS.%26aulast%3DRuaro%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DGas6%252C%2520the%2520ligand%2520of%2520AXL%2520tyrosine%2520kinase%2520receptor%252C%2520has%2520mitogenic%2520and%2520survival%2520activities%2520for%2520serum%2520starved%2520NIH3T3%2520fibroblasts%26jtitle%3DOncogene%26date%3D1996%26volume%3D12%26spage%3D471%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanagita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukatsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, T.</span></span> <span> </span><span class="NLM_article-title">Gas6 induces mesangial cell proliferation via latent transcription factor STAT3</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">42364</span>– <span class="NLM_lpage">42369</span>, <span class="refDoi"> DOI: 10.1074/jbc.M107488200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1074%2Fjbc.M107488200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=42364-42369&author=M.+Yanagitaauthor=H.+Araiauthor=T.+Nakanoauthor=K.+Ohashiauthor=K.+Mizunoauthor=A.+Fukatsuauthor=T.+Doiauthor=T.+Kita&title=Gas6+induces+mesangial+cell+proliferation+via+latent+transcription+factor+STAT3&doi=10.1074%2Fjbc.M107488200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M107488200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M107488200%26sid%3Dliteratum%253Aachs%26aulast%3DYanagita%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DK.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DFukatsu%26aufirst%3DA.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DKita%26aufirst%3DT.%26atitle%3DGas6%2520induces%2520mesangial%2520cell%2520proliferation%2520via%2520latent%2520transcription%2520factor%2520STAT3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D42364%26epage%3D42369%26doi%3D10.1074%2Fjbc.M107488200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holland, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friera, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pali, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogenberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorens, J. B.</span></span> <span> </span><span class="NLM_article-title">Multiple roles for the receptor tyrosine kinase AXL in tumor formation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">9294</span>– <span class="NLM_lpage">9303</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-0993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-05-0993" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=9294-9303&author=S.+J.+Hollandauthor=M.+J.+Powellauthor=C.+Franciauthor=E.+W.+Chanauthor=A.+M.+Frieraauthor=R.+E.+Atchisonauthor=J.+McLaughlinauthor=S.+E.+Swiftauthor=E.+S.+Paliauthor=G.+Yamauthor=S.+Wongauthor=J.+Lasagaauthor=M.+R.+Shenauthor=S.+Yuauthor=W.+Xuauthor=Y.+Hitoshiauthor=J.+Bogenbergerauthor=J.+E.+Norauthor=D.+G.+Payanauthor=J.+B.+Lorens&title=Multiple+roles+for+the+receptor+tyrosine+kinase+AXL+in+tumor+formation&doi=10.1158%2F0008-5472.CAN-05-0993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-0993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-0993%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DS.%2BJ.%26aulast%3DPowell%26aufirst%3DM.%2BJ.%26aulast%3DFranci%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DE.%2BW.%26aulast%3DFriera%26aufirst%3DA.%2BM.%26aulast%3DAtchison%26aufirst%3DR.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DJ.%26aulast%3DSwift%26aufirst%3DS.%2BE.%26aulast%3DPali%26aufirst%3DE.%2BS.%26aulast%3DYam%26aufirst%3DG.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DLasaga%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DM.%2BR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DHitoshi%26aufirst%3DY.%26aulast%3DBogenberger%26aufirst%3DJ.%26aulast%3DNor%26aufirst%3DJ.%2BE.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DLorens%26aufirst%3DJ.%2BB.%26atitle%3DMultiple%2520roles%2520for%2520the%2520receptor%2520tyrosine%2520kinase%2520AXL%2520in%2520tumor%2520formation%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D9294%26epage%3D9303%26doi%3D10.1158%2F0008-5472.CAN-05-0993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dufies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belhacene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cluzeau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassuto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberger, P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of AXL overexpression and function in imatinib-resistant chronic myeloid leukemia cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.18632%2Foncotarget.360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=874-885&author=M.+Dufiesauthor=A.+Jacquelauthor=N.+Belhaceneauthor=G.+Robertauthor=T.+Cluzeauauthor=F.+Lucianoauthor=J.+P.+Cassutoauthor=S.+Raynaudauthor=P.+Auberger&title=Mechanisms+of+AXL+overexpression+and+function+in+imatinib-resistant+chronic+myeloid+leukemia+cells&doi=10.18632%2Foncotarget.360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.360%26sid%3Dliteratum%253Aachs%26aulast%3DDufies%26aufirst%3DM.%26aulast%3DJacquel%26aufirst%3DA.%26aulast%3DBelhacene%26aufirst%3DN.%26aulast%3DRobert%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DT.%26aulast%3DLuciano%26aufirst%3DF.%26aulast%3DCassuto%26aufirst%3DJ.%2BP.%26aulast%3DRaynaud%26aufirst%3DS.%26aulast%3DAuberger%26aufirst%3DP.%26atitle%3DMechanisms%2520of%2520AXL%2520overexpression%2520and%2520function%2520in%2520imatinib-resistant%2520chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D874%26epage%3D885%26doi%3D10.18632%2Foncotarget.360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Croce, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakalya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garewal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, D.</span></span> <span> </span><span class="NLM_article-title">A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3909</span>– <span class="NLM_lpage">3919</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fsj.onc.1210173" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3909-3919&author=D.+Mahadevanauthor=L.+Cookeauthor=C.+Rileyauthor=R.+Swartauthor=B.+Simonsauthor=K.+Della+Croceauthor=L.+Wisnerauthor=M.+Iorioauthor=K.+Shakalyaauthor=H.+Garewalauthor=R.+Nagleauthor=D.+Bearss&title=A+novel+tyrosine+kinase+switch+is+a+mechanism+of+imatinib+resistance+in+gastrointestinal+stromal+tumors&doi=10.1038%2Fsj.onc.1210173"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210173%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DCooke%26aufirst%3DL.%26aulast%3DRiley%26aufirst%3DC.%26aulast%3DSwart%26aufirst%3DR.%26aulast%3DSimons%26aufirst%3DB.%26aulast%3DDella%2BCroce%26aufirst%3DK.%26aulast%3DWisner%26aufirst%3DL.%26aulast%3DIorio%26aufirst%3DM.%26aulast%3DShakalya%26aufirst%3DK.%26aulast%3DGarewal%26aufirst%3DH.%26aulast%3DNagle%26aufirst%3DR.%26aulast%3DBearss%26aufirst%3DD.%26atitle%3DA%2520novel%2520tyrosine%2520kinase%2520switch%2520is%2520a%2520mechanism%2520of%2520imatinib%2520resistance%2520in%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D3909%26epage%3D3919%26doi%3D10.1038%2Fsj.onc.1210173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knyazev, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheburkin, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knyazev, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Őrfi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daub, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span> <span> </span><span class="NLM_article-title">AXL is a potential target for therapeutic intervention in breast cancer progression</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1905</span>– <span class="NLM_lpage">1915</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-2661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-07-2661" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1905-1915&author=Y.+X.+Zhangauthor=P.+G.+Knyazevauthor=Y.+V.+Cheburkinauthor=K.+Sharmaauthor=Y.+P.+Knyazevauthor=L.+%C5%90rfiauthor=I.+Szabadkaiauthor=H.+Daubauthor=G.+K%C3%A9riauthor=A.+Ullrich&title=AXL+is+a+potential+target+for+therapeutic+intervention+in+breast+cancer+progression&doi=10.1158%2F0008-5472.CAN-07-2661"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-2661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-2661%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BX.%26aulast%3DKnyazev%26aufirst%3DP.%2BG.%26aulast%3DCheburkin%26aufirst%3DY.%2BV.%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DKnyazev%26aufirst%3DY.%2BP.%26aulast%3D%25C5%2590rfi%26aufirst%3DL.%26aulast%3DSzabadkai%26aufirst%3DI.%26aulast%3DDaub%26aufirst%3DH.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DAXL%2520is%2520a%2520potential%2520target%2520for%2520therapeutic%2520intervention%2520in%2520breast%2520cancer%2520progression%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1905%26epage%3D1915%26doi%3D10.1158%2F0008-5472.CAN-07-2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greshock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathe, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmer, T. M.</span></span> <span> </span><span class="NLM_article-title">Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">6871</span>– <span class="NLM_lpage">6878</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-08-4490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6871-6878&author=L.+Liuauthor=J.+Gregerauthor=H.+Shiauthor=Y.+Liuauthor=J.+Greshockauthor=R.+Annanauthor=W.+Halseyauthor=G.+M.+Satheauthor=A.+M.+Martinauthor=T.+M.+Gilmer&title=Novel+mechanism+of+lapatinib+resistance+in+HER2-positive+breast+tumor+cells%3A+activation+of+AXL&doi=10.1158%2F0008-5472.CAN-08-4490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4490%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGreger%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DAnnan%26aufirst%3DR.%26aulast%3DHalsey%26aufirst%3DW.%26aulast%3DSathe%26aufirst%3DG.%2BM.%26aulast%3DMartin%26aufirst%3DA.%2BM.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DNovel%2520mechanism%2520of%2520lapatinib%2520resistance%2520in%2520HER2-positive%2520breast%2520tumor%2520cells%253A%2520activation%2520of%2520AXL%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6871%26epage%3D6878%26doi%3D10.1158%2F0008-5472.CAN-08-4490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullo-Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaseelan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppenheimer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokarski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wautlet, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the MET kinase superfamily</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1254</span>, <span class="refDoi"> DOI: 10.1021/jm801586s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.+W.+Caiauthor=X.+T.+Chenauthor=C.+Clarkauthor=L.+A.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+MET+kinase+superfamily&doi=10.1021%2Fjm801586s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily</span></div><div class="casAuthors">Schroeder, Gretchen M.; An, Yongmi; Cai, Zhen-Wei; Chen, Xiao-Tao; Clark, Cheryl; Cornelius, Lyndon A. M.; Dai, Jun; Gullo-Brown, Johnni; Gupta, Ashok; Henley, Benjamin; Hunt, John T.; Jeyaseelan, Robert; Kamath, Amrita; Kim, Kyoung; Lippy, Jonathan; Lombardo, Louis J.; Manne, Veeraswamy; Oppenheimer, Simone; Sack, John S.; Schmidt, Robert J.; Shen, Guoxiang; Stefanski, Kevin; Tokarski, John S.; Trainor, George L.; Wautlet, Barri S.; Wei, Donna; Williams, David K.; Zhang, Yingru; Zhang, Yueping; Fargnoli, Joseph; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1254</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted N-(4-(2-aminopyridin-4-yloxy)-3-fluoro-phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamides were identified as potent and selective Met kinase inhibitors.  Substitution of the pyridine 3-position gave improved enzyme potency, while substitution of the pyridone 4-position led to improved aq. soly. and kinase selectivity.  Analog 10 demonstrated complete tumor stasis in a Met-dependent GTL-16 human gastric carcinoma xenograft model following oral administration.  Because of its excellent in vivo efficacy and favorable pharmacokinetic and preclin. safety profiles, 10 has been advanced into phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHEvJXf0Fq7Vg90H21EOLACvtfcHk0lg8gcW51zYXvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D&md5=784623be820fcc8b931200ced3a476df</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DX.%2BT.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520MET%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254%26doi%3D10.1021%2Fjm801586s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentzien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joly, A. H.</span></span> <span> </span><span class="NLM_article-title">Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2298</span>– <span class="NLM_lpage">2308</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F1535-7163.MCT-11-0264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=21926191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2298-2308&author=F.+M.+Yakesauthor=J.+Chenauthor=J.+Tanauthor=K.+Yamaguchiauthor=Y.+Shiauthor=P.+Yuauthor=F.+Qianauthor=F.+Chuauthor=F.+Bentzienauthor=B.+Cancillaauthor=J.+Orfauthor=A.+Youauthor=A.+D.+Lairdauthor=S.+Engstauthor=L.+Leeauthor=J.+Leschauthor=Y.+C.+Chouauthor=A.+H.+Joly&title=Cabozantinib+%28XL184%29%2C+a+novel+MET+and+VEGFR2+inhibitor%2C+simultaneously+suppresses+metastasis%2C+angiogenesis%2C+and+tumor+growth&doi=10.1158%2F1535-7163.MCT-11-0264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth</span></div><div class="casAuthors">Yakes, F. Michael; Chen, Jason; Tan, Jenny; Yamaguchi, Kyoko; Shi, Yongchang; Yu, Peiwen; Qian, Fawn; Chu, Felix; Bentzien, Frauke; Cancilla, Belinda; Orf, Jessica; You, Andrew; Laird, A. Douglas; Engst, Stefan; Lee, Lillian; Lesch, Justin; Chou, Yu-Chien; Joly, Alison H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2298-2308</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor (HGF) is important for cell growth, survival, and motility and is functionally linked to the signaling pathway of VEGF, which is widely recognized as a key effector in angiogenesis and cancer progression.  Dysregulation of the MET/VEGF axis is found in a no. of human malignancies and has been assocd. with tumorigenesis.  Cabozantinib (XL184) is a small-mol. kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a no. of other receptor tyrosine kinases that have also been implicated in tumor pathobiol., including RET, KIT, AXL, and FLT3.  Treatment with cabozantinib inhibited MET and VEGFR2 phosphorylation in vitro and in tumor models in vivo and led to significant redns. in cell invasion in vitro.  In mouse models, cabozantinib dramatically altered tumor pathol., resulting in decreased tumor and endothelial cell proliferation coupled with increased apoptosis and dose-dependent inhibition of tumor growth in breast, lung, and glioma tumor models.  Importantly, treatment with cabozantinib did not increase lung tumor burden in an exptl. model of metastasis, which has been obsd. with inhibitors of VEGF signaling that do not target MET.  Collectively, these data suggest that cabozantinib is a promising agent for inhibiting tumor angiogenesis and metastasis in cancers with dysregulated MET and VEGFR signaling.  Mol Cancer Ther; 10(12); 2298-308.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGtQ_JaTP9IrVg90H21EOLACvtfcHk0lg8gcW51zYXvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnF&md5=3f573795ecee42deeee25005f991868f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0264%26sid%3Dliteratum%253Aachs%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DCancilla%26aufirst%3DB.%26aulast%3DOrf%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DA.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DY.%2BC.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DCabozantinib%2520%2528XL184%2529%252C%2520a%2520novel%2520MET%2520and%2520VEGFR2%2520inhibitor%252C%2520simultaneously%2520suppresses%2520metastasis%252C%2520angiogenesis%252C%2520and%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2298%26epage%3D2308%26doi%3D10.1158%2F1535-7163.MCT-11-0264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burbridge, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fejes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léonce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Violante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouzom, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquet-Bescond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comoglio, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierré, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depil, S.</span></span> <span> </span><span class="NLM_article-title">S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in asociation with bevacizumab</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1762</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F1535-7163.MCT-13-0075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=23804704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1749-1762&author=M.+F.+Burbridgeauthor=C.+J.+Bossardauthor=C.+Saunierauthor=I.+Fejesauthor=A.+Brunoauthor=S.+L%C3%A9onceauthor=G.+Ferryauthor=G.+Da+Violanteauthor=F.+Bouzomauthor=V.+Cattanauthor=A.+Jacquet-Bescondauthor=P.+M.+Comoglioauthor=B.+P.+Lockhartauthor=J.+A.+Boutinauthor=A.+Cordiauthor=J.+C.+Ortunoauthor=A.+Pierr%C3%A9author=J.+A.+Hickmanauthor=F.+H.+Cruzaleguiauthor=S.+Depil&title=S49076+is+a+novel+kinase+inhibitor+of+MET%2C+AXL%2C+and+FGFR+with+strong+preclinical+activity+alone+and+in+asociation+with+bevacizumab&doi=10.1158%2F1535-7163.MCT-13-0075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab</span></div><div class="casAuthors">Burbridge, Mike F.; Bossard, Celine J.; Saunier, Carine; Fejes, Imre; Bruno, Alain; Leonce, Stephane; Ferry, Gilles; Da Violante, Georges; Bouzom, Francois; Cattan, Valerie; Jacquet-Bescond, Anne; Comoglio, Paolo M.; Lockhart, Brian P.; Boutin, Jean A.; Cordi, Alex; Ortuno, Jean-Claude; Pierre, Alain; Hickman, John A.; Cruzalegui, Francisco H.; Depil, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1749-1762</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant activity of the receptor tyrosine kinases MET, AXL, and FGFR1/2/3 has been assocd. with tumor progression in a wide variety of human malignancies, notably in instances of primary or acquired resistance to existing or emerging anticancer therapies.  This study describes the preclin. characterization of S49076, a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3.  S49076 potently blocked cellular phosphorylation of MET, AXL, and FGFRs and inhibited downstream signaling in vitro and in vivo.  In cell models, S49076 inhibited the proliferation of MET- and FGFR2-dependent gastric cancer cells, blocked MET-driven migration of lung carcinoma cells, and inhibited colony formation of hepatocarcinoma cells expressing FGFR1/2 and AXL.  In tumor xenograft models, a good pharmacokinetic/pharmacodynamic relationship for MET and FGFR2 inhibition following oral administration of S49076 was established and correlated well with impact on tumor growth.  MET, AXL, and the FGFRs have all been implicated in resistance to VEGF/VEGFR inhibitors such as bevacizumab.  Accordingly, combination of S49076 with bevacizumab in colon carcinoma xenograft models led to near total inhibition of tumor growth.  Moreover, S49076 alone caused tumor growth arrest in bevacizumab-resistant tumors.  On the basis of these preclin. studies showing a favorable and novel pharmacol. profile of S49076, a phase I study is currently underway in patients with advanced solid tumors.  Mol Cancer Ther; 12(9); 1749-62. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodE4VwyiV-HrVg90H21EOLACvtfcHk0ljBSaYLafIjzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7O&md5=a53009f7a7b0601cf45598ca5b8775c2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0075%26sid%3Dliteratum%253Aachs%26aulast%3DBurbridge%26aufirst%3DM.%2BF.%26aulast%3DBossard%26aufirst%3DC.%2BJ.%26aulast%3DSaunier%26aufirst%3DC.%26aulast%3DFejes%26aufirst%3DI.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DFerry%26aufirst%3DG.%26aulast%3DDa%2BViolante%26aufirst%3DG.%26aulast%3DBouzom%26aufirst%3DF.%26aulast%3DCattan%26aufirst%3DV.%26aulast%3DJacquet-Bescond%26aufirst%3DA.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DLockhart%26aufirst%3DB.%2BP.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26aulast%3DCordi%26aufirst%3DA.%26aulast%3DOrtuno%26aufirst%3DJ.%2BC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DCruzalegui%26aufirst%3DF.%2BH.%26aulast%3DDepil%26aufirst%3DS.%26atitle%3DS49076%2520is%2520a%2520novel%2520kinase%2520inhibitor%2520of%2520MET%252C%2520AXL%252C%2520and%2520FGFR%2520with%2520strong%2520preclinical%2520activity%2520alone%2520and%2520in%2520asociation%2520with%2520bevacizumab%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1749%26epage%3D1762%26doi%3D10.1158%2F1535-7163.MCT-13-0075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holland, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torneros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckrodt, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apatira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitoshi, Y.</span></span> <span> </span><span class="NLM_article-title">R428, a selective small molecule inhibitor of AXL kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1544</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-09-2997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1544-1554&author=S.+J.+Hollandauthor=A.+Panauthor=C.+Franciauthor=Y.+Huauthor=B.+Changauthor=W.+Liauthor=M.+Duanauthor=A.+Tornerosauthor=J.+Yuauthor=T.+J.+Heckrodtauthor=J.+Zhangauthor=P.+Dingauthor=A.+Apatiraauthor=J.+Chuaauthor=R.+Brandtauthor=P.+Pineauthor=D.+Goffauthor=R.+Singhauthor=D.+G.+Payanauthor=Y.+Hitoshi&title=R428%2C+a+selective+small+molecule+inhibitor+of+AXL+kinase%2C+blocks+tumor+spread+and+prolongs+survival+in+models+of+metastatic+breast+cancer&doi=10.1158%2F0008-5472.CAN-09-2997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2997%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DS.%2BJ.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DFranci%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DTorneros%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DHeckrodt%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DApatira%26aufirst%3DA.%26aulast%3DChua%26aufirst%3DJ.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DGoff%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DHitoshi%26aufirst%3DY.%26atitle%3DR428%252C%2520a%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520AXL%2520kinase%252C%2520blocks%2520tumor%2520spread%2520and%2520prolongs%2520survival%2520in%2520models%2520of%2520metastatic%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1544%26epage%3D1554%26doi%3D10.1158%2F0008-5472.CAN-09-2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Székelyhidi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bánhegyi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegymegi-Barakonyi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szántai-Kis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafenbradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erös, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horváth, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greff, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marosfalvi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pató, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szilágyi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szegedi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wáczek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Őrfi, L.</span></span> <span> </span><span class="NLM_article-title">Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1089/adt.2005.3.543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1089%2Fadt.2005.3.543" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=543-551&author=G.+K%C3%A9riauthor=Z.+Sz%C3%A9kelyhidiauthor=P.+B%C3%A1nhegyiauthor=Z.+Vargaauthor=B.+Hegymegi-Barakonyiauthor=C.+Sz%C3%A1ntai-Kisauthor=D.+Hafenbradlauthor=B.+Kleblauthor=G.+Mullerauthor=A.+Ullrichauthor=D.+Er%C3%B6sauthor=Z.+Horv%C3%A1thauthor=Z.+Greffauthor=J.+Marosfalviauthor=J.+Pat%C3%B3author=I.+Szabadkaiauthor=I.+Szil%C3%A1gyiauthor=Z.+Szegediauthor=I.+Vargaauthor=F.+W%C3%A1czekauthor=L.+%C5%90rfi&title=Drug+discovery+in+the+kinase+inhibitory+field+using+the+Nested+Chemical+Library+technology&doi=10.1089%2Fadt.2005.3.543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1089%2Fadt.2005.3.543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2005.3.543%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DSz%25C3%25A9kelyhidi%26aufirst%3DZ.%26aulast%3DB%25C3%25A1nhegyi%26aufirst%3DP.%26aulast%3DVarga%26aufirst%3DZ.%26aulast%3DHegymegi-Barakonyi%26aufirst%3DB.%26aulast%3DSz%25C3%25A1ntai-Kis%26aufirst%3DC.%26aulast%3DHafenbradl%26aufirst%3DD.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DG.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DEr%25C3%25B6s%26aufirst%3DD.%26aulast%3DHorv%25C3%25A1th%26aufirst%3DZ.%26aulast%3DGreff%26aufirst%3DZ.%26aulast%3DMarosfalvi%26aufirst%3DJ.%26aulast%3DPat%25C3%25B3%26aufirst%3DJ.%26aulast%3DSzabadkai%26aufirst%3DI.%26aulast%3DSzil%25C3%25A1gyi%26aufirst%3DI.%26aulast%3DSzegedi%26aufirst%3DZ.%26aulast%3DVarga%26aufirst%3DI.%26aulast%3DW%25C3%25A1czek%26aufirst%3DF.%26aulast%3D%25C5%2590rfi%26aufirst%3DL.%26atitle%3DDrug%2520discovery%2520in%2520the%2520kinase%2520inhibitory%2520field%2520using%2520the%2520Nested%2520Chemical%2520Library%2520technology%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2005%26volume%3D3%26spage%3D543%26epage%3D551%26doi%3D10.1089%2Fadt.2005.3.543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murooka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoe, T.</span></span> <span> </span><span class="NLM_article-title">Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N’-{4-(4-quinolyloxy)phenyl}ureas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1359</span>– <span class="NLM_lpage">1366</span>, <span class="refDoi"> DOI: 10.1021/jm030427r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030427r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1359-1366&author=K.+Kuboauthor=T.+Shimizuauthor=S.+Ohyamaauthor=H.+Murookaauthor=A.+Iwaiauthor=K.+Nakamuraauthor=K.+Hasegawaauthor=Y.+Kobayashiauthor=N.+Takahashiauthor=K.+Takahashiauthor=S.+Katoauthor=T.+Izawaauthor=T.+Isoe&title=Novel+potent+orally+active+selective+VEGFR-2+tyrosine+kinase+inhibitors%3A+synthesis%2C+structure-activity+relationships%2C+and+antitumor+activities+of+N-phenyl-N%E2%80%99-%7B4-%284-quinolyloxy%29phenyl%7Dureas&doi=10.1021%2Fjm030427r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm030427r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030427r%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DIwai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DIsoe%26aufirst%3DT.%26atitle%3DNovel%2520potent%2520orally%2520active%2520selective%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%253A%2520synthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520antitumor%2520activities%2520of%2520N-phenyl-N%25E2%2580%2599-%257B4-%25284-quinolyloxy%2529phenyl%257Dureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1359%26epage%3D1366%26doi%3D10.1021%2Fjm030427r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeppen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settleman, J.</span></span> <span> </span><span class="NLM_article-title">AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5878</span>– <span class="NLM_lpage">5890</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-1009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-14-1009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5878-5890&issue=20&author=C.+Wilsonauthor=X.+Yeauthor=T.+Phamauthor=E.+Linauthor=S.+Chanauthor=E.+McNamaraauthor=R.+M.+Neveauthor=L.+Belmontauthor=H.+Koeppenauthor=R.+L.+Yauchauthor=A.+Ashkenaziauthor=J.+Settleman&title=AXL+inhibition+sensitizes+mesenchymal+cancer+cells+to+antimitotic+drugs&doi=10.1158%2F0008-5472.CAN-14-1009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1009%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DMcNamara%26aufirst%3DE.%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DBelmont%26aufirst%3DL.%26aulast%3DKoeppen%26aufirst%3DH.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DAXL%2520inhibition%2520sensitizes%2520mesenchymal%2520cancer%2520cells%2520to%2520antimitotic%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D20%26spage%3D5878%26epage%3D5890%26doi%3D10.1158%2F0008-5472.CAN-14-1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Alfonso, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. J.</span></span> <span> </span><span class="NLM_article-title">AXL receptor tyrosine kinase expression in breast cancer</span>. <i>J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1136/jclinpath-2013-202161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1136%2Fjclinpath-2013-202161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=24904064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOqu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=690-696&author=T.+M.+D%E2%80%99Alfonsoauthor=J.+Hannahauthor=Z.+Chenauthor=Y.+Liuauthor=P.+Zhouauthor=S.+J.+Shin&title=AXL+receptor+tyrosine+kinase+expression+in+breast+cancer&doi=10.1136%2Fjclinpath-2013-202161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Axl receptor tyrosine kinase expression in breast cancer</span></div><div class="casAuthors">D'Alfonso, Timothy M.; Hannah, Jeffrey; Chen, Zhengming; Liu, Yifang; Zhou, Pengbo; Shin, Sandra J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">690-696</span>CODEN:
                <span class="NLM_cas:coden">JCPAAK</span>;
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Aims Triple-neg. breast cancer comprises a clin. aggressive group of invasive carcinomas.  We examd. a published gene expression screen of a panel of breast cancer cell lines to identify a potential triple-neg. breast cancer-specific gene signature, and attempted to verify our findings by performing immunohistochem. anal. on tissue microarrays contg. a large cohort of invasive breast carcinomas.  Methods The microarray dataset for a panel of human breast cancer cell lines was interrogated for triple-neg. breast cancer-specific genes.  Membranous immunohistochem. expression of the protein product of the AXL gene was assessed semiquant. in 569 invasive breast carcinomas grouped according to mol. subgroup by immunohistochem.  Results AXL was significantly upregulated in triple-neg./basal B cell lines compared with luminal or basal A cell lines.  No significant difference was obsd. in the level of immunohistochem. expression of Axl protein between triple-neg. breast cancers and other mol. subgroups (p=0.257).  Axl expression was significantly assocd. with lymphovascular invasion (LVI) in all subgroups combined (p=0.033), and within the luminal A (p=0.002) and triple-neg. breast cancer subgroups (p=0.026).  Conclusions Despite preferential upregulation of AXL in triple-neg./basal B cell lines, anal. of Axl protein expression in a large series of patients' breast tumors revealed no assocn. between Axl expression and triple-neg. breast cancer or other subtype.  The assocn. of Axl expression with LVI supports previous work that implicates Axl as a promoter of invasiveness in breast cancer cell lines.  Further studies are necessary to explore whether Axl expression of individual breast cancer tumors can be clin. useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcgtaivOWrLVg90H21EOLACvtfcHk0ljzxAPunA1Vjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOqu77E&md5=f856dcd153719c4f00c0d660d8bd85a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fjclinpath-2013-202161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjclinpath-2013-202161%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Alfonso%26aufirst%3DT.%2BM.%26aulast%3DHannah%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DShin%26aufirst%3DS.%2BJ.%26atitle%3DAXL%2520receptor%2520tyrosine%2520kinase%2520expression%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D2014%26volume%3D67%26spage%3D690%26epage%3D696%26doi%3D10.1136%2Fjclinpath-2013-202161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Phyllodes tumor of the breast: role of AXL and ST6GalNAcII in the development of mammary phyllodes tumors</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">9603</span>– <span class="NLM_lpage">9612</span>, <span class="refDoi"> DOI: 10.1007/s13277-014-2254-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1007%2Fs13277-014-2254-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=9603-9612&author=D.+Renauthor=Y.+Liauthor=Y.+Gongauthor=J.+Xuauthor=X.+Miaoauthor=X.+Liauthor=C.+Liuauthor=L.+Jiaauthor=Y.+Zhao&title=Phyllodes+tumor+of+the+breast%3A+role+of+AXL+and+ST6GalNAcII+in+the+development+of+mammary+phyllodes+tumors&doi=10.1007%2Fs13277-014-2254-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors</span></div><div class="casAuthors">Ren, Dongliang; Li, Yanyan; Gong, Yanxin; Xu, Jingchao; Miao, Xiaolong; Li, Xiangnan; Liu, Chen; Jia, Li; Zhao, Yongfu</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9603-9612</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Phyllodes tumor exhibits an aggressive growth.  The expression of many biol. markers has been explored to discriminate between different grades of phyllodes tumor and to predict their behavior.  The purpose of this study was to evaluate the implications of Axl and ST6GalNAcII in phyllodes tumors.  Real-time PCR, Western blot, and immunohistochem. were used to analyze differential expression of ST6GalNAcII and Axl in phyllodes tumor (PT) cell lines and tissue specimens.  RNAi assay, ECM invasion assay, and tumorigenicity assay were used to analyze the altered expression of ST6GalNAcII gene effects on the expression of Axl and invasive ability of phyllodes tumor cells in vitro and in vivo.  Compared to benign tumors, borderline and malignant ones showed a remarkable increase in mRNA levels of Axl and ST6GalNAcII gene, and it was higher in malignant tumor cells than in borderline tumor cells.  When ST6GalNAcII was silenced, compared to the control, the expression level of Axl was significantly reduced in malignant tumor cell transfectants and knockdown of ST6GalNAcII gene significantly inhibited invasive activity in malignant tumor cells.  The high expression of ST6GalNAcII and Axl was significantly correlated with tumor grade and distance metastasis by immunohistochem. anal.  Axl and ST6GalNAcII expression increases with increasing tumor grade in mammary phyllodes tumors.  ST6GalNAc II might be participated in the glycosylation of Axl, and this Axl glycosylation may mediate the tumorigenicity, invasion, and distant metastasis of PT cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUbERBhcisv7Vg90H21EOLACvtfcHk0ljzxAPunA1Vjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCisL7E&md5=d1178b243429dbef0eb1c241622baef5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs13277-014-2254-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-014-2254-9%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DPhyllodes%2520tumor%2520of%2520the%2520breast%253A%2520role%2520of%2520AXL%2520and%2520ST6GalNAcII%2520in%2520the%2520development%2520of%2520mammary%2520phyllodes%2520tumors%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D9603%26epage%3D9612%26doi%3D10.1007%2Fs13277-014-2254-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pénzes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Őrfi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torka, R.</span></span> <span> </span><span class="NLM_article-title">Combined inhibition of AXL, LYN and p130Cas kinases block migration of triple negative breast cancer cells</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1571</span>– <span class="NLM_lpage">1582</span>, <span class="refDoi"> DOI: 10.4161/15384047.2014.956634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.4161%2F15384047.2014.956634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=25482942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1CitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1571-1582&issue=11&author=K.+P%C3%A9nzesauthor=C.+Baumannauthor=I.+Szabadkaiauthor=L.+%C5%90rfiauthor=G.+K%C3%A9riauthor=A.+Ullrichauthor=R.+Torka&title=Combined+inhibition+of+AXL%2C+LYN+and+p130Cas+kinases+block+migration+of+triple+negative+breast+cancer+cells&doi=10.4161%2F15384047.2014.956634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells</span></div><div class="casAuthors">Penzes, Kinga; Baumann, Christine; Szabadkai, Istvan; Orfi, Laszlo; Keri, Gyoergy; Ullrich, Axel; Torka, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1571-1582</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Blocking the migration of metastatic cancer cells is a major goal in the therapy of cancer.  The receptor tyrosine kinase AXL is one of the main triggers for cancer cell migration in neoplasia of breast, colon, skin, thyroid and prostate.  In our study we analyzed the effect of AXL inhibition on cell motility and viability in triple neg. breast cancer cell lines overexpressing AXL.  Thereby we reveal that the compd. BMS777607, exhibiting the lowest IC50 values for inhibition of AXL kinase activity in the studied cell lines, attenuates cell motility to a lower extent than the kinase inhibitors MPCD84111 and SKI606.  By analyzing the target kinases of MPCD84111 and SKI606 with kinase profiling assays we identified Lyn, a Src family kinase, as a target of both compds.  Knockdown of Lyn and the migration-related CRK-assocd. substrate (p130Cas), had a significant inhibitory effect on cell migration.  Taken together, our findings highlight the importance of combinatorial or multikinase inhibition of non-receptor tyrosine kinases and AXL receptor tyrosine kinase in the therapy of triple neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhT0VlhaQCZLVg90H21EOLACvtfcHk0lgO88e8r5yjGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1CitbY%253D&md5=1e1de8bb8ab9a08df42ce9dbb061bee5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2F15384047.2014.956634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F15384047.2014.956634%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9nzes%26aufirst%3DK.%26aulast%3DBaumann%26aufirst%3DC.%26aulast%3DSzabadkai%26aufirst%3DI.%26aulast%3D%25C5%2590rfi%26aufirst%3DL.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DTorka%26aufirst%3DR.%26atitle%3DCombined%2520inhibition%2520of%2520AXL%252C%2520LYN%2520and%2520p130Cas%2520kinases%2520block%2520migration%2520of%2520triple%2520negative%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2014%26volume%3D15%26issue%3D11%26spage%3D1571%26epage%3D1582%26doi%3D10.4161%2F15384047.2014.956634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uribe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandell, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothlin, C. V.</span></span> <span> </span><span class="NLM_article-title">The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">e0179979</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0179979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1371%2Fjournal.pone.0179979" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0179979&issue=7&author=D.+J.+Uribeauthor=E.+K.+Mandellauthor=A.+Watsonauthor=J.+D.+Martinezauthor=J.+A.+Leightonauthor=S.+Ghoshauthor=C.+V.+Rothlin&title=The+receptor+tyrosine+kinase+AXL+promotes+migration+and+invasion+in+colorectal+cancer&doi=10.1371%2Fjournal.pone.0179979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0179979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0179979%26sid%3Dliteratum%253Aachs%26aulast%3DUribe%26aufirst%3DD.%2BJ.%26aulast%3DMandell%26aufirst%3DE.%2BK.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DJ.%2BD.%26aulast%3DLeighton%26aufirst%3DJ.%2BA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DRothlin%26aufirst%3DC.%2BV.%26atitle%3DThe%2520receptor%2520tyrosine%2520kinase%2520AXL%2520promotes%2520migration%2520and%2520invasion%2520in%2520colorectal%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D7%26spage%3De0179979%26doi%3D10.1371%2Fjournal.pone.0179979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leconet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chentouf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Manoir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirvent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aït-Arsa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarlier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radosevic-Robin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalbos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquet, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pèlegrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbouret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, B.</span></span> <span> </span><span class="NLM_article-title">Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasis</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2816</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F1078-0432.CCR-16-1316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=27923843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Sms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=2806-2816&issue=11&author=W.+Leconetauthor=M.+Chentoufauthor=S.+du+Manoirauthor=C.+Chevalierauthor=A.+Sirventauthor=I.+A%C3%AFt-Arsaauthor=M.+Bussonauthor=M.+Jarlierauthor=N.+Radosevic-Robinauthor=C.+Theilletauthor=D.+Chalbosauthor=J.+M.+Pasquetauthor=A.+P%C3%A8legrinauthor=C.+Larbouretauthor=B.+Robert&title=Therapeutic+activity+of+anti-AXL+antibody+against+triple-negative+breast+cancer+patient-derived+xenografts+and+metastasis&doi=10.1158%2F1078-0432.CCR-16-1316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis</span></div><div class="casAuthors">Leconet, Wilhem; Chentouf, Myriam; du Manoir, Stanislas; Chevalier, Clement; Sirvent, Audrey; Ait-Arsa, Imade; Busson, Muriel; Jarlier, Marta; Radosevic-Robin, Nina; Theillet, Charles; Chalbos, Dany; Pasquet, Jean-Max; Pelegrin, Andre; Larbouret, Christel; Robert, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2806-2816</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: AXL receptor tyrosine kinase has been described as a relevant mol. marker and a key player in invasiveness, esp. in triple-neg. breast cancer (TNBC).  Exptl. Design: We evaluate the antitumor efficacy of the anti-AXL monoclonal antibody 20G7-D9 in several TNBC cell xenografts or patient-derived xenograft (PDX) models and decipher the underlying mechanisms.  In a dataset of 254 basal-like breast cancer samples, genes correlated with AXL expression are enriched in EMT, migration, and invasion signaling pathways.  Results: Treatment with 20G7-D9 inhibited tumor growth and bone metastasis formation in AXL-pos. TNBC cell xenografts or PDX, but not in AXL-neg. PDX, highlighting AXL role in cancer growth and invasion.  In vitro stimulation of AXL-pos. cancer cells by its ligand GAS6 induced the expression of several EMT-assocd. genes (SNAIL, SLUG, and VIM) through an intracellular signaling implicating the transcription factor FRA-1, important in cell invasion and plasticity, and increased their migration/invasion capacity.  20G7-D9 induced AXL degrdn. and inhibited all AXL/GAS6-dependent cell signaling implicated in EMT and in cell migration/invasion.  Conclusions: The anti-AXL antibody 20G7-D9 represents a promising therapeutic strategy in TNBC with mesenchymal features by inhibiting AXL-dependent EMT, tumor growth, and metastasis formation.  Clin Cancer Res; 23(11); 2806-16. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryhj78vnIErLVg90H21EOLACvtfcHk0lgO88e8r5yjGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Sms7w%253D&md5=7acbd854a7b2ad9ea8cf02a73d8ba7c7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1316%26sid%3Dliteratum%253Aachs%26aulast%3DLeconet%26aufirst%3DW.%26aulast%3DChentouf%26aufirst%3DM.%26aulast%3Ddu%2BManoir%26aufirst%3DS.%26aulast%3DChevalier%26aufirst%3DC.%26aulast%3DSirvent%26aufirst%3DA.%26aulast%3DA%25C3%25AFt-Arsa%26aufirst%3DI.%26aulast%3DBusson%26aufirst%3DM.%26aulast%3DJarlier%26aufirst%3DM.%26aulast%3DRadosevic-Robin%26aufirst%3DN.%26aulast%3DTheillet%26aufirst%3DC.%26aulast%3DChalbos%26aufirst%3DD.%26aulast%3DPasquet%26aufirst%3DJ.%2BM.%26aulast%3DP%25C3%25A8legrin%26aufirst%3DA.%26aulast%3DLarbouret%26aufirst%3DC.%26aulast%3DRobert%26aufirst%3DB.%26atitle%3DTherapeutic%2520activity%2520of%2520anti-AXL%2520antibody%2520against%2520triple-negative%2520breast%2520cancer%2520patient-derived%2520xenografts%2520and%2520metastasis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26issue%3D11%26spage%3D2806%26epage%3D2816%26doi%3D10.1158%2F1078-0432.CCR-16-1316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerchia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camorani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rienzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stasio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insabato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Franciscis, V.</span></span> <span> </span><span class="NLM_article-title">Targeting Axl with an high-affinity inhibitory aptamer</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2291</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1038/mt.2012.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fmt.2012.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=22910292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1akt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2291-2303&issue=12&author=L.+Cerchiaauthor=C.+L.+Espositoauthor=S.+Camoraniauthor=A.+Rienzoauthor=L.+Stasioauthor=L.+Insabatoauthor=A.+Affusoauthor=V.+de+Franciscis&title=Targeting+Axl+with+an+high-affinity+inhibitory+aptamer&doi=10.1038%2Fmt.2012.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Axl With an High-affinity Inhibitory Aptamer</span></div><div class="casAuthors">Cerchia, Laura; Esposito, Carla L.; Camorani, Simona; Rienzo, Anna; Stasio, Loredana; Insabato, Luigi; Affuso, Andrea; de Franciscis, Vittorio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2291-2303</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Axl is a tyrosine kinase receptor that was first identified as a transforming gene in human myeloid leukemia.  Recent converging evidence suggests its implication in cancer progression and invasion for several solid tumors, including lung, breast, brain, thyroid, and pancreas.  In the last decade, Axl has thus become an attractive target for therapeutic development of more aggressive cancers.  An emerging class of therapeutic inhibitors is now represented by short nucleic acid aptamers.  These mols. act as high affinity ligands with several advantages over conventional antibodies for their use in vivo, including their small size and negligible immunogenicity.  Furthermore, these mols. can easily form conjugates able to drive the specific delivery of interfering RNAs, nanoparticles, or chemotherapeutics.  We have thus generated and characterized a selective RNA-based aptamer, GL21.  T that binds the extracellular domain of Axl at high affinity (12 nmol/l) and inhibits its catalytic activity.  GL21.  T blocked Axl-dependent transducing events in vitro, including Erk and Akt phosphorylation, cell migration and invasion, as well as in vivo lung tumor formation in mice xenografts.  In this respect, the GL21.  T aptamer represents a promising therapeutic mol. for Axl-dependent cancers whose importance is highlighted by the paucity of available Axl-specific inhibitory mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre_yrVIQ8jRbVg90H21EOLACvtfcHk0lilVmyYp7xbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1akt7%252FJ&md5=6c48a764272ab123bf1db79ca0de744b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fmt.2012.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2012.163%26sid%3Dliteratum%253Aachs%26aulast%3DCerchia%26aufirst%3DL.%26aulast%3DEsposito%26aufirst%3DC.%2BL.%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DRienzo%26aufirst%3DA.%26aulast%3DStasio%26aufirst%3DL.%26aulast%3DInsabato%26aufirst%3DL.%26aulast%3DAffuso%26aufirst%3DA.%26aulast%3Dde%2BFranciscis%26aufirst%3DV.%26atitle%3DTargeting%2520Axl%2520with%2520an%2520high-affinity%2520inhibitory%2520aptamer%26jtitle%3DMol.%2520Ther.%26date%3D2012%26volume%3D20%26issue%3D12%26spage%3D2291%26epage%3D2303%26doi%3D10.1038%2Fmt.2012.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paolino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choidas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pranjic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uribesalgo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langdon, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fededa, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz-Fademrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickhoff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menninger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinterleitner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebl, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span> <span> </span><span class="NLM_article-title">The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>507</i></span> (<span class="NLM_issue">7493</span>),  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1038/nature12998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnature12998" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2014&pages=508-512&issue=7493&author=M.+Paolinoauthor=A.+Choidasauthor=S.+Wallnerauthor=B.+Pranjicauthor=I.+Uribesalgoauthor=S.+Loeserauthor=A.+M.+Jamiesonauthor=W.+Y.+Langdonauthor=F.+Ikedaauthor=J.+P.+Fededaauthor=S.+J.+Croninauthor=R.+Nitschauthor=C.+Schultz-Fademrechtauthor=J.+Eickhoffauthor=S.+Menningerauthor=A.+Ungerauthor=R.+Torkaauthor=T.+Gruberauthor=R.+Hinterleitnerauthor=G.+Baierauthor=D.+Wolfauthor=A.+Ullrichauthor=B.+M.+Kleblauthor=J.+M.+Penninger&title=The+E3+ligase+Cbl-b+and+TAM+receptors+regulate+cancer+metastasis+via+natural+killer+cells&doi=10.1038%2Fnature12998"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature12998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12998%26sid%3Dliteratum%253Aachs%26aulast%3DPaolino%26aufirst%3DM.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DWallner%26aufirst%3DS.%26aulast%3DPranjic%26aufirst%3DB.%26aulast%3DUribesalgo%26aufirst%3DI.%26aulast%3DLoeser%26aufirst%3DS.%26aulast%3DJamieson%26aufirst%3DA.%2BM.%26aulast%3DLangdon%26aufirst%3DW.%2BY.%26aulast%3DIkeda%26aufirst%3DF.%26aulast%3DFededa%26aufirst%3DJ.%2BP.%26aulast%3DCronin%26aufirst%3DS.%2BJ.%26aulast%3DNitsch%26aufirst%3DR.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DEickhoff%26aufirst%3DJ.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DUnger%26aufirst%3DA.%26aulast%3DTorka%26aufirst%3DR.%26aulast%3DGruber%26aufirst%3DT.%26aulast%3DHinterleitner%26aufirst%3DR.%26aulast%3DBaier%26aufirst%3DG.%26aulast%3DWolf%26aufirst%3DD.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DKlebl%26aufirst%3DB.%2BM.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520E3%2520ligase%2520Cbl-b%2520and%2520TAM%2520receptors%2520regulate%2520cancer%2520metastasis%2520via%2520natural%2520killer%2520cells%26jtitle%3DNature%26date%3D2014%26volume%3D507%26issue%3D7493%26spage%3D508%26epage%3D512%26doi%3D10.1038%2Fnature12998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bairlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greff, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daub, H.</span></span> <span> </span><span class="NLM_article-title">Proteomics strategy for quantitative protein interaction profiling in cell extracts</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1038/nmeth.1373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnmeth.1373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=19749761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaju73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=741-744&issue=10&author=K.+Sharmaauthor=C.+Weberauthor=M.+Bairleinauthor=Z.+Greffauthor=G.+K%C3%A9riauthor=J.+Coxauthor=J.+V.+Olsenauthor=H.+Daub&title=Proteomics+strategy+for+quantitative+protein+interaction+profiling+in+cell+extracts&doi=10.1038%2Fnmeth.1373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomics strategy for quantitative protein interaction profiling in cell extracts</span></div><div class="casAuthors">Sharma, Kirti; Weber, Christoph; Bairlein, Michaela; Greff, Zoltan; Keri, Gyoergy; Cox, Juergen; Olsen, Jesper V.; Daub, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">741-744</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors report a proteomics strategy to both identify and quantify cellular target protein interactions with externally introduced ligands.  The authors detd. dissocn. consts. for target proteins interacting with the ligand of interest by combining quant. mass spectrometry with a defined set of affinity purifn. expts.  The authors demonstrate the general utility of this methodol. in interaction studies involving small-mol. kinase inhibitors, a tyrosine-phosphorylated peptide and an antibody as affinity ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9I5plLFxQRbVg90H21EOLACvtfcHk0lilVmyYp7xbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaju73O&md5=78732562cac1cc2af0938f5536134098</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.1373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.1373%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DBairlein%26aufirst%3DM.%26aulast%3DGreff%26aufirst%3DZ.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DDaub%26aufirst%3DH.%26atitle%3DProteomics%2520strategy%2520for%2520quantitative%2520protein%2520interaction%2520profiling%2520in%2520cell%2520extracts%26jtitle%3DNat.%2520Methods%26date%3D2009%26volume%3D6%26issue%3D10%26spage%3D741%26epage%3D744%26doi%3D10.1038%2Fnmeth.1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delehouzé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyère, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oumata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roumeliotis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannopoulou, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twitchell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galibert, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbis, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">5675</span>– <span class="NLM_lpage">5687</span>, <span class="refDoi"> DOI: 10.1038/onc.2013.513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fonc.2013.513" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=5675-5687&issue=50&author=C.+Delehouz%C3%A9author=K.+Godlauthor=N.+Loa%C3%ABcauthor=C.+Bruy%C3%A8reauthor=N.+Desbanauthor=N.+Oumataauthor=H.+Galonsauthor=T.+Roumeliotisauthor=E.+G.+Giannopoulouauthor=J.+Grenetauthor=D.+Twitchellauthor=J.+Lahtiauthor=N.+Mouchetauthor=M.+D.+Galibertauthor=S.+D.+Garbisauthor=L.+Meijer&title=CDK%2FCK1+inhibitors+roscovitine+and+CR8+downregulate+amplified+MYCN+in+neuroblastoma+cells&doi=10.1038%2Fonc.2013.513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.513%26sid%3Dliteratum%253Aachs%26aulast%3DDelehouz%25C3%25A9%26aufirst%3DC.%26aulast%3DGodl%26aufirst%3DK.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DDesban%26aufirst%3DN.%26aulast%3DOumata%26aufirst%3DN.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DRoumeliotis%26aufirst%3DT.%26aulast%3DGiannopoulou%26aufirst%3DE.%2BG.%26aulast%3DGrenet%26aufirst%3DJ.%26aulast%3DTwitchell%26aufirst%3DD.%26aulast%3DLahti%26aufirst%3DJ.%26aulast%3DMouchet%26aufirst%3DN.%26aulast%3DGalibert%26aufirst%3DM.%2BD.%26aulast%3DGarbis%26aufirst%3DS.%2BD.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DCDK%252FCK1%2520inhibitors%2520roscovitine%2520and%2520CR8%2520downregulate%2520amplified%2520MYCN%2520in%2520neuroblastoma%2520cells%26jtitle%3DOncogene%26date%3D2014%26volume%3D33%26issue%3D50%26spage%3D5675%26epage%3D5687%26doi%3D10.1038%2Fonc.2013.513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lélias, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lipdXG9NgU0Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faraoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lipdXG9NgU0Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ming-Shu Wang, Hong-Chuang Xu, Yi Gong, Ren-Yu Qu, Lin-Sheng Zhuo, <span class="NLM_string-name hlFld-ContribAuthor">Wei Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Arylation of 2,7-Naphthyridin-1(2H)-one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (9)
                                     , 457-467. <a href="https://doi.org/10.1021/acscombsci.0c00074" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00074%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BArylation%252Bof%252B2%25252C7-Naphthyridin-1%2525282H%252529-one%252Bwith%252BDiaryliodonium%252BSalts%252Band%252BDiscovery%252Bof%252Ba%252BNew%252BSelective%252BMET%25252FAXL%252BKinase%252BInhibitor%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03052020%26date%3D22062020%26date%3D10072020%26date%3D26062020%26volume%3D22%26issue%3D9%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Domenico Alberga, Daniela Trisciuzzi, Michele Montaruli, Francesco Leonetti, Giuseppe Felice Mangiatordi, <span class="NLM_string-name hlFld-ContribAuthor">Orazio Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">A New Approach for Drug Target and Bioactivity Prediction: The Multifingerprint Similarity Search Algorithm (MuSSeL). </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 586-596. <a href="https://doi.org/10.1021/acs.jcim.8b00698" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00698%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DA%252BNew%252BApproach%252Bfor%252BDrug%252BTarget%252Band%252BBioactivity%252BPrediction%25253A%252BThe%252BMultifingerprint%252BSimilarity%252BSearch%252BAlgorithm%252B%252528MuSSeL%252529%26aulast%3DAlberga%26aufirst%3DDomenico%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D08102018%26date%3D14122018%26date%3D28112018%26volume%3D59%26issue%3D1%26spage%3D586%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lavanya  Nagamalla</span>, <span class="hlFld-ContribAuthor ">J. V. Shanmukha  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              screening of FDA approved drugs on AXL kinase and validation for breast cancer cell line. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (6)
                                     , 2056-2070. <a href="https://doi.org/10.1080/07391102.2020.1742791" title="DOI URL">https://doi.org/10.1080/07391102.2020.1742791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1742791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1742791%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bscreening%252Bof%252BFDA%252Bapproved%252Bdrugs%252Bon%252BAXL%252Bkinase%252Band%252Bvalidation%252Bfor%252Bbreast%252Bcancer%252Bcell%252Bline%26aulast%3DNagamalla%26aufirst%3DLavanya%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D6%26spage%3D2056%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuting  Zhou</span>, <span class="hlFld-ContribAuthor ">Xingwei  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  He</span>, <span class="hlFld-ContribAuthor ">Baohui  Qi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104511. <a href="https://doi.org/10.1016/j.bioorg.2020.104511" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104511%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%252528%2525284-%2525284-%2525283-%2525282-%2525282%25252C6-difluorophenyl%252529-4-oxothiazolidin-3-yl%252529ureido%252529-2-fluorophenoxy%252529-6-methoxyquinolin-7-yl%252529oxy%252529-N%25252CN-diethylpiperidine-1-carboxamide%252Bas%252Bkinase%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Bcolorectal%252Bcancer%26aulast%3DZhou%26aufirst%3DYuting%26date%3D2021%26volume%3D106%26spage%3D104511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuting  Zhou</span>, <span class="hlFld-ContribAuthor ">Xingwei  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  He</span>, <span class="hlFld-ContribAuthor ">Guowei  Gong</span>, <span class="hlFld-ContribAuthor ">Li  Xiong</span>, <span class="hlFld-ContribAuthor ">Baohui  Qi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112643. <a href="https://doi.org/10.1016/j.ejmech.2020.112643" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112643%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bquinoline%252Banalogues%252Bbearing%252Bthiazolidinones%252Bas%252Bpotent%252Bkinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcolorectal%252Bcancer%26aulast%3DZhou%26aufirst%3DYuting%26date%3D2020%26volume%3D204%26spage%3D112643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selvaraj  Shyamsivappan</span>, <span class="hlFld-ContribAuthor ">Arjunan  Saravanan</span>, <span class="hlFld-ContribAuthor ">Raju  Vivek</span>, <span class="hlFld-ContribAuthor ">Thangaraj  Suresh</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Shankar</span>, <span class="hlFld-ContribAuthor ">K. M.  Gothandam</span>, <span class="hlFld-ContribAuthor ">Palathurai Subramaniam  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel phenyl and thiophene dispiro indenoquinoxaline pyrrolidine quinolones induced apoptosis
              via
              G1/S and G2/M phase cell cycle arrest in MCF-7 cells. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (35)
                                     , 15031-15045. <a href="https://doi.org/10.1039/D0NJ02588G" title="DOI URL">https://doi.org/10.1039/D0NJ02588G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ02588G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ02588G%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNovel%252Bphenyl%252Band%252Bthiophene%252Bdispiro%252Bindenoquinoxaline%252Bpyrrolidine%252Bquinolones%252Binduced%252Bapoptosis%252Bvia%252BG1%25252FS%252Band%252BG2%25252FM%252Bphase%252Bcell%252Bcycle%252Barrest%252Bin%252BMCF-7%252Bcells%26aulast%3DShyamsivappan%26aufirst%3DSelvaraj%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D35%26spage%3D15031%26epage%3D15045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Chen</span>, <span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Wei-Rong  Fang</span>, <span class="hlFld-ContribAuthor ">Yun-Man  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112174. <a href="https://doi.org/10.1016/j.ejmech.2020.112174" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112174%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1%25252C6-naphthyridinone-based%252BMET%252Bkinase%252Binhibitor%252Bbearing%252Bquinoline%252Bmoiety%252Bas%252Bpromising%252Bantitumor%252Bdrug%252Bcandidate%26aulast%3DChen%26aufirst%3DTao%26date%3D2020%26volume%3D192%26spage%3D112174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Gang  Sun</span>, <span class="hlFld-ContribAuthor ">Jian-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Jin-Mai  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of Axl Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (15)
                                     , 1338-1349. <a href="https://doi.org/10.2174/1568026619666190620155613" title="DOI URL">https://doi.org/10.2174/1568026619666190620155613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190620155613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190620155613%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DResearch%252BProgress%252Bof%252BAxl%252BInhibitors%26aulast%3DSun%26aufirst%3DZhi-Gang%26date%3D2019%26volume%3D19%26issue%3D15%26spage%3D1338%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roya  Ahmadi</span>, <span class="hlFld-ContribAuthor ">Bakhtyar  Sepehri</span>, <span class="hlFld-ContribAuthor ">Raouf  Ghavami</span>. </span><span class="cited-content_cbyCitation_article-title">Development linear and non-linear QSAR models for predicting AXL kinase inhibitory activity of N-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 264-275. <a href="https://doi.org/10.1080/10799893.2019.1660898" title="DOI URL">https://doi.org/10.1080/10799893.2019.1660898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2019.1660898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2019.1660898%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DDevelopment%252Blinear%252Band%252Bnon-linear%252BQSAR%252Bmodels%252Bfor%252Bpredicting%252BAXL%252Bkinase%252Binhibitory%252Bactivity%252Bof%252BN-%25255B4-%252528quinolin-4-yloxy%252529phenyl%25255Dbenzenesulfonamides%26aulast%3DAhmadi%26aufirst%3DRoya%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D3%26spage%3D264%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of reported small-molecule tyrosine kinase inhibitors exhibiting activity against AXL kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of an <i>N</i>-phenyl-<i>N</i>′-{4-(4-quinolyloxy)phenyl}urea derivative.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-[4-(6,7-Dimethoxyquinolin-4-yloxy)phenyl]benzenesulfonamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-nitrophenols, chlorobenzene, DIPEA, reflux, 2 days; (b) Zn, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, reflux, 3 h; (c) benzenesulfonyl chlorides, pyridine, rt, 2 days.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-[4-(Substituted-quinolin-4-yloxy)phenyl]benzenesulfonamide Derivatives Bearing a Side Chain (R<sup>7</sup>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-nitrophenols, chlorobenzene, reflux, 2 days; (b) 33% HBr solution, rt, 2 h; (c) alkyl halogenides, acetonitrile, Cs<sub>2</sub>CO<sub>3</sub>, KI, rt, 45 min, then reflux 3 h; (d) Zn, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, reflux, 3 h; (e) benzenesulfonyl chlorides, pyridine, 60 °C, 3 days, (f) transformation of <b>20k</b> and <b>21k</b>, HCl, ethyl acetate, rt, 3 h.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General structure of the prepared <i>N</i>-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamide series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Five point pharmacophore of AXL kinase inhibitors. Compounds <b>18d</b> (orange), <b>19h</b> (gray), and <b>21f</b> (green) are shown on the image.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinase selectivity profile against a panel of 36 human kinases proves AXL as a common target of <i>N</i>-[4-(quinolin-4-yloxy)phenyl]-benzenesulfonamides derivates. The selectivity profiling was performed in triplicate at a compound concentration of 10 μmol/L. The plots indicate the percentages of inhibition for each individual kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Migration inhibition (%) of the compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative images of MDA-MB231 transmigrating the porous membrane. MDA-MB231 cells were incubated with indicated compound concentrations relative to DMSO control for 3.5 h. Scale bars indicate 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Invasion inhibition (%) of the molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative images of MDA-MB231 aggregates. MDA-MB231 cells were incubated with indicated compound concentrations relative to DMSO control for 5 h. Scale bars indicate 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Tumor volume reduction of compound <b>21f</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Average body weight of female SCID/beige mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Growth of MDA-MB-231 tumor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Mean total number of lung surface metastases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/medium/jm-2018-00672b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Mean score for tumor cell infiltration in lymph nodes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00672/20180719/images/large/jm-2018-00672b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00672&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Bryan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogswell, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokop, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le
Beau, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E. T.</span></span> <span> </span><span class="NLM_article-title">AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5016</span>– <span class="NLM_lpage">5031</span>, <span class="refDoi"> DOI: 10.1128/MCB.11.10.5016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1128%2FMCB.11.10.5016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1656220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADyaK38XlvVGrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=5016-5031&author=J.+P.+O%E2%80%99Bryanauthor=R.+A.+Fryeauthor=P.+C.+Cogswellauthor=A.+Neubauerauthor=B.+Kitchauthor=C.+Prokopauthor=R.+Espinosaauthor=M.+M.+Le%0ABeauauthor=H.+S.+Earpauthor=E.+T.+Liu&title=AXL%2C+a+transforming+gene+isolated+from+primary+human+myeloid+leukemia+cells%2C+encodes+a+novel+receptor+tyrosine+kinase&doi=10.1128%2FMCB.11.10.5016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">axl, A transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase</span></div><div class="casAuthors">O'Bryan, John P.; Frye, Roy A.; Cogswell, Patricia C.; Neubauer, Andreas; Kitch, Barry; Prokop, Carol; Espinosa, Rafael, III; Le Beau, Michelle M.; Earp, H. Shelton; Liu, Edison T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5016-31</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A sensitive transfection-tumorigenicity assay was used to isolate a novel transforming gene from the DNA of 2 patients with chronic myelogenous leukemia.  Sequence anal. indicates that the product of this gene, axl, is a receptor tyrosine kinase.  Overexpression of axl cDNA in NIH 3T3 cells induces neoplastic transformation with the concomitant appearance of a 140-kDa axl tyrosine-phosphorylated protein.  Expression of axl cDNA in the baculovirus system results in the expression of the appropriate recombinant protein that is tyrosine kinase.  The juxtaposition of fibronectin type III and immunoglobulinlike repeats in the extracellular domain, as well as distinct amino acid sequences in the kinase domain, indicate that the axl protein represents a novel subclass of receptor tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCIaouGK3RfrVg90H21EOLACvtfcHk0lgbziPMNUwKNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVGrsLs%253D&md5=f244ff83822fdb98c22a35f918723d3a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FMCB.11.10.5016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.11.10.5016%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Bryan%26aufirst%3DJ.%2BP.%26aulast%3DFrye%26aufirst%3DR.%2BA.%26aulast%3DCogswell%26aufirst%3DP.%2BC.%26aulast%3DNeubauer%26aufirst%3DA.%26aulast%3DKitch%26aufirst%3DB.%26aulast%3DProkop%26aufirst%3DC.%26aulast%3DEspinosa%26aufirst%3DR.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26atitle%3DAXL%252C%2520a%2520transforming%2520gene%2520isolated%2520from%2520primary%2520human%2520myeloid%2520leukemia%2520cells%252C%2520encodes%2520a%2520novel%2520receptor%2520tyrosine%2520kinase%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1991%26volume%3D11%26spage%3D5016%26epage%3D5031%26doi%3D10.1128%2FMCB.11.10.5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steenvoorden, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strehl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambros, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartram, C. R.</span></span> <span> </span><span class="NLM_article-title">A novel putative tyrosine kinase receptor with oncogenic potential</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2113</span>– <span class="NLM_lpage">2120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=2113-2120&author=J.+W.+Janssenauthor=A.+S.+Schulzauthor=A.+C.+Steenvoordenauthor=M.+Schmidbergerauthor=S.+Strehlauthor=P.+F.+Ambrosauthor=C.+R.+Bartram&title=A+novel+putative+tyrosine+kinase+receptor+with+oncogenic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DJ.%2BW.%26aulast%3DSchulz%26aufirst%3DA.%2BS.%26aulast%3DSteenvoorden%26aufirst%3DA.%2BC.%26aulast%3DSchmidberger%26aufirst%3DM.%26aulast%3DStrehl%26aufirst%3DS.%26aulast%3DAmbros%26aufirst%3DP.%2BF.%26aulast%3DBartram%26aufirst%3DC.%2BR.%26atitle%3DA%2520novel%2520putative%2520tyrosine%2520kinase%2520receptor%2520with%2520oncogenic%2520potential%26jtitle%3DOncogene%26date%3D1991%26volume%3D6%26spage%3D2113%26epage%3D2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paccez, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelsang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerbini, L. F.</span></span> <span> </span><span class="NLM_article-title">The receptor tyrosine kinase AXL in cancer: Biological functions and therapeutic implications</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1002/ijc.28246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1002%2Fijc.28246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=23649974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFOls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=1024-1033&issue=5&author=J.+D.+Paccezauthor=M.+Vogelsangauthor=M.+I.+Parkerauthor=L.+F.+Zerbini&title=The+receptor+tyrosine+kinase+AXL+in+cancer%3A+Biological+functions+and+therapeutic+implications&doi=10.1002%2Fijc.28246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implications</span></div><div class="casAuthors">Paccez, Juliano D.; Vogelsang, Matjaz; Parker, M. Iqbal; Zerbini, Luiz F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1024-1033</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The receptor tyrosine kinase Axl has been implicated in the malignancy of different types of cancer.  Emerging evidence of Axl upregulation in numerous cancers, as well as reports demonstrating that its inhibition blocks tumor formation in animal models, highlight the importance of Axl as a new potential therapeutic target.  Furthermore, recent data demonstrate that Axl plays a pivotal role in resistance to chemotherapeutic regimens.  In this review we discuss the functions of Axl and its regulation and role in cancer development, resistance to therapy, and its importance as a potential drug target, focusing on acute myeloid leukemia, breast, prostate and non-small cell lung cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj6kP36FkPT7Vg90H21EOLACvtfcHk0lj6fgrzzyINPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFOls7w%253D&md5=3a4604c7451c3b64911230c4ca2841b3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.28246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28246%26sid%3Dliteratum%253Aachs%26aulast%3DPaccez%26aufirst%3DJ.%2BD.%26aulast%3DVogelsang%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DM.%2BI.%26aulast%3DZerbini%26aufirst%3DL.%2BF.%26atitle%3DThe%2520receptor%2520tyrosine%2520kinase%2520AXL%2520in%2520cancer%253A%2520Biological%2520functions%2520and%2520therapeutic%2520implications%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2014%26volume%3D134%26issue%3D5%26spage%3D1024%26epage%3D1033%26doi%3D10.1002%2Fijc.28246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stitt, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goret, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radzlejewski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masiakowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobkes, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiStefano, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basilico, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfarb, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yancopoulos, G. D.</span></span> <span> </span><span class="NLM_article-title">The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro3/AXL family of receptor tyrosine kinases</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90520-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1016%2F0092-8674%2895%2990520-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=661-670&author=T.+N.+Stittauthor=G.+Connauthor=M.+Goretauthor=C.+Laiauthor=J.+Brunoauthor=C.+Radzlejewskiauthor=K.+Mattssonauthor=J.+Fisherauthor=D.+R.+Giesauthor=P.+F.+Jonesauthor=P.+Masiakowskiauthor=T.+E.+Ryanauthor=N.+J.+Tobkesauthor=D.+H.+Chenauthor=P.+S.+DiStefanoauthor=G.+L.+Longauthor=C.+Basilicoauthor=M.+P.+Goldfarbauthor=G.+Lemkeauthor=D.+J.+Glassauthor=G.+D.+Yancopoulos&title=The+anticoagulation+factor+protein+S+and+its+relative%2C+Gas6%2C+are+ligands+for+the+Tyro3%2FAXL+family+of+receptor+tyrosine+kinases&doi=10.1016%2F0092-8674%2895%2990520-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990520-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990520-0%26sid%3Dliteratum%253Aachs%26aulast%3DStitt%26aufirst%3DT.%2BN.%26aulast%3DConn%26aufirst%3DG.%26aulast%3DGoret%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DC.%26aulast%3DBruno%26aufirst%3DJ.%26aulast%3DRadzlejewski%26aufirst%3DC.%26aulast%3DMattsson%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DJ.%26aulast%3DGies%26aufirst%3DD.%2BR.%26aulast%3DJones%26aufirst%3DP.%2BF.%26aulast%3DMasiakowski%26aufirst%3DP.%26aulast%3DRyan%26aufirst%3DT.%2BE.%26aulast%3DTobkes%26aufirst%3DN.%2BJ.%26aulast%3DChen%26aufirst%3DD.%2BH.%26aulast%3DDiStefano%26aufirst%3DP.%2BS.%26aulast%3DLong%26aufirst%3DG.%2BL.%26aulast%3DBasilico%26aufirst%3DC.%26aulast%3DGoldfarb%26aufirst%3DM.%2BP.%26aulast%3DLemke%26aufirst%3DG.%26aulast%3DGlass%26aufirst%3DD.%2BJ.%26aulast%3DYancopoulos%26aufirst%3DG.%2BD.%26atitle%3DThe%2520anticoagulation%2520factor%2520protein%2520S%2520and%2520its%2520relative%252C%2520Gas6%252C%2520are%2520ligands%2520for%2520the%2520Tyro3%252FAXL%2520family%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCell%26date%3D1995%26volume%3D80%26spage%3D661%26epage%3D670%26doi%3D10.1016%2F0092-8674%2895%2990520-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goruppi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruaro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnum, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span> <span> </span><span class="NLM_article-title">Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-AXL mitogenic and survival activities in NIH3T3 fibroblasts</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4442</span>– <span class="NLM_lpage">4453</span>, <span class="refDoi"> DOI: 10.1128/MCB.17.8.4442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1128%2FMCB.17.8.4442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=9234702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVersbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=4442-4453&author=S.+Goruppiauthor=E.+Ruaroauthor=B.+Varnumauthor=C.+Schneider&title=Requirement+of+phosphatidylinositol+3-kinase-dependent+pathway+and+Src+for+Gas6-AXL+mitogenic+and+survival+activities+in+NIH3T3+fibroblasts&doi=10.1128%2FMCB.17.8.4442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts</span></div><div class="casAuthors">Goruppi, Sandro; Ruaro, Elisabetta; Varnum, Brian; Schneider, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4442-4453</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Gas6 is a secreted protein previously identified as the ligand of the Axl receptor tyrosine kinase.  We have shown that Gas6 is able to induce cell cycle reentry of serum-starved NIH 3T3 cells and to efficiently prevent apoptosis after complete growth factor removal, a survival effect uncoupled from Gas6-induced mitogenesis.  Here we report that the mitogenic effect of Gas6 requires phosphatidylinositol 3-kinase (PI3K) activity since it is abrogated both by the specific inhibitor wortmannin and by overexpression of the dominant neg. PI3K p85 subunit.  Consistently, Gas6 activates the PI3K downstream targets S6K and Akt, whose activation is abrogated by addn. to wortmannin.  Moreover, rapamycin treatment blocks Gas6-induced entry into the S phase of serum-starved NIH 3T3 cells.  We also demonstrate the requirement of Src tyrosine kinase for Gas6 signalling since stable or transient expression of a catalytically inactive form of Src significantly inhibited Gas6-stimulated entry into the S phase.  Accordingly, Gas6 addn. to serum-starved NIH 3T3 cells causes activation of the intrinsic Src kinase activity.  When specifically analyzed in a survival assay, these elements were found to be required for the survival effect of Gas6.  Taken together, the evidence presented here identifies elements involved in the Gas6 transduction pathway that are responsible for its antiapoptotic effect and suggests that Src is involved in the events regulating cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCEApQM2nLQ7Vg90H21EOLACvtfcHk0lj6fgrzzyINPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVersbY%253D&md5=b12b92b14568e2e41f04818caf82a1dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FMCB.17.8.4442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.17.8.4442%26sid%3Dliteratum%253Aachs%26aulast%3DGoruppi%26aufirst%3DS.%26aulast%3DRuaro%26aufirst%3DE.%26aulast%3DVarnum%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DRequirement%2520of%2520phosphatidylinositol%25203-kinase-dependent%2520pathway%2520and%2520Src%2520for%2520Gas6-AXL%2520mitogenic%2520and%2520survival%2520activities%2520in%2520NIH3T3%2520fibroblasts%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1997%26volume%3D17%26spage%3D4442%26epage%3D4453%26doi%3D10.1128%2FMCB.17.8.4442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verardo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnum, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span> <span> </span><span class="NLM_article-title">Gas6 anti-apoptotic signaling requires NF-kappa B activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">31738</span>– <span class="NLM_lpage">31744</span>, <span class="refDoi"> DOI: 10.1074/jbc.M104457200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1074%2Fjbc.M104457200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=31738-31744&author=F.+Demarchiauthor=R.+Verardoauthor=B.+Varnumauthor=C.+Brancoliniauthor=C.+Schneider&title=Gas6+anti-apoptotic+signaling+requires+NF-kappa+B+activation&doi=10.1074%2Fjbc.M104457200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M104457200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M104457200%26sid%3Dliteratum%253Aachs%26aulast%3DDemarchi%26aufirst%3DF.%26aulast%3DVerardo%26aufirst%3DR.%26aulast%3DVarnum%26aufirst%3DB.%26aulast%3DBrancolini%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DGas6%2520anti-apoptotic%2520signaling%2520requires%2520NF-kappa%2520B%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D31738%26epage%3D31744%26doi%3D10.1074%2Fjbc.M104457200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goruppi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruaro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span> <span> </span><span class="NLM_article-title">Gas6, the ligand of AXL tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1996&pages=471-480&author=S.+Goruppiauthor=E.+Ruaroauthor=C.+Schneider&title=Gas6%2C+the+ligand+of+AXL+tyrosine+kinase+receptor%2C+has+mitogenic+and+survival+activities+for+serum+starved+NIH3T3+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoruppi%26aufirst%3DS.%26aulast%3DRuaro%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DC.%26atitle%3DGas6%252C%2520the%2520ligand%2520of%2520AXL%2520tyrosine%2520kinase%2520receptor%252C%2520has%2520mitogenic%2520and%2520survival%2520activities%2520for%2520serum%2520starved%2520NIH3T3%2520fibroblasts%26jtitle%3DOncogene%26date%3D1996%26volume%3D12%26spage%3D471%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanagita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukatsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, T.</span></span> <span> </span><span class="NLM_article-title">Gas6 induces mesangial cell proliferation via latent transcription factor STAT3</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">42364</span>– <span class="NLM_lpage">42369</span>, <span class="refDoi"> DOI: 10.1074/jbc.M107488200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1074%2Fjbc.M107488200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=42364-42369&author=M.+Yanagitaauthor=H.+Araiauthor=T.+Nakanoauthor=K.+Ohashiauthor=K.+Mizunoauthor=A.+Fukatsuauthor=T.+Doiauthor=T.+Kita&title=Gas6+induces+mesangial+cell+proliferation+via+latent+transcription+factor+STAT3&doi=10.1074%2Fjbc.M107488200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M107488200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M107488200%26sid%3Dliteratum%253Aachs%26aulast%3DYanagita%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DK.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DFukatsu%26aufirst%3DA.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DKita%26aufirst%3DT.%26atitle%3DGas6%2520induces%2520mesangial%2520cell%2520proliferation%2520via%2520latent%2520transcription%2520factor%2520STAT3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D42364%26epage%3D42369%26doi%3D10.1074%2Fjbc.M107488200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holland, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friera, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pali, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogenberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorens, J. B.</span></span> <span> </span><span class="NLM_article-title">Multiple roles for the receptor tyrosine kinase AXL in tumor formation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">9294</span>– <span class="NLM_lpage">9303</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-0993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-05-0993" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=9294-9303&author=S.+J.+Hollandauthor=M.+J.+Powellauthor=C.+Franciauthor=E.+W.+Chanauthor=A.+M.+Frieraauthor=R.+E.+Atchisonauthor=J.+McLaughlinauthor=S.+E.+Swiftauthor=E.+S.+Paliauthor=G.+Yamauthor=S.+Wongauthor=J.+Lasagaauthor=M.+R.+Shenauthor=S.+Yuauthor=W.+Xuauthor=Y.+Hitoshiauthor=J.+Bogenbergerauthor=J.+E.+Norauthor=D.+G.+Payanauthor=J.+B.+Lorens&title=Multiple+roles+for+the+receptor+tyrosine+kinase+AXL+in+tumor+formation&doi=10.1158%2F0008-5472.CAN-05-0993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-0993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-0993%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DS.%2BJ.%26aulast%3DPowell%26aufirst%3DM.%2BJ.%26aulast%3DFranci%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DE.%2BW.%26aulast%3DFriera%26aufirst%3DA.%2BM.%26aulast%3DAtchison%26aufirst%3DR.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DJ.%26aulast%3DSwift%26aufirst%3DS.%2BE.%26aulast%3DPali%26aufirst%3DE.%2BS.%26aulast%3DYam%26aufirst%3DG.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DLasaga%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DM.%2BR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DHitoshi%26aufirst%3DY.%26aulast%3DBogenberger%26aufirst%3DJ.%26aulast%3DNor%26aufirst%3DJ.%2BE.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DLorens%26aufirst%3DJ.%2BB.%26atitle%3DMultiple%2520roles%2520for%2520the%2520receptor%2520tyrosine%2520kinase%2520AXL%2520in%2520tumor%2520formation%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D9294%26epage%3D9303%26doi%3D10.1158%2F0008-5472.CAN-05-0993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dufies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belhacene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cluzeau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassuto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberger, P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of AXL overexpression and function in imatinib-resistant chronic myeloid leukemia cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.18632%2Foncotarget.360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=874-885&author=M.+Dufiesauthor=A.+Jacquelauthor=N.+Belhaceneauthor=G.+Robertauthor=T.+Cluzeauauthor=F.+Lucianoauthor=J.+P.+Cassutoauthor=S.+Raynaudauthor=P.+Auberger&title=Mechanisms+of+AXL+overexpression+and+function+in+imatinib-resistant+chronic+myeloid+leukemia+cells&doi=10.18632%2Foncotarget.360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.360%26sid%3Dliteratum%253Aachs%26aulast%3DDufies%26aufirst%3DM.%26aulast%3DJacquel%26aufirst%3DA.%26aulast%3DBelhacene%26aufirst%3DN.%26aulast%3DRobert%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DT.%26aulast%3DLuciano%26aufirst%3DF.%26aulast%3DCassuto%26aufirst%3DJ.%2BP.%26aulast%3DRaynaud%26aufirst%3DS.%26aulast%3DAuberger%26aufirst%3DP.%26atitle%3DMechanisms%2520of%2520AXL%2520overexpression%2520and%2520function%2520in%2520imatinib-resistant%2520chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D874%26epage%3D885%26doi%3D10.18632%2Foncotarget.360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Croce, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakalya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garewal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, D.</span></span> <span> </span><span class="NLM_article-title">A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3909</span>– <span class="NLM_lpage">3919</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fsj.onc.1210173" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3909-3919&author=D.+Mahadevanauthor=L.+Cookeauthor=C.+Rileyauthor=R.+Swartauthor=B.+Simonsauthor=K.+Della+Croceauthor=L.+Wisnerauthor=M.+Iorioauthor=K.+Shakalyaauthor=H.+Garewalauthor=R.+Nagleauthor=D.+Bearss&title=A+novel+tyrosine+kinase+switch+is+a+mechanism+of+imatinib+resistance+in+gastrointestinal+stromal+tumors&doi=10.1038%2Fsj.onc.1210173"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210173%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DCooke%26aufirst%3DL.%26aulast%3DRiley%26aufirst%3DC.%26aulast%3DSwart%26aufirst%3DR.%26aulast%3DSimons%26aufirst%3DB.%26aulast%3DDella%2BCroce%26aufirst%3DK.%26aulast%3DWisner%26aufirst%3DL.%26aulast%3DIorio%26aufirst%3DM.%26aulast%3DShakalya%26aufirst%3DK.%26aulast%3DGarewal%26aufirst%3DH.%26aulast%3DNagle%26aufirst%3DR.%26aulast%3DBearss%26aufirst%3DD.%26atitle%3DA%2520novel%2520tyrosine%2520kinase%2520switch%2520is%2520a%2520mechanism%2520of%2520imatinib%2520resistance%2520in%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D3909%26epage%3D3919%26doi%3D10.1038%2Fsj.onc.1210173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knyazev, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheburkin, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knyazev, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Őrfi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daub, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span> <span> </span><span class="NLM_article-title">AXL is a potential target for therapeutic intervention in breast cancer progression</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1905</span>– <span class="NLM_lpage">1915</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-2661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-07-2661" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1905-1915&author=Y.+X.+Zhangauthor=P.+G.+Knyazevauthor=Y.+V.+Cheburkinauthor=K.+Sharmaauthor=Y.+P.+Knyazevauthor=L.+%C5%90rfiauthor=I.+Szabadkaiauthor=H.+Daubauthor=G.+K%C3%A9riauthor=A.+Ullrich&title=AXL+is+a+potential+target+for+therapeutic+intervention+in+breast+cancer+progression&doi=10.1158%2F0008-5472.CAN-07-2661"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-2661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-2661%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BX.%26aulast%3DKnyazev%26aufirst%3DP.%2BG.%26aulast%3DCheburkin%26aufirst%3DY.%2BV.%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DKnyazev%26aufirst%3DY.%2BP.%26aulast%3D%25C5%2590rfi%26aufirst%3DL.%26aulast%3DSzabadkai%26aufirst%3DI.%26aulast%3DDaub%26aufirst%3DH.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DAXL%2520is%2520a%2520potential%2520target%2520for%2520therapeutic%2520intervention%2520in%2520breast%2520cancer%2520progression%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1905%26epage%3D1915%26doi%3D10.1158%2F0008-5472.CAN-07-2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greshock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathe, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmer, T. M.</span></span> <span> </span><span class="NLM_article-title">Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">6871</span>– <span class="NLM_lpage">6878</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-08-4490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6871-6878&author=L.+Liuauthor=J.+Gregerauthor=H.+Shiauthor=Y.+Liuauthor=J.+Greshockauthor=R.+Annanauthor=W.+Halseyauthor=G.+M.+Satheauthor=A.+M.+Martinauthor=T.+M.+Gilmer&title=Novel+mechanism+of+lapatinib+resistance+in+HER2-positive+breast+tumor+cells%3A+activation+of+AXL&doi=10.1158%2F0008-5472.CAN-08-4490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4490%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGreger%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DAnnan%26aufirst%3DR.%26aulast%3DHalsey%26aufirst%3DW.%26aulast%3DSathe%26aufirst%3DG.%2BM.%26aulast%3DMartin%26aufirst%3DA.%2BM.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DNovel%2520mechanism%2520of%2520lapatinib%2520resistance%2520in%2520HER2-positive%2520breast%2520tumor%2520cells%253A%2520activation%2520of%2520AXL%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6871%26epage%3D6878%26doi%3D10.1158%2F0008-5472.CAN-08-4490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullo-Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaseelan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppenheimer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokarski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wautlet, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the MET kinase superfamily</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1254</span>, <span class="refDoi"> DOI: 10.1021/jm801586s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.+W.+Caiauthor=X.+T.+Chenauthor=C.+Clarkauthor=L.+A.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+MET+kinase+superfamily&doi=10.1021%2Fjm801586s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily</span></div><div class="casAuthors">Schroeder, Gretchen M.; An, Yongmi; Cai, Zhen-Wei; Chen, Xiao-Tao; Clark, Cheryl; Cornelius, Lyndon A. M.; Dai, Jun; Gullo-Brown, Johnni; Gupta, Ashok; Henley, Benjamin; Hunt, John T.; Jeyaseelan, Robert; Kamath, Amrita; Kim, Kyoung; Lippy, Jonathan; Lombardo, Louis J.; Manne, Veeraswamy; Oppenheimer, Simone; Sack, John S.; Schmidt, Robert J.; Shen, Guoxiang; Stefanski, Kevin; Tokarski, John S.; Trainor, George L.; Wautlet, Barri S.; Wei, Donna; Williams, David K.; Zhang, Yingru; Zhang, Yueping; Fargnoli, Joseph; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1254</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted N-(4-(2-aminopyridin-4-yloxy)-3-fluoro-phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamides were identified as potent and selective Met kinase inhibitors.  Substitution of the pyridine 3-position gave improved enzyme potency, while substitution of the pyridone 4-position led to improved aq. soly. and kinase selectivity.  Analog 10 demonstrated complete tumor stasis in a Met-dependent GTL-16 human gastric carcinoma xenograft model following oral administration.  Because of its excellent in vivo efficacy and favorable pharmacokinetic and preclin. safety profiles, 10 has been advanced into phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHEvJXf0Fq7Vg90H21EOLACvtfcHk0lgfV9DtwC6bDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCnsLc%253D&md5=784623be820fcc8b931200ced3a476df</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DX.%2BT.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520MET%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254%26doi%3D10.1021%2Fjm801586s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentzien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joly, A. H.</span></span> <span> </span><span class="NLM_article-title">Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2298</span>– <span class="NLM_lpage">2308</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F1535-7163.MCT-11-0264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=21926191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2298-2308&author=F.+M.+Yakesauthor=J.+Chenauthor=J.+Tanauthor=K.+Yamaguchiauthor=Y.+Shiauthor=P.+Yuauthor=F.+Qianauthor=F.+Chuauthor=F.+Bentzienauthor=B.+Cancillaauthor=J.+Orfauthor=A.+Youauthor=A.+D.+Lairdauthor=S.+Engstauthor=L.+Leeauthor=J.+Leschauthor=Y.+C.+Chouauthor=A.+H.+Joly&title=Cabozantinib+%28XL184%29%2C+a+novel+MET+and+VEGFR2+inhibitor%2C+simultaneously+suppresses+metastasis%2C+angiogenesis%2C+and+tumor+growth&doi=10.1158%2F1535-7163.MCT-11-0264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth</span></div><div class="casAuthors">Yakes, F. Michael; Chen, Jason; Tan, Jenny; Yamaguchi, Kyoko; Shi, Yongchang; Yu, Peiwen; Qian, Fawn; Chu, Felix; Bentzien, Frauke; Cancilla, Belinda; Orf, Jessica; You, Andrew; Laird, A. Douglas; Engst, Stefan; Lee, Lillian; Lesch, Justin; Chou, Yu-Chien; Joly, Alison H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2298-2308</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor (HGF) is important for cell growth, survival, and motility and is functionally linked to the signaling pathway of VEGF, which is widely recognized as a key effector in angiogenesis and cancer progression.  Dysregulation of the MET/VEGF axis is found in a no. of human malignancies and has been assocd. with tumorigenesis.  Cabozantinib (XL184) is a small-mol. kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a no. of other receptor tyrosine kinases that have also been implicated in tumor pathobiol., including RET, KIT, AXL, and FLT3.  Treatment with cabozantinib inhibited MET and VEGFR2 phosphorylation in vitro and in tumor models in vivo and led to significant redns. in cell invasion in vitro.  In mouse models, cabozantinib dramatically altered tumor pathol., resulting in decreased tumor and endothelial cell proliferation coupled with increased apoptosis and dose-dependent inhibition of tumor growth in breast, lung, and glioma tumor models.  Importantly, treatment with cabozantinib did not increase lung tumor burden in an exptl. model of metastasis, which has been obsd. with inhibitors of VEGF signaling that do not target MET.  Collectively, these data suggest that cabozantinib is a promising agent for inhibiting tumor angiogenesis and metastasis in cancers with dysregulated MET and VEGFR signaling.  Mol Cancer Ther; 10(12); 2298-308.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGtQ_JaTP9IrVg90H21EOLACvtfcHk0lgfV9DtwC6bDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnF&md5=3f573795ecee42deeee25005f991868f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0264%26sid%3Dliteratum%253Aachs%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DCancilla%26aufirst%3DB.%26aulast%3DOrf%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DA.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DY.%2BC.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DCabozantinib%2520%2528XL184%2529%252C%2520a%2520novel%2520MET%2520and%2520VEGFR2%2520inhibitor%252C%2520simultaneously%2520suppresses%2520metastasis%252C%2520angiogenesis%252C%2520and%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2298%26epage%3D2308%26doi%3D10.1158%2F1535-7163.MCT-11-0264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burbridge, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fejes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léonce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Violante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouzom, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquet-Bescond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comoglio, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierré, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depil, S.</span></span> <span> </span><span class="NLM_article-title">S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in asociation with bevacizumab</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1762</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F1535-7163.MCT-13-0075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=23804704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1749-1762&author=M.+F.+Burbridgeauthor=C.+J.+Bossardauthor=C.+Saunierauthor=I.+Fejesauthor=A.+Brunoauthor=S.+L%C3%A9onceauthor=G.+Ferryauthor=G.+Da+Violanteauthor=F.+Bouzomauthor=V.+Cattanauthor=A.+Jacquet-Bescondauthor=P.+M.+Comoglioauthor=B.+P.+Lockhartauthor=J.+A.+Boutinauthor=A.+Cordiauthor=J.+C.+Ortunoauthor=A.+Pierr%C3%A9author=J.+A.+Hickmanauthor=F.+H.+Cruzaleguiauthor=S.+Depil&title=S49076+is+a+novel+kinase+inhibitor+of+MET%2C+AXL%2C+and+FGFR+with+strong+preclinical+activity+alone+and+in+asociation+with+bevacizumab&doi=10.1158%2F1535-7163.MCT-13-0075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab</span></div><div class="casAuthors">Burbridge, Mike F.; Bossard, Celine J.; Saunier, Carine; Fejes, Imre; Bruno, Alain; Leonce, Stephane; Ferry, Gilles; Da Violante, Georges; Bouzom, Francois; Cattan, Valerie; Jacquet-Bescond, Anne; Comoglio, Paolo M.; Lockhart, Brian P.; Boutin, Jean A.; Cordi, Alex; Ortuno, Jean-Claude; Pierre, Alain; Hickman, John A.; Cruzalegui, Francisco H.; Depil, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1749-1762</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant activity of the receptor tyrosine kinases MET, AXL, and FGFR1/2/3 has been assocd. with tumor progression in a wide variety of human malignancies, notably in instances of primary or acquired resistance to existing or emerging anticancer therapies.  This study describes the preclin. characterization of S49076, a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3.  S49076 potently blocked cellular phosphorylation of MET, AXL, and FGFRs and inhibited downstream signaling in vitro and in vivo.  In cell models, S49076 inhibited the proliferation of MET- and FGFR2-dependent gastric cancer cells, blocked MET-driven migration of lung carcinoma cells, and inhibited colony formation of hepatocarcinoma cells expressing FGFR1/2 and AXL.  In tumor xenograft models, a good pharmacokinetic/pharmacodynamic relationship for MET and FGFR2 inhibition following oral administration of S49076 was established and correlated well with impact on tumor growth.  MET, AXL, and the FGFRs have all been implicated in resistance to VEGF/VEGFR inhibitors such as bevacizumab.  Accordingly, combination of S49076 with bevacizumab in colon carcinoma xenograft models led to near total inhibition of tumor growth.  Moreover, S49076 alone caused tumor growth arrest in bevacizumab-resistant tumors.  On the basis of these preclin. studies showing a favorable and novel pharmacol. profile of S49076, a phase I study is currently underway in patients with advanced solid tumors.  Mol Cancer Ther; 12(9); 1749-62. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodE4VwyiV-HrVg90H21EOLACvtfcHk0linrk7LFX98_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2lur7O&md5=a53009f7a7b0601cf45598ca5b8775c2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0075%26sid%3Dliteratum%253Aachs%26aulast%3DBurbridge%26aufirst%3DM.%2BF.%26aulast%3DBossard%26aufirst%3DC.%2BJ.%26aulast%3DSaunier%26aufirst%3DC.%26aulast%3DFejes%26aufirst%3DI.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DFerry%26aufirst%3DG.%26aulast%3DDa%2BViolante%26aufirst%3DG.%26aulast%3DBouzom%26aufirst%3DF.%26aulast%3DCattan%26aufirst%3DV.%26aulast%3DJacquet-Bescond%26aufirst%3DA.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DLockhart%26aufirst%3DB.%2BP.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26aulast%3DCordi%26aufirst%3DA.%26aulast%3DOrtuno%26aufirst%3DJ.%2BC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DCruzalegui%26aufirst%3DF.%2BH.%26aulast%3DDepil%26aufirst%3DS.%26atitle%3DS49076%2520is%2520a%2520novel%2520kinase%2520inhibitor%2520of%2520MET%252C%2520AXL%252C%2520and%2520FGFR%2520with%2520strong%2520preclinical%2520activity%2520alone%2520and%2520in%2520asociation%2520with%2520bevacizumab%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1749%26epage%3D1762%26doi%3D10.1158%2F1535-7163.MCT-13-0075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holland, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torneros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckrodt, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apatira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitoshi, Y.</span></span> <span> </span><span class="NLM_article-title">R428, a selective small molecule inhibitor of AXL kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1544</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-09-2997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1544-1554&author=S.+J.+Hollandauthor=A.+Panauthor=C.+Franciauthor=Y.+Huauthor=B.+Changauthor=W.+Liauthor=M.+Duanauthor=A.+Tornerosauthor=J.+Yuauthor=T.+J.+Heckrodtauthor=J.+Zhangauthor=P.+Dingauthor=A.+Apatiraauthor=J.+Chuaauthor=R.+Brandtauthor=P.+Pineauthor=D.+Goffauthor=R.+Singhauthor=D.+G.+Payanauthor=Y.+Hitoshi&title=R428%2C+a+selective+small+molecule+inhibitor+of+AXL+kinase%2C+blocks+tumor+spread+and+prolongs+survival+in+models+of+metastatic+breast+cancer&doi=10.1158%2F0008-5472.CAN-09-2997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2997%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DS.%2BJ.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DFranci%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DTorneros%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DHeckrodt%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DApatira%26aufirst%3DA.%26aulast%3DChua%26aufirst%3DJ.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DGoff%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DHitoshi%26aufirst%3DY.%26atitle%3DR428%252C%2520a%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520AXL%2520kinase%252C%2520blocks%2520tumor%2520spread%2520and%2520prolongs%2520survival%2520in%2520models%2520of%2520metastatic%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1544%26epage%3D1554%26doi%3D10.1158%2F0008-5472.CAN-09-2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Székelyhidi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bánhegyi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegymegi-Barakonyi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szántai-Kis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafenbradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erös, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horváth, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greff, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marosfalvi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pató, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szilágyi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szegedi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wáczek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Őrfi, L.</span></span> <span> </span><span class="NLM_article-title">Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1089/adt.2005.3.543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1089%2Fadt.2005.3.543" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=543-551&author=G.+K%C3%A9riauthor=Z.+Sz%C3%A9kelyhidiauthor=P.+B%C3%A1nhegyiauthor=Z.+Vargaauthor=B.+Hegymegi-Barakonyiauthor=C.+Sz%C3%A1ntai-Kisauthor=D.+Hafenbradlauthor=B.+Kleblauthor=G.+Mullerauthor=A.+Ullrichauthor=D.+Er%C3%B6sauthor=Z.+Horv%C3%A1thauthor=Z.+Greffauthor=J.+Marosfalviauthor=J.+Pat%C3%B3author=I.+Szabadkaiauthor=I.+Szil%C3%A1gyiauthor=Z.+Szegediauthor=I.+Vargaauthor=F.+W%C3%A1czekauthor=L.+%C5%90rfi&title=Drug+discovery+in+the+kinase+inhibitory+field+using+the+Nested+Chemical+Library+technology&doi=10.1089%2Fadt.2005.3.543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1089%2Fadt.2005.3.543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2005.3.543%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DSz%25C3%25A9kelyhidi%26aufirst%3DZ.%26aulast%3DB%25C3%25A1nhegyi%26aufirst%3DP.%26aulast%3DVarga%26aufirst%3DZ.%26aulast%3DHegymegi-Barakonyi%26aufirst%3DB.%26aulast%3DSz%25C3%25A1ntai-Kis%26aufirst%3DC.%26aulast%3DHafenbradl%26aufirst%3DD.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DG.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DEr%25C3%25B6s%26aufirst%3DD.%26aulast%3DHorv%25C3%25A1th%26aufirst%3DZ.%26aulast%3DGreff%26aufirst%3DZ.%26aulast%3DMarosfalvi%26aufirst%3DJ.%26aulast%3DPat%25C3%25B3%26aufirst%3DJ.%26aulast%3DSzabadkai%26aufirst%3DI.%26aulast%3DSzil%25C3%25A1gyi%26aufirst%3DI.%26aulast%3DSzegedi%26aufirst%3DZ.%26aulast%3DVarga%26aufirst%3DI.%26aulast%3DW%25C3%25A1czek%26aufirst%3DF.%26aulast%3D%25C5%2590rfi%26aufirst%3DL.%26atitle%3DDrug%2520discovery%2520in%2520the%2520kinase%2520inhibitory%2520field%2520using%2520the%2520Nested%2520Chemical%2520Library%2520technology%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2005%26volume%3D3%26spage%3D543%26epage%3D551%26doi%3D10.1089%2Fadt.2005.3.543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murooka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoe, T.</span></span> <span> </span><span class="NLM_article-title">Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N’-{4-(4-quinolyloxy)phenyl}ureas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1359</span>– <span class="NLM_lpage">1366</span>, <span class="refDoi"> DOI: 10.1021/jm030427r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030427r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1359-1366&author=K.+Kuboauthor=T.+Shimizuauthor=S.+Ohyamaauthor=H.+Murookaauthor=A.+Iwaiauthor=K.+Nakamuraauthor=K.+Hasegawaauthor=Y.+Kobayashiauthor=N.+Takahashiauthor=K.+Takahashiauthor=S.+Katoauthor=T.+Izawaauthor=T.+Isoe&title=Novel+potent+orally+active+selective+VEGFR-2+tyrosine+kinase+inhibitors%3A+synthesis%2C+structure-activity+relationships%2C+and+antitumor+activities+of+N-phenyl-N%E2%80%99-%7B4-%284-quinolyloxy%29phenyl%7Dureas&doi=10.1021%2Fjm030427r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm030427r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030427r%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DIwai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DIsoe%26aufirst%3DT.%26atitle%3DNovel%2520potent%2520orally%2520active%2520selective%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%253A%2520synthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520antitumor%2520activities%2520of%2520N-phenyl-N%25E2%2580%2599-%257B4-%25284-quinolyloxy%2529phenyl%257Dureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1359%26epage%3D1366%26doi%3D10.1021%2Fjm030427r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeppen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settleman, J.</span></span> <span> </span><span class="NLM_article-title">AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5878</span>– <span class="NLM_lpage">5890</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-1009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F0008-5472.CAN-14-1009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5878-5890&issue=20&author=C.+Wilsonauthor=X.+Yeauthor=T.+Phamauthor=E.+Linauthor=S.+Chanauthor=E.+McNamaraauthor=R.+M.+Neveauthor=L.+Belmontauthor=H.+Koeppenauthor=R.+L.+Yauchauthor=A.+Ashkenaziauthor=J.+Settleman&title=AXL+inhibition+sensitizes+mesenchymal+cancer+cells+to+antimitotic+drugs&doi=10.1158%2F0008-5472.CAN-14-1009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1009%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DMcNamara%26aufirst%3DE.%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DBelmont%26aufirst%3DL.%26aulast%3DKoeppen%26aufirst%3DH.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DAXL%2520inhibition%2520sensitizes%2520mesenchymal%2520cancer%2520cells%2520to%2520antimitotic%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D20%26spage%3D5878%26epage%3D5890%26doi%3D10.1158%2F0008-5472.CAN-14-1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Alfonso, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. J.</span></span> <span> </span><span class="NLM_article-title">AXL receptor tyrosine kinase expression in breast cancer</span>. <i>J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1136/jclinpath-2013-202161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1136%2Fjclinpath-2013-202161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=24904064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOqu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=690-696&author=T.+M.+D%E2%80%99Alfonsoauthor=J.+Hannahauthor=Z.+Chenauthor=Y.+Liuauthor=P.+Zhouauthor=S.+J.+Shin&title=AXL+receptor+tyrosine+kinase+expression+in+breast+cancer&doi=10.1136%2Fjclinpath-2013-202161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Axl receptor tyrosine kinase expression in breast cancer</span></div><div class="casAuthors">D'Alfonso, Timothy M.; Hannah, Jeffrey; Chen, Zhengming; Liu, Yifang; Zhou, Pengbo; Shin, Sandra J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">690-696</span>CODEN:
                <span class="NLM_cas:coden">JCPAAK</span>;
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Aims Triple-neg. breast cancer comprises a clin. aggressive group of invasive carcinomas.  We examd. a published gene expression screen of a panel of breast cancer cell lines to identify a potential triple-neg. breast cancer-specific gene signature, and attempted to verify our findings by performing immunohistochem. anal. on tissue microarrays contg. a large cohort of invasive breast carcinomas.  Methods The microarray dataset for a panel of human breast cancer cell lines was interrogated for triple-neg. breast cancer-specific genes.  Membranous immunohistochem. expression of the protein product of the AXL gene was assessed semiquant. in 569 invasive breast carcinomas grouped according to mol. subgroup by immunohistochem.  Results AXL was significantly upregulated in triple-neg./basal B cell lines compared with luminal or basal A cell lines.  No significant difference was obsd. in the level of immunohistochem. expression of Axl protein between triple-neg. breast cancers and other mol. subgroups (p=0.257).  Axl expression was significantly assocd. with lymphovascular invasion (LVI) in all subgroups combined (p=0.033), and within the luminal A (p=0.002) and triple-neg. breast cancer subgroups (p=0.026).  Conclusions Despite preferential upregulation of AXL in triple-neg./basal B cell lines, anal. of Axl protein expression in a large series of patients' breast tumors revealed no assocn. between Axl expression and triple-neg. breast cancer or other subtype.  The assocn. of Axl expression with LVI supports previous work that implicates Axl as a promoter of invasiveness in breast cancer cell lines.  Further studies are necessary to explore whether Axl expression of individual breast cancer tumors can be clin. useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcgtaivOWrLVg90H21EOLACvtfcHk0lhoWuSIMkoo0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOqu77E&md5=f856dcd153719c4f00c0d660d8bd85a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fjclinpath-2013-202161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjclinpath-2013-202161%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Alfonso%26aufirst%3DT.%2BM.%26aulast%3DHannah%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DShin%26aufirst%3DS.%2BJ.%26atitle%3DAXL%2520receptor%2520tyrosine%2520kinase%2520expression%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D2014%26volume%3D67%26spage%3D690%26epage%3D696%26doi%3D10.1136%2Fjclinpath-2013-202161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Phyllodes tumor of the breast: role of AXL and ST6GalNAcII in the development of mammary phyllodes tumors</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">9603</span>– <span class="NLM_lpage">9612</span>, <span class="refDoi"> DOI: 10.1007/s13277-014-2254-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1007%2Fs13277-014-2254-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=9603-9612&author=D.+Renauthor=Y.+Liauthor=Y.+Gongauthor=J.+Xuauthor=X.+Miaoauthor=X.+Liauthor=C.+Liuauthor=L.+Jiaauthor=Y.+Zhao&title=Phyllodes+tumor+of+the+breast%3A+role+of+AXL+and+ST6GalNAcII+in+the+development+of+mammary+phyllodes+tumors&doi=10.1007%2Fs13277-014-2254-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors</span></div><div class="casAuthors">Ren, Dongliang; Li, Yanyan; Gong, Yanxin; Xu, Jingchao; Miao, Xiaolong; Li, Xiangnan; Liu, Chen; Jia, Li; Zhao, Yongfu</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9603-9612</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Phyllodes tumor exhibits an aggressive growth.  The expression of many biol. markers has been explored to discriminate between different grades of phyllodes tumor and to predict their behavior.  The purpose of this study was to evaluate the implications of Axl and ST6GalNAcII in phyllodes tumors.  Real-time PCR, Western blot, and immunohistochem. were used to analyze differential expression of ST6GalNAcII and Axl in phyllodes tumor (PT) cell lines and tissue specimens.  RNAi assay, ECM invasion assay, and tumorigenicity assay were used to analyze the altered expression of ST6GalNAcII gene effects on the expression of Axl and invasive ability of phyllodes tumor cells in vitro and in vivo.  Compared to benign tumors, borderline and malignant ones showed a remarkable increase in mRNA levels of Axl and ST6GalNAcII gene, and it was higher in malignant tumor cells than in borderline tumor cells.  When ST6GalNAcII was silenced, compared to the control, the expression level of Axl was significantly reduced in malignant tumor cell transfectants and knockdown of ST6GalNAcII gene significantly inhibited invasive activity in malignant tumor cells.  The high expression of ST6GalNAcII and Axl was significantly correlated with tumor grade and distance metastasis by immunohistochem. anal.  Axl and ST6GalNAcII expression increases with increasing tumor grade in mammary phyllodes tumors.  ST6GalNAc II might be participated in the glycosylation of Axl, and this Axl glycosylation may mediate the tumorigenicity, invasion, and distant metastasis of PT cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUbERBhcisv7Vg90H21EOLACvtfcHk0lhZlRWouSqwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCisL7E&md5=d1178b243429dbef0eb1c241622baef5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs13277-014-2254-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-014-2254-9%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DPhyllodes%2520tumor%2520of%2520the%2520breast%253A%2520role%2520of%2520AXL%2520and%2520ST6GalNAcII%2520in%2520the%2520development%2520of%2520mammary%2520phyllodes%2520tumors%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D9603%26epage%3D9612%26doi%3D10.1007%2Fs13277-014-2254-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pénzes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Őrfi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torka, R.</span></span> <span> </span><span class="NLM_article-title">Combined inhibition of AXL, LYN and p130Cas kinases block migration of triple negative breast cancer cells</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1571</span>– <span class="NLM_lpage">1582</span>, <span class="refDoi"> DOI: 10.4161/15384047.2014.956634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.4161%2F15384047.2014.956634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=25482942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1CitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1571-1582&issue=11&author=K.+P%C3%A9nzesauthor=C.+Baumannauthor=I.+Szabadkaiauthor=L.+%C5%90rfiauthor=G.+K%C3%A9riauthor=A.+Ullrichauthor=R.+Torka&title=Combined+inhibition+of+AXL%2C+LYN+and+p130Cas+kinases+block+migration+of+triple+negative+breast+cancer+cells&doi=10.4161%2F15384047.2014.956634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells</span></div><div class="casAuthors">Penzes, Kinga; Baumann, Christine; Szabadkai, Istvan; Orfi, Laszlo; Keri, Gyoergy; Ullrich, Axel; Torka, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1571-1582</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Blocking the migration of metastatic cancer cells is a major goal in the therapy of cancer.  The receptor tyrosine kinase AXL is one of the main triggers for cancer cell migration in neoplasia of breast, colon, skin, thyroid and prostate.  In our study we analyzed the effect of AXL inhibition on cell motility and viability in triple neg. breast cancer cell lines overexpressing AXL.  Thereby we reveal that the compd. BMS777607, exhibiting the lowest IC50 values for inhibition of AXL kinase activity in the studied cell lines, attenuates cell motility to a lower extent than the kinase inhibitors MPCD84111 and SKI606.  By analyzing the target kinases of MPCD84111 and SKI606 with kinase profiling assays we identified Lyn, a Src family kinase, as a target of both compds.  Knockdown of Lyn and the migration-related CRK-assocd. substrate (p130Cas), had a significant inhibitory effect on cell migration.  Taken together, our findings highlight the importance of combinatorial or multikinase inhibition of non-receptor tyrosine kinases and AXL receptor tyrosine kinase in the therapy of triple neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhT0VlhaQCZLVg90H21EOLACvtfcHk0lhZlRWouSqwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1CitbY%253D&md5=1e1de8bb8ab9a08df42ce9dbb061bee5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2F15384047.2014.956634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F15384047.2014.956634%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9nzes%26aufirst%3DK.%26aulast%3DBaumann%26aufirst%3DC.%26aulast%3DSzabadkai%26aufirst%3DI.%26aulast%3D%25C5%2590rfi%26aufirst%3DL.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DTorka%26aufirst%3DR.%26atitle%3DCombined%2520inhibition%2520of%2520AXL%252C%2520LYN%2520and%2520p130Cas%2520kinases%2520block%2520migration%2520of%2520triple%2520negative%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2014%26volume%3D15%26issue%3D11%26spage%3D1571%26epage%3D1582%26doi%3D10.4161%2F15384047.2014.956634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uribe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandell, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothlin, C. V.</span></span> <span> </span><span class="NLM_article-title">The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">e0179979</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0179979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1371%2Fjournal.pone.0179979" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0179979&issue=7&author=D.+J.+Uribeauthor=E.+K.+Mandellauthor=A.+Watsonauthor=J.+D.+Martinezauthor=J.+A.+Leightonauthor=S.+Ghoshauthor=C.+V.+Rothlin&title=The+receptor+tyrosine+kinase+AXL+promotes+migration+and+invasion+in+colorectal+cancer&doi=10.1371%2Fjournal.pone.0179979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0179979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0179979%26sid%3Dliteratum%253Aachs%26aulast%3DUribe%26aufirst%3DD.%2BJ.%26aulast%3DMandell%26aufirst%3DE.%2BK.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DJ.%2BD.%26aulast%3DLeighton%26aufirst%3DJ.%2BA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DRothlin%26aufirst%3DC.%2BV.%26atitle%3DThe%2520receptor%2520tyrosine%2520kinase%2520AXL%2520promotes%2520migration%2520and%2520invasion%2520in%2520colorectal%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D7%26spage%3De0179979%26doi%3D10.1371%2Fjournal.pone.0179979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leconet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chentouf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Manoir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirvent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aït-Arsa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarlier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radosevic-Robin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalbos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquet, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pèlegrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbouret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, B.</span></span> <span> </span><span class="NLM_article-title">Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasis</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2816</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1158%2F1078-0432.CCR-16-1316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=27923843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Sms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=2806-2816&issue=11&author=W.+Leconetauthor=M.+Chentoufauthor=S.+du+Manoirauthor=C.+Chevalierauthor=A.+Sirventauthor=I.+A%C3%AFt-Arsaauthor=M.+Bussonauthor=M.+Jarlierauthor=N.+Radosevic-Robinauthor=C.+Theilletauthor=D.+Chalbosauthor=J.+M.+Pasquetauthor=A.+P%C3%A8legrinauthor=C.+Larbouretauthor=B.+Robert&title=Therapeutic+activity+of+anti-AXL+antibody+against+triple-negative+breast+cancer+patient-derived+xenografts+and+metastasis&doi=10.1158%2F1078-0432.CCR-16-1316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis</span></div><div class="casAuthors">Leconet, Wilhem; Chentouf, Myriam; du Manoir, Stanislas; Chevalier, Clement; Sirvent, Audrey; Ait-Arsa, Imade; Busson, Muriel; Jarlier, Marta; Radosevic-Robin, Nina; Theillet, Charles; Chalbos, Dany; Pasquet, Jean-Max; Pelegrin, Andre; Larbouret, Christel; Robert, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2806-2816</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: AXL receptor tyrosine kinase has been described as a relevant mol. marker and a key player in invasiveness, esp. in triple-neg. breast cancer (TNBC).  Exptl. Design: We evaluate the antitumor efficacy of the anti-AXL monoclonal antibody 20G7-D9 in several TNBC cell xenografts or patient-derived xenograft (PDX) models and decipher the underlying mechanisms.  In a dataset of 254 basal-like breast cancer samples, genes correlated with AXL expression are enriched in EMT, migration, and invasion signaling pathways.  Results: Treatment with 20G7-D9 inhibited tumor growth and bone metastasis formation in AXL-pos. TNBC cell xenografts or PDX, but not in AXL-neg. PDX, highlighting AXL role in cancer growth and invasion.  In vitro stimulation of AXL-pos. cancer cells by its ligand GAS6 induced the expression of several EMT-assocd. genes (SNAIL, SLUG, and VIM) through an intracellular signaling implicating the transcription factor FRA-1, important in cell invasion and plasticity, and increased their migration/invasion capacity.  20G7-D9 induced AXL degrdn. and inhibited all AXL/GAS6-dependent cell signaling implicated in EMT and in cell migration/invasion.  Conclusions: The anti-AXL antibody 20G7-D9 represents a promising therapeutic strategy in TNBC with mesenchymal features by inhibiting AXL-dependent EMT, tumor growth, and metastasis formation.  Clin Cancer Res; 23(11); 2806-16. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryhj78vnIErLVg90H21EOLACvtfcHk0lhZlRWouSqwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Sms7w%253D&md5=7acbd854a7b2ad9ea8cf02a73d8ba7c7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1316%26sid%3Dliteratum%253Aachs%26aulast%3DLeconet%26aufirst%3DW.%26aulast%3DChentouf%26aufirst%3DM.%26aulast%3Ddu%2BManoir%26aufirst%3DS.%26aulast%3DChevalier%26aufirst%3DC.%26aulast%3DSirvent%26aufirst%3DA.%26aulast%3DA%25C3%25AFt-Arsa%26aufirst%3DI.%26aulast%3DBusson%26aufirst%3DM.%26aulast%3DJarlier%26aufirst%3DM.%26aulast%3DRadosevic-Robin%26aufirst%3DN.%26aulast%3DTheillet%26aufirst%3DC.%26aulast%3DChalbos%26aufirst%3DD.%26aulast%3DPasquet%26aufirst%3DJ.%2BM.%26aulast%3DP%25C3%25A8legrin%26aufirst%3DA.%26aulast%3DLarbouret%26aufirst%3DC.%26aulast%3DRobert%26aufirst%3DB.%26atitle%3DTherapeutic%2520activity%2520of%2520anti-AXL%2520antibody%2520against%2520triple-negative%2520breast%2520cancer%2520patient-derived%2520xenografts%2520and%2520metastasis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26issue%3D11%26spage%3D2806%26epage%3D2816%26doi%3D10.1158%2F1078-0432.CCR-16-1316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerchia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camorani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rienzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stasio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insabato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Franciscis, V.</span></span> <span> </span><span class="NLM_article-title">Targeting Axl with an high-affinity inhibitory aptamer</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2291</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1038/mt.2012.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fmt.2012.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=22910292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1akt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2291-2303&issue=12&author=L.+Cerchiaauthor=C.+L.+Espositoauthor=S.+Camoraniauthor=A.+Rienzoauthor=L.+Stasioauthor=L.+Insabatoauthor=A.+Affusoauthor=V.+de+Franciscis&title=Targeting+Axl+with+an+high-affinity+inhibitory+aptamer&doi=10.1038%2Fmt.2012.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Axl With an High-affinity Inhibitory Aptamer</span></div><div class="casAuthors">Cerchia, Laura; Esposito, Carla L.; Camorani, Simona; Rienzo, Anna; Stasio, Loredana; Insabato, Luigi; Affuso, Andrea; de Franciscis, Vittorio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2291-2303</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Axl is a tyrosine kinase receptor that was first identified as a transforming gene in human myeloid leukemia.  Recent converging evidence suggests its implication in cancer progression and invasion for several solid tumors, including lung, breast, brain, thyroid, and pancreas.  In the last decade, Axl has thus become an attractive target for therapeutic development of more aggressive cancers.  An emerging class of therapeutic inhibitors is now represented by short nucleic acid aptamers.  These mols. act as high affinity ligands with several advantages over conventional antibodies for their use in vivo, including their small size and negligible immunogenicity.  Furthermore, these mols. can easily form conjugates able to drive the specific delivery of interfering RNAs, nanoparticles, or chemotherapeutics.  We have thus generated and characterized a selective RNA-based aptamer, GL21.  T that binds the extracellular domain of Axl at high affinity (12 nmol/l) and inhibits its catalytic activity.  GL21.  T blocked Axl-dependent transducing events in vitro, including Erk and Akt phosphorylation, cell migration and invasion, as well as in vivo lung tumor formation in mice xenografts.  In this respect, the GL21.  T aptamer represents a promising therapeutic mol. for Axl-dependent cancers whose importance is highlighted by the paucity of available Axl-specific inhibitory mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre_yrVIQ8jRbVg90H21EOLACvtfcHk0lggJDg2AYGcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1akt7%252FJ&md5=6c48a764272ab123bf1db79ca0de744b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fmt.2012.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2012.163%26sid%3Dliteratum%253Aachs%26aulast%3DCerchia%26aufirst%3DL.%26aulast%3DEsposito%26aufirst%3DC.%2BL.%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DRienzo%26aufirst%3DA.%26aulast%3DStasio%26aufirst%3DL.%26aulast%3DInsabato%26aufirst%3DL.%26aulast%3DAffuso%26aufirst%3DA.%26aulast%3Dde%2BFranciscis%26aufirst%3DV.%26atitle%3DTargeting%2520Axl%2520with%2520an%2520high-affinity%2520inhibitory%2520aptamer%26jtitle%3DMol.%2520Ther.%26date%3D2012%26volume%3D20%26issue%3D12%26spage%3D2291%26epage%3D2303%26doi%3D10.1038%2Fmt.2012.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paolino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choidas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pranjic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uribesalgo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langdon, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fededa, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz-Fademrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickhoff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menninger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinterleitner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebl, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span> <span> </span><span class="NLM_article-title">The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>507</i></span> (<span class="NLM_issue">7493</span>),  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1038/nature12998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnature12998" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2014&pages=508-512&issue=7493&author=M.+Paolinoauthor=A.+Choidasauthor=S.+Wallnerauthor=B.+Pranjicauthor=I.+Uribesalgoauthor=S.+Loeserauthor=A.+M.+Jamiesonauthor=W.+Y.+Langdonauthor=F.+Ikedaauthor=J.+P.+Fededaauthor=S.+J.+Croninauthor=R.+Nitschauthor=C.+Schultz-Fademrechtauthor=J.+Eickhoffauthor=S.+Menningerauthor=A.+Ungerauthor=R.+Torkaauthor=T.+Gruberauthor=R.+Hinterleitnerauthor=G.+Baierauthor=D.+Wolfauthor=A.+Ullrichauthor=B.+M.+Kleblauthor=J.+M.+Penninger&title=The+E3+ligase+Cbl-b+and+TAM+receptors+regulate+cancer+metastasis+via+natural+killer+cells&doi=10.1038%2Fnature12998"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature12998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12998%26sid%3Dliteratum%253Aachs%26aulast%3DPaolino%26aufirst%3DM.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DWallner%26aufirst%3DS.%26aulast%3DPranjic%26aufirst%3DB.%26aulast%3DUribesalgo%26aufirst%3DI.%26aulast%3DLoeser%26aufirst%3DS.%26aulast%3DJamieson%26aufirst%3DA.%2BM.%26aulast%3DLangdon%26aufirst%3DW.%2BY.%26aulast%3DIkeda%26aufirst%3DF.%26aulast%3DFededa%26aufirst%3DJ.%2BP.%26aulast%3DCronin%26aufirst%3DS.%2BJ.%26aulast%3DNitsch%26aufirst%3DR.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DEickhoff%26aufirst%3DJ.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DUnger%26aufirst%3DA.%26aulast%3DTorka%26aufirst%3DR.%26aulast%3DGruber%26aufirst%3DT.%26aulast%3DHinterleitner%26aufirst%3DR.%26aulast%3DBaier%26aufirst%3DG.%26aulast%3DWolf%26aufirst%3DD.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DKlebl%26aufirst%3DB.%2BM.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520E3%2520ligase%2520Cbl-b%2520and%2520TAM%2520receptors%2520regulate%2520cancer%2520metastasis%2520via%2520natural%2520killer%2520cells%26jtitle%3DNature%26date%3D2014%26volume%3D507%26issue%3D7493%26spage%3D508%26epage%3D512%26doi%3D10.1038%2Fnature12998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bairlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greff, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daub, H.</span></span> <span> </span><span class="NLM_article-title">Proteomics strategy for quantitative protein interaction profiling in cell extracts</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1038/nmeth.1373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnmeth.1373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=19749761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaju73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=741-744&issue=10&author=K.+Sharmaauthor=C.+Weberauthor=M.+Bairleinauthor=Z.+Greffauthor=G.+K%C3%A9riauthor=J.+Coxauthor=J.+V.+Olsenauthor=H.+Daub&title=Proteomics+strategy+for+quantitative+protein+interaction+profiling+in+cell+extracts&doi=10.1038%2Fnmeth.1373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomics strategy for quantitative protein interaction profiling in cell extracts</span></div><div class="casAuthors">Sharma, Kirti; Weber, Christoph; Bairlein, Michaela; Greff, Zoltan; Keri, Gyoergy; Cox, Juergen; Olsen, Jesper V.; Daub, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">741-744</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors report a proteomics strategy to both identify and quantify cellular target protein interactions with externally introduced ligands.  The authors detd. dissocn. consts. for target proteins interacting with the ligand of interest by combining quant. mass spectrometry with a defined set of affinity purifn. expts.  The authors demonstrate the general utility of this methodol. in interaction studies involving small-mol. kinase inhibitors, a tyrosine-phosphorylated peptide and an antibody as affinity ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9I5plLFxQRbVg90H21EOLACvtfcHk0lggJDg2AYGcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaju73O&md5=78732562cac1cc2af0938f5536134098</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.1373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.1373%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DBairlein%26aufirst%3DM.%26aulast%3DGreff%26aufirst%3DZ.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DDaub%26aufirst%3DH.%26atitle%3DProteomics%2520strategy%2520for%2520quantitative%2520protein%2520interaction%2520profiling%2520in%2520cell%2520extracts%26jtitle%3DNat.%2520Methods%26date%3D2009%26volume%3D6%26issue%3D10%26spage%3D741%26epage%3D744%26doi%3D10.1038%2Fnmeth.1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delehouzé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyère, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oumata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roumeliotis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannopoulou, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twitchell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galibert, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbis, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">5675</span>– <span class="NLM_lpage">5687</span>, <span class="refDoi"> DOI: 10.1038/onc.2013.513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fonc.2013.513" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=5675-5687&issue=50&author=C.+Delehouz%C3%A9author=K.+Godlauthor=N.+Loa%C3%ABcauthor=C.+Bruy%C3%A8reauthor=N.+Desbanauthor=N.+Oumataauthor=H.+Galonsauthor=T.+Roumeliotisauthor=E.+G.+Giannopoulouauthor=J.+Grenetauthor=D.+Twitchellauthor=J.+Lahtiauthor=N.+Mouchetauthor=M.+D.+Galibertauthor=S.+D.+Garbisauthor=L.+Meijer&title=CDK%2FCK1+inhibitors+roscovitine+and+CR8+downregulate+amplified+MYCN+in+neuroblastoma+cells&doi=10.1038%2Fonc.2013.513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.513%26sid%3Dliteratum%253Aachs%26aulast%3DDelehouz%25C3%25A9%26aufirst%3DC.%26aulast%3DGodl%26aufirst%3DK.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DDesban%26aufirst%3DN.%26aulast%3DOumata%26aufirst%3DN.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DRoumeliotis%26aufirst%3DT.%26aulast%3DGiannopoulou%26aufirst%3DE.%2BG.%26aulast%3DGrenet%26aufirst%3DJ.%26aulast%3DTwitchell%26aufirst%3DD.%26aulast%3DLahti%26aufirst%3DJ.%26aulast%3DMouchet%26aufirst%3DN.%26aulast%3DGalibert%26aufirst%3DM.%2BD.%26aulast%3DGarbis%26aufirst%3DS.%2BD.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DCDK%252FCK1%2520inhibitors%2520roscovitine%2520and%2520CR8%2520downregulate%2520amplified%2520MYCN%2520in%2520neuroblastoma%2520cells%26jtitle%3DOncogene%26date%3D2014%26volume%3D33%26issue%3D50%26spage%3D5675%26epage%3D5687%26doi%3D10.1038%2Fonc.2013.513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lélias, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lgNgovhwhpCww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faraoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhUDTOUbB131Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00672">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88418"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00672">10.1021/acs.jmedchem.8b00672</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed synthesis procedures and characterization data for all compounds, 1D and correlation NMR spectra for the selected compounds (<b>18d</b>, <b>19e</b>, <b>19h</b>, <b>19i</b>, <b>20b</b>, <b>20g</b>, <b>21f</b>), DiscoveRx Kinomescan kinase selectivity panel (442 kinases) at 5 μM concentration for <b>20b</b> and <b>20g</b> (Tables S1 and S2), and complete lists of all kinases that bound to the KinAffinity matrix and of all identified target kinases (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound characterization checklist (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_002.xls">XLS</a>)</p></li><li><p class="inline">Molecular formula strings and AXL IC<sub>50</sub>values (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_001.pdf">jm8b00672_si_001.pdf (3.93 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_002.xls">jm8b00672_si_002.xls (121.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00672/suppl_file/jm8b00672_si_003.csv">jm8b00672_si_003.csv (5.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00672&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00672" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00672" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ab080abe43de3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
